data_2k17_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k17 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.513 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . 0.422 ' CD1' HG21 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.464 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.469 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.507 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.57 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt . . . . . 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.594 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.541 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 44.6 m-80 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . 0.453 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 26.0 t-20 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 880' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.753 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.753 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 893' ' ' HIS . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.518 0.675 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.415 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.711 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.521 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . 0.415 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.467 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m . . . . . 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . 0.526 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.427 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.405 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.503 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.777 0.322 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.467 HG13 HE21 ' A' ' 866' ' ' GLN . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.415 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 24.0 m-80 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.467 HE21 HG13 ' A' ' 858' ' ' VAL . 60.4 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.414 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.426 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.402 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.634 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.576 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 893' ' ' HIS . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.414 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 45.1 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.426 HG12 HE21 ' A' ' 866' ' ' GLN . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.5 m-80 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.426 HE21 HG12 ' A' ' 858' ' ' VAL . 56.3 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 13.6 m120 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.46 ' HG2' ' CD2' ' A' ' 893' ' ' HIS . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' HE21 ' A' ' 908' ' ' GLN . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 50.8 m80 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.591 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.591 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . 0.493 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 886' ' ' ASP . 50.5 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.535 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt . . . . . 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 . . . . . 0 C--O 1.215 -0.715 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 38.8 m-80 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 880' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.737 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . 0.474 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.7 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.414 -2.226 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.442 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 46.5 m-80 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 893' ' ' HIS . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt . . . . . 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.423 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . 0.431 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.4 tt0 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.453 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.431 ' HG3' ' NE2' ' P' ' 5' ' ' GLN . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 914' ' ' CYS . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.423 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.738 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.738 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt . . . . . 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.45 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 3' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p . . . . . 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.461 HG11 HE21 ' A' ' 866' ' ' GLN . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.516 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.7 m-80 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.461 HE21 HG11 ' A' ' 858' ' ' VAL . 59.7 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.472 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.472 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.519 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.54 ' HA ' HE21 ' A' ' 908' ' ' GLN . 0.0 OUTLIER -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.454 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.431 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.0 m . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.537 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.404 ' HB2' ' HB1' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 910' ' ' PHE . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.283 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 . . . . . 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.413 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.506 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.692 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.576 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.448 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 14.4 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.454 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . 0.408 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.494 HG12 HE21 ' A' ' 866' ' ' GLN . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.494 HE21 HG12 ' A' ' 858' ' ' VAL . 54.3 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 880' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.408 ' HG3' ' NE2' ' P' ' 5' ' ' GLN . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.538 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.217 -0.653 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.538 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.544 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . 0.467 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 907' ' ' MET . . . . . 0.467 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 3' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p . . . . . 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . 0.4 ' CD1' ' HD1' ' A' ' 891' ' ' TRP . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . 0.4 ' HD1' ' CD1' ' A' ' 868' ' ' TRP . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.544 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.418 ' HB2' ' HB1' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.496 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.303 0.573 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.432 HG13 HE21 ' A' ' 866' ' ' GLN . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.462 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 31.2 m-80 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.432 HE21 HG13 ' A' ' 858' ' ' VAL . 45.1 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.644 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . 0.417 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.618 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.618 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 907' ' ' MET . . . . . 0.46 ' HA ' ' HE3' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.644 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.529 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.455 ' HZ3' ' CG ' ' A' ' 887' ' ' ASP . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 3' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 882' ' ' MET . 8.3 p . . . . . 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . 0.422 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.5 tt0 . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m . . . . . 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.431 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.44 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.537 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 907' ' ' MET . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 907' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 906' ' ' GLU . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm . . . . . 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 908' ' ' GLN . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 3' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 95.0 m-85 . . . . . 0 N--CA 1.438 -1.046 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . 0.41 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . 0.41 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' P' ' 1' ' ' ALA . 18.2 mm-40 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . 0.457 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.01 0.909 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.406 HG12 HE21 ' A' ' 866' ' ' GLN . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 50.3 m-80 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.406 HE21 HG12 ' A' ' 858' ' ' VAL . 52.8 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . 0.615 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 882' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 893' ' ' HIS . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . 0.444 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . 0.682 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' P' P ' 2' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' P' P ' 6' ' ' THR . . . . . 0.505 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 858' ' ' VAL . . . . . 0.443 HG13 HE21 ' A' ' 866' ' ' GLN . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 863' ' ' TRP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 865' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 866' ' ' GLN . . . . . 0.443 HE21 HG13 ' A' ' 858' ' ' VAL . 55.0 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 869' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 870' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 873' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 876' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 879' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 883' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 885' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 886' ' ' ASP . . . . . 0.657 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 888' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 893' ' ' HIS . . . . . 0.652 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 894' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 896' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 893' ' ' HIS . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 3.3 p -114.26 127.95 56.12 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.595 HM12 ' OG1' ' P' ' 6' ' ' THR . . . . . . . . 0 C--N 1.308 -1.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.33 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -116.82 125.43 51.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.595 ' OG1' HM12 ' P' ' 4' ' ' M3L . 0.3 OUTLIER -79.4 75.88 5.99 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.98 140.52 52.25 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.65 0.738 . . . . 0.0 112.872 -171.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -99.14 -5.99 29.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.197 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -152.32 119.3 5.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 34.4 t -137.87 149.83 46.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 23.8 m -97.94 104.59 16.63 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.04 -63.6 2.79 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.441 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 50.2 m -75.95 -15.46 60.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.185 0.493 . . . . 0.0 111.399 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -69.67 99.05 1.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.104 0.954 . . . . 0.0 111.263 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.07 -73.95 0.61 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 178.97 89.04 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 124.155 0.982 . . . . 0.0 109.898 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 41.8 tpp -85.54 77.13 9.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.181 0.991 . . . . 0.0 108.446 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.53 -176.86 2.58 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.513 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 -87.96 64.92 8.06 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.422 HG21 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.422 ' CD1' HG21 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.464 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.469 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.507 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.57 ' O ' HG13 ' A' ' 918' ' ' ILE . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt -65.22 -43.88 95.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 82.25 -40.34 0.12 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.684 1.593 . . . . 0.0 112.23 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 920' ' ' LYS . 7.9 mtmp? 62.56 65.01 0.87 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.451 ' OD1' ' HG2' ' A' ' 923' ' ' LYS . 10.6 t70 -65.84 161.36 21.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.329 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.45 -37.81 88.83 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.511 0.725 . . . . 0.0 110.388 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.451 ' HG2' ' OD1' ' A' ' 921' ' ' ASP . 60.7 pttt -68.14 126.37 29.31 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.657 0.741 . . . . 0.0 110.864 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 C--N 1.29 -1.986 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.754 -178.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.594 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.6 p -124.4 139.32 54.01 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.48 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 CA--C 1.496 -1.134 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.229 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 144.15 46.8 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 166.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.414 ' OG1' HM21 ' P' ' 4' ' ' M3L . 0.5 OUTLIER -56.56 -66.01 0.51 Allowed 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -179.93 -87.51 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.914 0.885 . . . . 0.0 108.883 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -138.84 -51.62 0.56 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . 0.414 ' HD3' ' CA ' ' A' ' 879' ' ' GLY . 58.1 mtpt 63.92 20.18 12.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.395 1.093 . . . . 0.0 111.922 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 41.8 t -125.0 132.72 53.21 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -103.96 26.02 9.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.033 0.92 . . . . 0.0 109.405 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.37 -16.81 6.64 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.377 -0.916 . . . . 0.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.834 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 69.4 m -107.23 176.94 5.0 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 122.615 -0.344 . . . . 0.0 110.264 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -78.1 94.2 4.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.59 0.709 . . . . 0.0 110.287 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 853' ' ' MET . . . . . 0.411 ' HE3' ' ND2' ' A' ' 874' ' ' ASN . 77.8 mtp -105.69 -63.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.41 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 52.64 -96.61 0.05 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 52.8 mtm -149.41 161.04 42.88 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.11 90.63 0.09 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 125.485 1.514 . . . . 0.0 110.048 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.541 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 -107.9 11.32 28.1 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.981 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 44.6 m-80 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.453 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 26.0 t-20 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.414 ' CA ' ' HD3' ' P' ' 9' ' ' LYS . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 880' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.753 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.753 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 893' ' ' HIS . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.593 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt -91.48 -42.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -82.75 -31.98 28.09 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.942 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 54.75 28.5 10.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.971 0.908 . . . . 0.0 111.74 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 923' ' ' LYS . 0.6 OUTLIER 60.09 107.81 0.02 OUTLIER 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.125 0.97 . . . . 0.0 111.5 -172.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.65 -24.23 67.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.462 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 921' ' ' ASP . 61.9 mttp 75.19 119.67 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 125.328 1.451 . . . . 0.0 113.288 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.418 -2.053 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.863 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -118.19 134.13 55.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.745 HM31 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -164.13 138.03 5.47 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.444 ' O ' ' HG3' ' P' ' 9' ' ' LYS . 9.2 t -152.86 -40.31 0.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.78 -155.13 0.29 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -118.59 85.05 2.29 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' P' ' 6' ' ' THR . 67.8 mttm -70.62 135.27 48.3 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.431 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -67.12 -41.93 85.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -152.7 132.93 13.56 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.278 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.18 -41.89 3.88 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.662 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 6.4 p -94.93 175.24 6.72 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -66.55 -59.96 3.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.69 100.44 3.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.659 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.04 7.48 1.82 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.418 172.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 89.1 mtp 65.87 36.95 5.76 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.023 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 71.5 173.94 0.3 Allowed 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.792 1.637 . . . . 0.0 109.642 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -84.64 48.85 1.59 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.557 -0.714 . . . . 0.0 112.071 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.502 ' CZ3' HM23 ' P' ' 4' ' ' M3L . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.593 ' OD2' HM13 ' P' ' 4' ' ' M3L . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.745 ' SD ' HM31 ' P' ' 4' ' ' M3L . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.415 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.711 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.521 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . 0.415 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt -86.96 -42.71 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -76.09 -58.35 3.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.338 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 62.22 -176.41 0.13 Allowed 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.207 0.942 . . . . 0.0 111.64 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -147.47 125.29 11.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 70.42 174.73 0.3 Allowed 'General case' 0 C--O 1.246 0.873 0 O-C-N 124.28 0.988 . . . . 0.0 111.69 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -93.7 95.06 8.93 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.44 0.638 . . . . 0.0 109.903 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.423 -1.791 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.135 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p -121.96 127.31 50.2 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.458 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -142.73 115.86 8.89 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.467 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m -67.81 -31.24 70.97 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.08 151.06 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.201 . . . . 0.0 112.966 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -87.77 -3.69 58.93 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.969 -0.457 . . . . 0.0 110.579 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 63.46 28.89 15.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.692 0.797 . . . . 0.0 110.785 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -135.15 14.47 3.54 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.38 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m 67.17 92.52 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.668 0.747 . . . . 0.0 110.496 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.36 143.85 29.94 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.223 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.464 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.7 t -82.72 93.01 7.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.64 99.6 8.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -90.88 155.74 18.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.128 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -79.51 95.99 5.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -146.01 19.29 1.43 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.489 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 67.72 -158.99 0.22 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.407 1.083 . . . . 0.0 109.556 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.34 7.32 19.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.526 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.405 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.426 ' SD ' HM32 ' P' ' 4' ' ' M3L . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.503 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.34 -33.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -83.75 -16.4 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.14 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -66.83 -32.32 73.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.3 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.37 -45.88 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.52 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 64.8 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.878 0.871 . . . . 0.0 112.967 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -86.7 172.25 10.33 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 74.4 t60 . . . . . 0 C--N 1.291 -1.953 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.6 p -123.66 133.42 53.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.604 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -114.26 127.82 56.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.228 0.33 . . . . 0.0 110.326 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.511 ' OG1' HM21 ' P' ' 4' ' ' M3L . 0.2 OUTLIER -92.56 37.22 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.18 10.72 23.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.425 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 67.45 5.36 4.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.498 1.119 . . . . 0.0 110.864 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -92.02 92.08 8.13 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.8 p -121.11 157.09 30.87 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.255 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -91.7 -74.39 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.78 11.58 10.17 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 105.411 -3.076 . . . . 0.0 105.411 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.766 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.3 m -83.38 174.07 10.99 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -88.1 68.94 9.23 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.687 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 96.1 mmm -65.04 -45.0 87.24 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -93.64 101.08 13.23 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.6 ptp -105.01 9.7 34.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.903 0.859 . . . . 0.0 109.863 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -83.84 148.2 27.12 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -95.35 19.61 10.54 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.467 HG13 HE21 ' A' ' 866' ' ' GLN . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.415 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 24.0 m-80 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.467 HE21 HG13 ' A' ' 858' ' ' VAL . 60.4 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.414 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.426 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.604 ' SD ' HM12 ' P' ' 4' ' ' M3L . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.402 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.634 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.576 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 893' ' ' HIS . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.414 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 45.1 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.411 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt -67.65 -43.65 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -76.17 -7.68 55.34 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.339 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 916' ' ' ASN . 62.4 mtpt -85.83 4.38 37.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.682 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.49 -5.73 59.31 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . 0.309 47.0 tptt 89.43 92.27 0.02 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 127.409 2.284 . . . . 0.0 112.736 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -92.31 145.4 24.51 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.433 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.622 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -119.64 145.62 46.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.543 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.23 -58.69 0.15 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m 57.94 76.87 0.31 Allowed 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.91 81.86 3.47 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -122.76 6.59 9.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.301 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . 0.404 ' HE3' ' OD1' ' A' ' 878' ' ' ASP . 38.8 ttpt -156.98 -64.97 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m 69.39 151.95 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -82.47 -31.83 29.2 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.606 0.717 . . . . 0.0 109.183 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.67 -36.46 0.02 OUTLIER Glycine 0 CA--C 1.491 -1.448 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.087 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 176.002 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -73.78 109.39 7.26 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -74.53 104.96 5.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 853' ' ' MET . . . . . 0.451 ' SD ' ' HE2' ' A' ' 855' ' ' MET . 27.1 ttt -68.92 119.37 13.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.39 0.23 Allowed 'General case' 0 C--N 1.317 -0.806 0 O-C-N 123.757 0.66 . . . . 0.0 111.849 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 855' ' ' MET . . . . . 0.451 ' HE2' ' SD ' ' A' ' 853' ' ' MET . 59.2 mtt -141.72 116.53 9.81 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.928 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.54 136.35 42.14 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.15 -3.42 52.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.426 HG12 HE21 ' A' ' 866' ' ' GLN . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.52 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.5 m-80 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.426 HE21 HG12 ' A' ' 858' ' ' VAL . 56.3 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 13.6 m120 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . 0.404 ' OD1' ' HE3' ' P' ' 9' ' ' LYS . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.46 ' HG2' ' CD2' ' A' ' 893' ' ' HIS . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.441 ' HB3' HE21 ' A' ' 908' ' ' GLN . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.749 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 50.8 m80 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.591 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.749 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.591 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.493 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 886' ' ' ASP . 50.5 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.535 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt -62.51 -42.85 97.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -170.3 -45.74 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.442 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.277 23.4 pttp 49.79 77.92 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 122.531 1.158 . . . . 0.0 110.719 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.14 146.29 53.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.859 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -75.75 -14.98 60.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.896 0.379 . . . . 0.0 111.46 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -91.74 109.6 20.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.263 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -120.41 137.5 54.28 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.447 HM31 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -149.9 125.48 10.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m -69.23 -50.8 43.9 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -173.14 -171.24 0.71 Allowed 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -133.32 111.78 11.1 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.762 0.791 . . . . 0.0 111.455 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 114.89 18.25 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.983 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 t -131.18 123.42 28.47 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -89.8 -24.81 21.36 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.46 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.38 -59.35 3.03 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 178.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.713 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 33.5 p -119.79 25.07 10.22 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 120.963 0.411 . . . . 0.0 110.778 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.12 -38.05 78.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 90.8 mtp -79.29 118.21 20.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.044 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.39 -178.76 4.99 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.191 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 72.0 mtm -68.57 117.33 10.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -66.98 78.11 0.12 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 64.79 -39.87 0.26 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 127.406 2.282 . . . . 0.0 116.809 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 38.8 m-80 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.447 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 880' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.737 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . 0.474 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.7 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm -66.87 -45.52 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -89.19 -21.14 23.43 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.65 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 920' ' ' LYS 0.256 0.0 OUTLIER -64.62 121.38 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.223 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -100.48 -61.23 1.39 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 57.4 tttm 43.52 85.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.571 ' HG2' ' H ' ' A' ' 924' ' ' HIS 0.306 0.0 OUTLIER -170.27 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.855 1.262 . . . . 0.0 109.96 167.176 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . 0.571 ' H ' ' HG2' ' A' ' 923' ' ' LYS . 30.2 p80 . . . . . 0 C--N 1.282 -2.365 0 C-N-CA 128.324 2.65 . . . . 0.0 104.583 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p -124.09 130.37 52.45 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.69 HM21 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 N--CA 1.439 -1.006 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.071 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -146.18 149.72 34.5 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.442 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m -56.81 -46.05 81.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.58 100.26 5.69 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.72 -40.42 48.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt 68.37 29.43 5.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.919 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -85.54 -30.09 23.66 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.975 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 12.2 m -85.35 75.85 10.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.57 -169.97 35.73 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.757 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.236 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.77 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 13.9 p -74.48 -44.48 51.3 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.263 0.554 . . . . 0.0 110.679 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -103.15 87.93 3.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 17.1 tpt -97.93 -53.42 3.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 52.09 -159.15 0.12 Allowed 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.797 1.311 . . . . 0.0 112.266 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 28.3 ttt -143.02 86.39 1.92 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.44 0.85 Allowed 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.854 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -85.58 -7.8 58.65 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 46.5 m-80 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.442 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.69 ' SD ' HM21 ' P' ' 4' ' ' M3L . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.533 ' CH2' ' HG3' ' P' ' 4' ' ' M3L . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 893' ' ' HIS . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.568 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' MET . . . . . 0.45 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.519 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt -74.89 -31.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -98.65 78.89 2.4 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.155 0.978 . . . . 0.0 111.208 -173.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -136.48 18.41 3.12 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.395 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.31 100.89 0.11 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.929 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 57.88 26.87 13.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.061 0.944 . . . . 0.0 110.955 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -141.16 -179.01 5.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.906 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.423 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -113.37 134.59 54.55 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.512 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.416 -2.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . 0.431 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.4 tt0 -164.45 152.32 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m -135.06 80.32 1.83 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.42 -175.78 3.81 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.202 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.95 -47.89 70.82 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 124.449 1.1 . . . . 0.0 108.457 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -104.98 134.73 47.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.9 t 65.02 82.0 0.2 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.917 0.865 . . . . 0.0 109.429 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -95.72 -20.54 18.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.629 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.66 -143.93 6.56 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.817 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 32.2 t -162.41 137.39 6.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . 0.435 ' CE1' ' HB ' ' A' ' 858' ' ' VAL . 68.0 t60 -137.56 104.66 5.4 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.376 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 853' ' ' MET . . . . . 0.416 ' HA ' ' HE3' ' A' ' 853' ' ' MET . 3.7 tpt -147.4 34.46 0.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -117.53 144.78 44.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.895 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.49 88.7 4.45 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.38 -153.88 0.58 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.237 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.435 ' HB ' ' CE1' ' A' ' 852' ' ' HIS . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.489 ' CZ3' HM13 ' P' ' 4' ' ' M3L . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.455 ' SD ' HM23 ' P' ' 4' ' ' M3L . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.423 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.738 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.556 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.738 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.43 ' HB3' ' CB ' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt -63.47 -52.91 52.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 919' ' ' LYS . 36.8 ttmt 72.4 -38.29 0.41 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.952 1.701 . . . . 0.0 114.08 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 76.3 -26.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.958 1.303 . . . . 0.0 114.391 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.58 -45.24 94.97 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.3 17.83 10.78 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.657 1.183 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -141.99 107.76 5.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 23.6 t60 . . . . . 0 C--O 1.248 1.021 0 C-N-CA 124.906 1.282 . . . . 0.0 110.735 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.45 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 3' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p -108.17 141.56 39.73 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.571 HM13 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -128.09 -63.69 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.741 0.651 . . . . 0.0 110.018 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 10.7 m 62.68 50.37 3.48 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . -56.67 103.71 0.12 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.103 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 54.63 26.11 7.07 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 110.103 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp 63.68 18.99 11.48 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.612 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 52.7 p -156.53 -76.05 0.09 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.408 0.623 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t 172.09 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 126.383 1.873 . . . . 0.0 106.74 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.37 -133.44 11.66 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.1 m -89.45 118.38 29.06 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -148.56 153.33 38.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt -78.91 77.89 5.37 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.077 0.942 . . . . 0.0 109.557 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -104.42 86.02 2.45 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.586 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 94.4 mmm -128.64 28.48 5.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.8 175.19 0.29 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.268 1.427 . . . . 0.0 110.701 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 -103.22 -0.19 30.76 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.461 HG11 HE21 ' A' ' 866' ' ' GLN . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.516 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.7 m-80 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.461 HE21 HG11 ' A' ' 858' ' ' VAL . 59.7 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.406 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.536 ' OD2' HM23 ' P' ' 4' ' ' M3L . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.571 ' SD ' HM13 ' P' ' 4' ' ' M3L . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.519 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.54 ' HA ' HE21 ' A' ' 908' ' ' GLN . 0.0 OUTLIER -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.454 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -78.95 -59.18 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 62.14 -48.98 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.113 2.165 . . . . 0.0 113.547 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 72.02 98.99 0.07 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 124.999 1.319 . . . . 0.0 112.424 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.38 -165.07 1.27 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.87 103.11 8.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -85.87 97.29 10.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.856 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.644 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -103.75 119.88 39.82 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.495 HM12 ' OG1' ' P' ' 6' ' ' THR . . . . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.99 108.28 4.59 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.495 ' OG1' HM12 ' P' ' 4' ' ' M3L . 24.0 m -61.47 -48.66 80.1 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . 62.37 163.13 0.09 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.993 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.47 20.3 3.14 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -117.09 83.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.198 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -84.8 -60.77 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -101.95 -38.66 7.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 166.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.9 -44.4 0.28 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.068 -1.423 . . . . 0.0 109.612 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.767 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -69.92 -37.56 75.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.184 0.516 . . . . 0.0 109.645 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -84.77 121.7 28.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.307 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 ttt -78.18 -32.24 50.01 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -140.43 139.99 35.35 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 85.6 mtp -68.52 -28.88 67.38 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 122.538 1.161 . . . . 0.0 109.889 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.0 142.85 7.62 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 112.067 -2.333 . . . . 0.0 105.808 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.437 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 -85.46 61.88 7.13 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.437 ' CE3' HM23 ' P' ' 4' ' ' M3L . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.537 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.482 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.574 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.404 ' HB2' ' HB1' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt -94.87 -33.13 4.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 33.0 mmtp -82.19 -37.14 26.52 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.264 64.8 mttm 69.69 127.24 0.03 OUTLIER 'General case' 0 C--O 1.246 0.902 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -92.32 167.52 11.94 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.414 -1.721 . . . . 0.0 106.429 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -69.83 -79.49 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.475 0.58 . . . . 0.0 109.831 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -179.22 90.29 0.02 OUTLIER 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.087 0.946 . . . . 0.0 110.511 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.414 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p -128.06 143.38 51.07 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.567 HM31 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER -161.8 171.16 18.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 O-C-N 124.149 0.906 . . . . 0.0 111.283 177.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -105.53 -50.5 3.2 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.76 176.6 9.75 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.756 0.789 . . . . 0.0 111.159 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -139.42 121.46 15.69 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.98 90.02 4.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 110.38 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -83.35 119.82 25.1 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.02 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.1 m -109.85 36.72 2.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.67 -64.69 0.56 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.423 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 175.693 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 24.0 t -154.36 95.59 1.83 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -108.38 -67.73 0.95 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.9 mtp -119.3 14.0 12.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.018 0.914 . . . . 0.0 108.996 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -159.92 176.35 11.98 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -126.22 108.18 11.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.84 111.68 23.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 65.34 5.53 3.17 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.413 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.506 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.567 ' SD ' HM31 ' P' ' 4' ' ' M3L . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.448 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.692 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.576 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.448 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 14.4 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.454 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm -79.06 -48.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 919' ' ' LYS 0.334 0.2 OUTLIER -83.33 76.66 9.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.347 1.07 . . . . 0.0 112.906 -178.079 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.431 ' HZ1' ' HB2' ' A' ' 920' ' ' LYS . 0.1 OUTLIER -158.06 178.82 9.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 175.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 922' ' ' LYS . 10.7 t70 -91.16 -165.55 1.38 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.41 ' H ' ' CG ' ' A' ' 921' ' ' ASP . 75.9 mmtt -71.02 140.88 50.93 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -115.26 130.3 56.87 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.358 0.599 . . . . 0.0 112.196 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 176.699 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p -123.46 137.23 54.84 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.464 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . 0.408 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 -167.0 90.61 0.38 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 124.579 1.174 . . . . 0.0 107.968 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -75.96 -40.31 54.2 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.08 81.38 0.14 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.826 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -66.44 -32.3 73.59 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.054 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . 0.509 ' O ' ' HD2' ' P' ' 9' ' ' LYS . 0.1 OUTLIER -102.52 119.94 39.69 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 172.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.0 m -135.03 -7.54 2.34 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.384 0.612 . . . . 0.0 110.708 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 33.1 m -119.15 143.33 47.26 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.38 66.26 3.93 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.518 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 -176.377 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.574 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.7 m 63.81 -78.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.026 1.33 . . . . 0.0 113.485 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 65.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.0 109.511 -172.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.7 ttt -114.35 134.7 54.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.22 90.75 3.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 57.8 ttp -152.14 100.24 2.6 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.379 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -89.55 177.06 6.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -88.33 8.62 26.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.494 HG12 HE21 ' A' ' 866' ' ' GLN . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.494 HE21 HG12 ' A' ' 858' ' ' VAL . 54.3 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.402 ' CZ3' HM11 ' P' ' 4' ' ' M3L . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 880' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.421 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm -82.31 -19.69 10.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -115.62 172.99 6.77 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? 64.24 -32.48 0.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 922' ' ' LYS . 14.3 t70 70.81 -165.84 0.15 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 125.293 1.437 . . . . 0.0 107.829 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 921' ' ' ASP . 93.5 mttt -115.88 83.72 1.99 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -134.06 109.37 8.91 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.858 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 . . . . . 0 C--N 1.286 -2.172 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.934 175.036 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -113.67 114.81 26.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.541 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.81 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -156.78 142.46 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.538 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m -90.21 -57.93 2.68 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.99 -66.95 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 120.782 0.325 . . . . 0.0 111.591 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 64.8 mtm-85 -64.31 96.17 0.15 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.612 1.196 . . . . 0.0 114.04 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -93.31 161.83 14.24 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.397 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 37.6 m -88.0 111.35 21.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -120.31 125.05 47.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.505 0.669 . . . . 0.0 110.347 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.43 43.66 1.66 Allowed Glycine 0 CA--C 1.492 -1.377 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.501 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -177.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.8 m -123.6 149.29 45.51 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -73.88 -40.66 63.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt 69.02 3.85 4.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.358 1.463 . . . . 0.0 111.374 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -164.79 -175.42 3.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.8 mtm 52.23 73.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.916 0.76 . . . . 0.0 111.064 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.63 56.89 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 122.06 -0.4 . . . . 0.0 110.321 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -94.62 10.09 36.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.477 ' CZ3' HM32 ' P' ' 4' ' ' M3L . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.538 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.537 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.544 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.467 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' MET . . . . . 0.467 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm -59.55 -58.21 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.5 tttp 42.67 72.92 0.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.774 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.8 97.21 3.1 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.687 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 160.95 27.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.58 167.23 22.67 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.532 ' HB2' ' HZ1' ' A' ' 923' ' ' LYS . 0.0 OUTLIER -126.55 174.33 8.75 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 3' ' ' THR . . . . . 0.409 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p -113.32 143.21 44.83 Favored 'General case' 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.652 HM13 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -166.3 115.14 0.93 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -70.57 -51.79 26.05 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.02 -145.7 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 69.66 84.89 0.14 Allowed 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.963 1.305 . . . . 0.0 114.164 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -131.28 80.27 1.93 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -94.8 92.53 7.0 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.659 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -89.07 79.89 7.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.198 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.49 -38.44 0.59 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.836 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.687 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.621 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.697 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.9 t 71.07 145.93 0.07 Allowed 'General case' 0 C--O 1.249 1.047 0 C-N-CA 125.262 1.425 . . . . 0.0 110.871 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -98.52 -57.88 2.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.167 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp 49.92 75.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.115 0.966 . . . . 0.0 110.357 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -114.69 -67.93 0.96 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.06 0.933 . . . . 0.0 111.658 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.4 ptm -175.52 -154.96 0.05 OUTLIER 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.71 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -78.34 174.97 10.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -86.07 56.95 4.21 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.4 ' CD1' ' HD1' ' A' ' 891' ' ' TRP . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.652 ' SD ' HM13 ' P' ' 4' ' ' M3L . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.529 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.544 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.418 ' HB2' ' HB1' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.496 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -79.0 -23.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -114.09 -41.5 3.51 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.845 0.831 . . . . 0.0 110.808 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -132.98 -174.89 3.6 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.927 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.99 -56.13 2.22 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -170.94 -173.7 1.37 Allowed 'General case' 0 C--O 1.251 1.165 0 C-N-CA 124.163 0.985 . . . . 0.0 108.406 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 73.51 -177.6 0.18 Allowed 'General case' 0 C--O 1.253 1.283 0 C-N-CA 124.354 1.061 . . . . 0.0 109.952 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 34.9 p80 . . . . . 0 C--N 1.313 -1.01 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.414 178.528 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -107.84 128.45 54.62 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.648 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.289 -2.026 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -136.26 115.29 12.33 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -105.89 30.75 5.57 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.39 141.29 31.84 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.961 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -89.79 -17.75 27.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -130.29 115.34 16.8 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.701 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.5 m -74.36 100.82 3.88 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.82 92.92 6.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.228 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -41.89 6.12 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.903 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 177.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 63.21 81.25 0.21 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.917 1.287 . . . . 0.0 111.983 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 854' ' ' ALA . 31.3 p-80 -89.51 134.76 33.96 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.848 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 15.9 tpt -91.26 -11.99 36.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.659 0.742 . . . . 0.0 109.141 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . 0.412 ' O ' ' HD2' ' A' ' 852' ' ' HIS . . . -91.24 -168.67 2.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.119 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -140.29 167.06 23.02 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.33 -175.85 2.46 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 123.633 0.583 . . . . 0.0 110.287 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 69.33 6.68 5.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.138 0.975 . . . . 0.0 111.738 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.432 HG13 HE21 ' A' ' 866' ' ' GLN . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.462 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.462 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 31.2 m-80 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.432 HE21 HG13 ' A' ' 858' ' ' VAL . 45.1 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.648 ' SD ' HM12 ' P' ' 4' ' ' M3L . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.644 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.505 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . 0.417 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.758 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.618 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.618 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' MET . . . . . 0.46 ' HA ' ' HE3' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.644 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.529 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 920' ' ' LYS . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt -63.13 -29.81 48.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.19 19.13 20.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.406 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 917' ' ' LYS . 61.5 pttt -127.14 -14.31 5.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.728 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.29 -79.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 922' ' ' LYS . 0.0 OUTLIER -88.17 -6.68 57.72 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.508 0.671 . . . . 0.0 110.072 178.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -100.62 121.35 41.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.344 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.617 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 3' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 882' ' ' MET . 8.3 p -119.34 133.6 55.64 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.67 HM32 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.283 -2.318 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . 0.422 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.5 tt0 -149.75 111.91 4.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m -67.61 -30.28 69.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.36 -174.58 0.17 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.304 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' P' ' 8' ' ' ARG . 0.0 OUTLIER -122.6 81.71 1.89 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 177.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -79.33 100.5 7.61 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.971 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -71.25 99.39 1.91 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.902 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 43.9 m -83.62 102.44 12.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.774 0.797 . . . . 0.0 110.08 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.56 -91.46 0.1 OUTLIER Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.689 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.184 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.155 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.535 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 36.5 m -58.0 -23.3 53.52 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -62.93 -30.88 71.9 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 120.565 0.221 . . . . 0.0 110.828 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 mmt -111.5 18.59 18.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.53 0.681 . . . . 0.0 109.164 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.46 40.81 1.59 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.0 mtt -74.8 85.02 2.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.861 0.839 . . . . 0.0 111.756 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -126.96 175.03 8.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -102.05 3.68 38.99 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . 0.67 ' CZ3' HM32 ' P' ' 4' ' ' M3L . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.431 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . 0.416 ' CE2' HM33 ' P' ' 4' ' ' M3L . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.537 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . 0.48 ' HG3' HD11 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 907' ' ' MET . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 906' ' ' GLU . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm -90.73 -45.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 13.7 ptmm? -90.26 73.03 7.14 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.248 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -138.58 122.83 18.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.13 -41.02 59.32 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -92.48 138.51 31.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -86.17 126.66 34.4 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--N 1.32 -0.701 0 C-N-CA 125.32 1.448 . . . . 0.0 111.097 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 908' ' ' GLN . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 3' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p -115.61 145.12 42.98 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.548 HM13 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -135.61 113.85 11.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -102.78 63.95 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -34.42 19.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.898 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -162.16 -29.3 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.596 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 55.45 44.73 26.54 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.175 0.99 . . . . 0.0 112.296 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 m -68.37 -33.34 74.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -100.0 96.21 7.38 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.0 -76.61 0.25 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.493 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.094 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -81.56 -78.12 0.2 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.887 0.343 . . . . 0.0 111.893 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -81.11 -29.02 34.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.046 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 27.2 ptm -82.1 144.34 30.86 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.86 97.19 2.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.81 71.91 8.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.393 1.092 . . . . 0.0 110.769 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -131.74 107.25 8.66 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 95.0 m-85 -83.23 62.35 6.61 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . 0.41 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . 0.41 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.548 ' OD2' HM13 ' P' ' 4' ' ' M3L . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.698 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' P' ' 1' ' ' ALA . 18.2 mm-40 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt -72.93 -46.24 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -155.01 -57.19 0.1 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.684 -1.206 . . . . 0.0 114.03 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 70.55 99.47 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.54 -59.72 0.44 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.208 -0.997 . . . . 0.0 112.981 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.51 -71.26 0.54 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.63 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 64.42 81.59 0.2 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -171.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -124.09 117.1 23.91 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.46 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . 0.457 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 -163.9 103.84 0.9 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.47 38.9 1.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.21 -36.76 34.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.585 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 71.35 -62.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.344 1.058 . . . . 0.0 110.125 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -82.17 -48.15 11.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.7 m 69.64 -177.99 0.22 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.008 0.923 . . . . 0.0 109.521 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.5 p -73.52 -49.66 25.38 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.275 0.559 . . . . 0.0 110.258 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.46 -14.84 32.74 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.555 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.245 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.2 m -91.0 91.07 8.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.186 -0.596 . . . . 0.0 110.265 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -158.5 -174.2 4.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -80.92 136.63 36.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.014 0.435 . . . . 0.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -92.74 138.5 31.44 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -75.79 -33.43 60.15 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.209 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 23.55 -101.6 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.874 1.984 . . . . 0.0 113.653 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.39 34.69 3.71 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.133 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.406 HG12 HE21 ' A' ' 866' ' ' GLN . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 50.3 m-80 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.406 HE21 HG12 ' A' ' 858' ' ' VAL . 52.8 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.615 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.673 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 893' ' ' HIS . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . 0.444 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . 0.682 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.682 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt -76.35 -14.07 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.62 -0.25 57.08 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.944 0.878 . . . . 0.0 108.98 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.468 ' HB2' ' HZ3' ' A' ' 920' ' ' LYS . 10.2 mtmp? -91.21 117.75 29.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 64.6 -156.29 0.3 Allowed 'General case' 0 C--O 1.246 0.907 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 55.36 43.76 28.37 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -65.36 144.31 57.18 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.25 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--N 1.289 -2.049 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.684 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 2' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.19 123.03 20.05 Favored 'General case' 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 4' ' ' M3L . . . . . 0.538 HM12 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -111.4 112.81 24.82 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 6' ' ' THR . . . . . 0.505 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m -69.18 -11.16 60.56 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.95 98.53 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.542 1.137 . . . . 0.0 112.453 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -76.85 -14.68 59.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.186 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -104.91 148.96 26.12 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -118.2 88.69 2.97 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -161.46 18.72 0.11 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.632 0.73 . . . . 0.0 109.09 -176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.11 68.77 2.45 Favored Glycine 0 CA--C 1.503 -0.704 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.275 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.461 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 178.171 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 7.9 p -83.51 -26.73 29.93 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.8 m80 66.08 171.75 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.493 1.139 . . . . 0.0 112.509 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -145.42 113.96 6.74 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 71.39 157.49 0.18 Allowed 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.291 0.994 . . . . 0.0 109.325 -168.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 66.98 11.69 8.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.596 0.758 . . . . 0.0 112.229 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -112.08 -171.05 1.77 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -101.23 13.3 35.56 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 858' ' ' VAL . . . . . 0.443 HG13 HE21 ' A' ' 866' ' ' GLN . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 863' ' ' TRP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 865' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 866' ' ' GLN . . . . . 0.443 HE21 HG13 ' A' ' 858' ' ' VAL . 55.0 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 869' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 870' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 873' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 876' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 877' ' ' ASP . . . . . 0.538 ' OD2' HM12 ' P' ' 4' ' ' M3L . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 879' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 882' ' ' MET . . . . . 0.441 ' SD ' HM11 ' P' ' 4' ' ' M3L . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 883' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 885' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 886' ' ' ASP . . . . . 0.657 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 888' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 893' ' ' HIS . . . . . 0.652 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 894' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 896' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 893' ' ' HIS . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' CYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt -60.65 -41.79 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -97.05 -35.79 10.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.065 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 917' ' ' LYS . 29.6 mtmm 69.76 -47.8 0.61 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.891 1.677 . . . . 0.0 114.076 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -111.91 126.78 55.48 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.885 0.374 . . . . 0.0 110.33 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -115.77 99.41 7.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.743 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' LYS . . . . . 0.526 ' HG3' ' H ' ' A' ' 924' ' ' HIS 0.319 10.5 ptpp? 46.05 -106.72 0.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.061 1.344 . . . . 0.0 114.056 -178.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' HIS . . . . . 0.526 ' H ' ' HG3' ' A' ' 923' ' ' LYS . 22.6 t60 . . . . . 0 C--N 1.288 -2.107 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 905' ' ' GLU . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.471 HG21 ' HD2' ' A' ' 903' ' ' PRO . 3.3 p . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.405 HG13 ' HB ' ' A' ' 867' ' ' ILE . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.405 ' HB ' HG13 ' A' ' 859' ' ' ILE . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.461 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.498 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 899' ' ' ILE . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' P' ' 3' ' ' THR . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' P' ' 2' ' ' ARG . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt . . . . . 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.608 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.472 HG21 ' HD2' ' A' ' 903' ' ' PRO . 5.6 p . . . . . 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.66 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 23.7 m120 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 26.0 t-20 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.555 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.432 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 880' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 899' ' ' ILE . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 897' ' ' VAL . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' P' ' 3' ' ' THR . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.518 0.675 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.724 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.531 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.489 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.533 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m . . . . . 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.405 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.533 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.443 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.484 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 899' ' ' ILE . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 882' ' ' MET . 30.6 p . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.777 0.322 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 869' ' ' ILE . 85.6 m-85 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 13.4 m120 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 857' ' ' TYR . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' P' ' 3' ' ' THR . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.414 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 899' ' ' ILE . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.577 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.415 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 44.7 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 17.2 m120 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.452 ' H ' ' H ' ' A' ' 889' ' ' ASP . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 99.5 m-70 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.598 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 899' ' ' ILE . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 904' ' ' PRO . . . . . 0.583 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.568 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt . . . . . 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 . . . . . 0 C--O 1.215 -0.715 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m120 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 880' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 891' ' ' TRP . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.464 ' H ' ' HB3' ' A' ' 890' ' ' ASP . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 899' ' ' ILE . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.483 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.702 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.414 -2.226 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.441 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 907' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.444 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt . . . . . 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.426 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.489 ' SG ' ' SG ' ' A' ' 914' ' ' CYS . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.426 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.564 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt . . . . . 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.458 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.619 HG21 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p . . . . . 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.408 HG13 ' HB ' ' A' ' 867' ' ' ILE . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 24.8 m120 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.408 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.469 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.412 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.8 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.8 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.45 HG23 HG12 ' A' ' 899' ' ' ILE . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.619 ' HD2' HG21 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.403 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 19.9 mm-40 -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.453 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.605 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.0 m . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.461 ' NE1' HD11 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' P' P ' 5' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.283 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 . . . . . 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 59.3 t30 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.584 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 899' ' ' ILE . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.462 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 60.2 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' P' P ' 5' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 880' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.432 ' HG3' ' NE2' ' P' ' 5' ' ' GLN . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 891' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.694 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 899' ' ' ILE . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.425 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.424 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.559 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.217 -0.653 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.77 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.549 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.77 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 899' ' ' ILE . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 904' ' ' PRO . . . . . 0.483 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 907' ' ' MET . . . . . 0.483 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p . . . . . 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 857' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 868' ' ' TRP . 78.0 m-85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.455 ' HB3' HG13 ' A' ' 867' ' ' ILE . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 861' ' ' ASP . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 857' ' ' TYR . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.722 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 899' ' ' ILE . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.501 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.303 0.573 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.513 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 16.5 m120 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.64 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 889' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 890' ' ' ASP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.626 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 907' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 913' ' ' LYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.522 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.431 HG22 ' HE1' ' A' ' 894' ' ' TRP . 8.3 p . . . . . 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m . . . . . 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 858' ' ' VAL . . . . . 0.403 ' HB ' ' NE1' ' A' ' 868' ' ' TRP . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 868' ' ' TRP . . . . . 0.403 ' NE1' ' HB ' ' A' ' 858' ' ' VAL . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.546 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.646 HD12 ' HG3' ' A' ' 903' ' ' PRO . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' P' ' 3' ' ' THR . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.646 ' HG3' HD12 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 904' ' ' PRO . . . . . 0.433 ' HB2' ' C ' ' A' ' 906' ' ' GLU . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 905' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 906' ' ' GLU . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.433 ' C ' ' HB2' ' A' ' 904' ' ' PRO . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 905' ' ' GLU . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm . . . . . 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 3' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 879' ' ' GLY . 8.8 t . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.438 -1.046 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 871' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' P' ' 6' ' ' THR . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.484 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.503 ' CD2' ' HB2' ' A' ' 881' ' ' PRO . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 899' ' ' ILE . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 897' ' ' VAL . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 907' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 908' ' ' GLN . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 907' ' ' MET . 15.0 mm100 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.473 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.675 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' P' P ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.01 0.909 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 859' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 867' ' ' ILE . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 26.5 m120 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 867' ' ' ILE . . . . . 0.427 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 877' ' ' ASP . . . . . 0.618 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 882' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 899' ' ' ILE . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 897' ' ' VAL . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 902' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 903' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 904' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 907' ' ' MET . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 907' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 904' ' ' PRO . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 908' ' ' GLN . . . . . 0.453 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 909' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 914' ' ' CYS . . . . . 0.696 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 915' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 918' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' P' P ' 2' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' P' P ' 6' ' ' THR . . . . . 0.649 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 860' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 863' ' ' TRP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 865' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 869' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 876' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 879' ' ' GLY . . . . . 0.649 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 883' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 886' ' ' ASP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 897' ' ' VAL . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 910' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 911' ' ' CYS . . . . . 0.45 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 912' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 905' ' ' GLU . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.471 HG21 ' HD2' ' A' ' 903' ' ' PRO . 3.3 p -114.26 127.95 56.12 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.509 HM13 ' OG1' ' P' ' 6' ' ' THR . . . . . . . . 0 C--N 1.308 -1.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.33 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -116.82 125.43 51.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.509 ' OG1' HM13 ' P' ' 4' ' ' M3L . 0.3 OUTLIER -79.4 75.88 5.99 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.98 140.52 52.25 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.65 0.738 . . . . 0.0 112.872 -171.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -99.14 -5.99 29.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.197 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -152.32 119.3 5.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 34.4 t -137.87 149.83 46.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 23.8 m -97.94 104.59 16.63 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.04 -63.6 2.79 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.441 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 50.2 m -75.95 -15.46 60.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.185 0.493 . . . . 0.0 111.399 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -69.67 99.05 1.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.104 0.954 . . . . 0.0 111.263 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.07 -73.95 0.61 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 178.97 89.04 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 124.155 0.982 . . . . 0.0 109.898 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 41.8 tpp -85.54 77.13 9.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.181 0.991 . . . . 0.0 108.446 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.53 -176.86 2.58 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 -87.96 64.92 8.06 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.405 HG13 ' HB ' ' A' ' 867' ' ' ILE . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.405 ' HB ' HG13 ' A' ' 859' ' ' ILE . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.517 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.498 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 899' ' ' ILE . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' P' ' 3' ' ' THR . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' P' ' 2' ' ' ARG . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt -65.22 -43.88 95.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 82.25 -40.34 0.12 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.684 1.593 . . . . 0.0 112.23 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.455 ' HB2' ' NZ ' ' A' ' 920' ' ' LYS . 7.9 mtmp? 62.56 65.01 0.87 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 923' ' ' LYS . 10.6 t70 -65.84 161.36 21.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.329 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.45 -37.81 88.83 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.511 0.725 . . . . 0.0 110.388 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 921' ' ' ASP . 60.7 pttt -68.14 126.37 29.31 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.657 0.741 . . . . 0.0 110.864 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 C--N 1.29 -1.986 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.754 -178.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.608 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.472 HG21 ' HD2' ' A' ' 903' ' ' PRO . 5.6 p -124.4 139.32 54.01 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.517 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 CA--C 1.496 -1.134 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.229 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 144.15 46.8 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 166.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.56 -66.01 0.51 Allowed 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -179.93 -87.51 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.914 0.885 . . . . 0.0 108.883 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -138.84 -51.62 0.56 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 9' ' ' LYS . . . . . 0.422 ' HD3' ' CA ' ' A' ' 879' ' ' GLY . 58.1 mtpt 63.92 20.18 12.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.395 1.093 . . . . 0.0 111.922 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 41.8 t -125.0 132.72 53.21 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -103.96 26.02 9.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.033 0.92 . . . . 0.0 109.405 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.37 -16.81 6.64 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.377 -0.916 . . . . 0.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.834 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 69.4 m -107.23 176.94 5.0 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 122.615 -0.344 . . . . 0.0 110.264 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -78.1 94.2 4.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.59 0.709 . . . . 0.0 110.287 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 77.8 mtp -105.69 -63.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.41 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 854' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 855' ' ' MET . . . 52.64 -96.61 0.05 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 855' ' ' MET . . . . . 0.411 ' H ' ' HB3' ' A' ' 854' ' ' ALA . 52.8 mtm -149.41 161.04 42.88 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.11 90.63 0.09 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 125.485 1.514 . . . . 0.0 110.048 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.66 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 -107.9 11.32 28.1 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.981 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 23.7 m120 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 10.7 t30 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.555 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.432 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 880' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 899' ' ' ILE . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 897' ' ' VAL . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' P' ' 3' ' ' THR . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt -91.48 -42.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -82.75 -31.98 28.09 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.942 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 54.75 28.5 10.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.971 0.908 . . . . 0.0 111.74 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 923' ' ' LYS . 0.6 OUTLIER 60.09 107.81 0.02 OUTLIER 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.125 0.97 . . . . 0.0 111.5 -172.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.65 -24.23 67.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.462 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 921' ' ' ASP . 61.9 mttp 75.19 119.67 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 125.328 1.451 . . . . 0.0 113.288 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.418 -2.053 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.863 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -118.19 134.13 55.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.748 HM32 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -164.13 138.03 5.47 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' P' ' 9' ' ' LYS . 9.2 t -152.86 -40.31 0.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.78 -155.13 0.29 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -118.59 85.05 2.29 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 9' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' P' ' 6' ' ' THR . 67.8 mttm -70.62 135.27 48.3 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.431 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -67.12 -41.93 85.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -152.7 132.93 13.56 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.278 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.18 -41.89 3.88 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.662 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 6.4 p -94.93 175.24 6.72 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -66.55 -59.96 3.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.69 100.44 3.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.659 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.04 7.48 1.82 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.418 172.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 89.1 mtp 65.87 36.95 5.76 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.023 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 71.5 173.94 0.3 Allowed 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.792 1.637 . . . . 0.0 109.642 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -84.64 48.85 1.59 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.557 -0.714 . . . . 0.0 112.071 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.443 ' CZ3' HM21 ' P' ' 4' ' ' M3L . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.748 ' SD ' HM32 ' P' ' 4' ' ' M3L . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.724 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.531 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.489 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt -86.96 -42.71 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -76.09 -58.35 3.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.338 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 62.22 -176.41 0.13 Allowed 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.207 0.942 . . . . 0.0 111.64 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -147.47 125.29 11.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 70.42 174.73 0.3 Allowed 'General case' 0 C--O 1.246 0.873 0 O-C-N 124.28 0.988 . . . . 0.0 111.69 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -93.7 95.06 8.93 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.44 0.638 . . . . 0.0 109.903 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.423 -1.791 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.135 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p -121.96 127.31 50.2 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.545 HM33 ' HD3' ' P' ' 4' ' ' M3L . . . . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -142.73 115.86 8.89 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.533 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m -67.81 -31.24 70.97 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.08 151.06 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.201 . . . . 0.0 112.966 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -87.77 -3.69 58.93 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.969 -0.457 . . . . 0.0 110.579 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 63.46 28.89 15.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.692 0.797 . . . . 0.0 110.785 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -135.15 14.47 3.54 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.38 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m 67.17 92.52 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.668 0.747 . . . . 0.0 110.496 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.36 143.85 29.94 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.223 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.464 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.553 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.7 t -82.72 93.01 7.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.64 99.6 8.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -90.88 155.74 18.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.128 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -79.51 95.99 5.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -146.01 19.29 1.43 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.489 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 67.72 -158.99 0.22 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.407 1.083 . . . . 0.0 109.556 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.34 7.32 19.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.521 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.533 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.521 ' SD ' HM32 ' P' ' 4' ' ' M3L . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.484 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 899' ' ' ILE . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.34 -33.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -83.75 -16.4 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.14 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -66.83 -32.32 73.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.3 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.37 -45.88 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.52 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 64.8 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.878 0.871 . . . . 0.0 112.967 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -86.7 172.25 10.33 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 74.4 t60 . . . . . 0 C--N 1.291 -1.953 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.788 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 882' ' ' MET . 30.6 p -123.66 133.42 53.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.563 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -114.26 127.82 56.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.228 0.33 . . . . 0.0 110.326 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.511 ' OG1' HM23 ' P' ' 4' ' ' M3L . 0.2 OUTLIER -92.56 37.22 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 7' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 879' ' ' GLY . . . -110.18 10.72 23.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.425 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 67.45 5.36 4.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.498 1.119 . . . . 0.0 110.864 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -92.02 92.08 8.13 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.8 p -121.11 157.09 30.87 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.255 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -91.7 -74.39 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.78 11.58 10.17 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 105.411 -3.076 . . . . 0.0 105.411 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.766 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.3 m -83.38 174.07 10.99 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -88.1 68.94 9.23 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.687 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 96.1 mmm -65.04 -45.0 87.24 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -93.64 101.08 13.23 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.6 ptp -105.01 9.7 34.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.903 0.859 . . . . 0.0 109.863 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -83.84 148.2 27.12 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 869' ' ' ILE . 85.6 m-85 -95.35 19.61 10.54 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 13.4 m120 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 857' ' ' TYR . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.524 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' P' ' 7' ' ' ALA . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.563 ' SD ' HM12 ' P' ' 4' ' ' M3L . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.414 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 899' ' ' ILE . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 905' ' ' GLU . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.415 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 44.7 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt -67.65 -43.65 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -76.17 -7.68 55.34 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.339 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 916' ' ' ASN . 62.4 mtpt -85.83 4.38 37.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.682 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.49 -5.73 59.31 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . 0.309 47.0 tptt 89.43 92.27 0.02 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 127.409 2.284 . . . . 0.0 112.736 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -92.31 145.4 24.51 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.433 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.622 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -119.64 145.62 46.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.581 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.23 -58.69 0.15 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m 57.94 76.87 0.31 Allowed 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.91 81.86 3.47 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -122.76 6.59 9.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.301 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 878' ' ' ASP . 38.8 ttpt -156.98 -64.97 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m 69.39 151.95 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -82.47 -31.83 29.2 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.606 0.717 . . . . 0.0 109.183 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.67 -36.46 0.02 OUTLIER Glycine 0 CA--C 1.491 -1.448 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.087 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 176.002 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -73.78 109.39 7.26 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -74.53 104.96 5.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.92 119.37 13.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.39 0.23 Allowed 'General case' 0 C--N 1.317 -0.806 0 O-C-N 123.757 0.66 . . . . 0.0 111.849 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 59.2 mtt -141.72 116.53 9.81 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.928 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.54 136.35 42.14 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.15 -3.42 52.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 17.2 m120 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 878' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' P' ' 9' ' ' LYS . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.476 ' HG2' ' CD2' ' A' ' 893' ' ' HIS . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.452 ' H ' ' H ' ' A' ' 889' ' ' ASP . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 50.8 m80 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.598 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 899' ' ' ILE . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.583 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.568 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt -62.51 -42.85 97.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -170.3 -45.74 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.442 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.277 23.4 pttp 49.79 77.92 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 122.531 1.158 . . . . 0.0 110.719 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.14 146.29 53.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.859 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -75.75 -14.98 60.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.896 0.379 . . . . 0.0 111.46 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -91.74 109.6 20.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.263 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -120.41 137.5 54.28 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.458 HM31 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -149.9 125.48 10.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m -69.23 -50.8 43.9 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -173.14 -171.24 0.71 Allowed 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -133.32 111.78 11.1 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.762 0.791 . . . . 0.0 111.455 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 114.89 18.25 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.983 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 t -131.18 123.42 28.47 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -89.8 -24.81 21.36 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.46 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.38 -59.35 3.03 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 178.795 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.713 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 33.5 p -119.79 25.07 10.22 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 120.963 0.411 . . . . 0.0 110.778 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.12 -38.05 78.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 90.8 mtp -79.29 118.21 20.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.044 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.39 -178.76 4.99 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.191 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 72.0 mtm -68.57 117.33 10.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -66.98 78.11 0.12 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 64.79 -39.87 0.26 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 127.406 2.282 . . . . 0.0 116.809 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m120 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 880' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 891' ' ' TRP . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.464 ' H ' ' HB3' ' A' ' 890' ' ' ASP . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 899' ' ' ILE . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.483 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.702 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm -66.87 -45.52 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -89.19 -21.14 23.43 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.65 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 920' ' ' LYS 0.256 0.0 OUTLIER -64.62 121.38 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.223 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -100.48 -61.23 1.39 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 57.4 tttm 43.52 85.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.673 ' HG2' ' H ' ' A' ' 924' ' ' HIS 0.306 0.0 OUTLIER -170.27 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.855 1.262 . . . . 0.0 109.96 167.176 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 924' ' ' HIS . . . . . 0.673 ' H ' ' HG2' ' A' ' 923' ' ' LYS . 30.2 p80 . . . . . 0 C--N 1.282 -2.365 0 C-N-CA 128.324 2.65 . . . . 0.0 104.583 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p -124.09 130.37 52.45 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.549 ' HG3' ' CH2' ' A' ' 891' ' ' TRP . . . . . . . . 0 N--CA 1.439 -1.006 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.071 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -146.18 149.72 34.5 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.441 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m -56.81 -46.05 81.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.58 100.26 5.69 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 8' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' P' ' 8' ' ' ARG . 5.7 mpt_? -76.72 -40.42 48.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt 68.37 29.43 5.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.919 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -85.54 -30.09 23.66 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.975 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 12.2 m -85.35 75.85 10.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.57 -169.97 35.73 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.757 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.236 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.77 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 13.9 p -74.48 -44.48 51.3 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.263 0.554 . . . . 0.0 110.679 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -103.15 87.93 3.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 17.1 tpt -97.93 -53.42 3.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 52.09 -159.15 0.12 Allowed 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.797 1.311 . . . . 0.0 112.266 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 28.3 ttt -143.02 86.39 1.92 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.44 0.85 Allowed 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.854 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -85.58 -7.8 58.65 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.473 ' SD ' HM22 ' P' ' 4' ' ' M3L . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.549 ' CH2' ' HG3' ' P' ' 4' ' ' M3L . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.444 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt -74.89 -31.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -98.65 78.89 2.4 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.155 0.978 . . . . 0.0 111.208 -173.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -136.48 18.41 3.12 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.395 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.31 100.89 0.11 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.929 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 57.88 26.87 13.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.061 0.944 . . . . 0.0 110.955 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -141.16 -179.01 5.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.906 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.937 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.426 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -113.37 134.59 54.55 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.54 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.416 -2.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -164.45 152.32 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m -135.06 80.32 1.83 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.42 -175.78 3.81 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.202 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.95 -47.89 70.82 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 124.449 1.1 . . . . 0.0 108.457 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -104.98 134.73 47.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.9 t 65.02 82.0 0.2 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.917 0.865 . . . . 0.0 109.429 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -95.72 -20.54 18.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.629 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.66 -143.93 6.56 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.817 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 32.2 t -162.41 137.39 6.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 852' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 858' ' ' VAL . 68.0 t60 -137.56 104.66 5.4 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.376 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 3.7 tpt -147.4 34.46 0.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -117.53 144.78 44.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.895 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.49 88.7 4.45 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.38 -153.88 0.58 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.237 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 852' ' ' HIS . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.429 ' CZ3' HM11 ' P' ' 4' ' ' M3L . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.426 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.564 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt -63.47 -52.91 52.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 919' ' ' LYS . 36.8 ttmt 72.4 -38.29 0.41 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.952 1.701 . . . . 0.0 114.08 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 76.3 -26.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.958 1.303 . . . . 0.0 114.391 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.58 -45.24 94.97 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.3 17.83 10.78 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.657 1.183 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -141.99 107.76 5.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 23.6 t60 . . . . . 0 C--O 1.248 1.021 0 C-N-CA 124.906 1.282 . . . . 0.0 110.735 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.458 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.619 HG21 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p -108.17 141.56 39.73 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.507 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -128.09 -63.69 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.741 0.651 . . . . 0.0 110.018 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.419 HG22 ' HA ' ' P' ' 9' ' ' LYS . 10.7 m 62.68 50.37 3.48 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 7' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . -56.67 103.71 0.12 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.103 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 54.63 26.11 7.07 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 110.103 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 9' ' ' LYS . . . . . 0.419 ' HA ' HG22 ' P' ' 6' ' ' THR . 28.8 mtpp 63.68 18.99 11.48 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.612 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 52.7 p -156.53 -76.05 0.09 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.408 0.623 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t 172.09 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 126.383 1.873 . . . . 0.0 106.74 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.37 -133.44 11.66 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.1 m -89.45 118.38 29.06 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -148.56 153.33 38.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt -78.91 77.89 5.37 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.077 0.942 . . . . 0.0 109.557 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -104.42 86.02 2.45 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.586 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 94.4 mmm -128.64 28.48 5.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.8 175.19 0.29 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.268 1.427 . . . . 0.0 110.701 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 -103.22 -0.19 30.76 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.408 HG13 ' HB ' ' A' ' 867' ' ' ILE . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.539 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.7 m-80 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.408 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.451 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.469 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.507 ' SD ' HM12 ' P' ' 4' ' ' M3L . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.412 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.8 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.8 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.45 HG23 HG12 ' A' ' 899' ' ' ILE . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.619 ' HD2' HG21 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.403 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 19.9 mm-40 -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.453 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.605 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -78.95 -59.18 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 62.14 -48.98 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.113 2.165 . . . . 0.0 113.547 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 72.02 98.99 0.07 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 124.999 1.319 . . . . 0.0 112.424 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.38 -165.07 1.27 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.87 103.11 8.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -85.87 97.29 10.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.856 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.644 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -103.75 119.88 39.82 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.488 ' HG3' ' CZ3' ' A' ' 891' ' ' TRP . . . . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.99 108.28 4.59 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.0 m -61.47 -48.66 80.1 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . 62.37 163.13 0.09 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.993 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.47 20.3 3.14 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -117.09 83.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.198 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -84.8 -60.77 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -101.95 -38.66 7.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 166.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.9 -44.4 0.28 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.068 -1.423 . . . . 0.0 109.612 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.767 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.831 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -69.92 -37.56 75.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.184 0.516 . . . . 0.0 109.645 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -84.77 121.7 28.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.307 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 ttt -78.18 -32.24 50.01 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -140.43 139.99 35.35 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 85.6 mtp -68.52 -28.88 67.38 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 122.538 1.161 . . . . 0.0 109.889 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.0 142.85 7.62 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 112.067 -2.333 . . . . 0.0 105.808 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 -85.46 61.88 7.13 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.447 ' CE3' HM21 ' P' ' 4' ' ' M3L . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.488 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.461 ' NE1' HD11 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt -94.87 -33.13 4.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 33.0 mmtp -82.19 -37.14 26.52 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.264 64.8 mttm 69.69 127.24 0.03 OUTLIER 'General case' 0 C--O 1.246 0.902 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -92.32 167.52 11.94 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.414 -1.721 . . . . 0.0 106.429 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -69.83 -79.49 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.475 0.58 . . . . 0.0 109.831 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -179.22 90.29 0.02 OUTLIER 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.087 0.946 . . . . 0.0 110.511 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.414 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p -128.06 143.38 51.07 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.497 HM21 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 5' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER -161.8 171.16 18.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 O-C-N 124.149 0.906 . . . . 0.0 111.283 177.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -105.53 -50.5 3.2 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.76 176.6 9.75 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.756 0.789 . . . . 0.0 111.159 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -139.42 121.46 15.69 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.98 90.02 4.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 110.38 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -83.35 119.82 25.1 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.02 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.1 m -109.85 36.72 2.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.67 -64.69 0.56 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.423 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 175.693 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 24.0 t -154.36 95.59 1.83 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -108.38 -67.73 0.95 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.9 mtp -119.3 14.0 12.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.018 0.914 . . . . 0.0 108.996 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -159.92 176.35 11.98 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -126.22 108.18 11.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.84 111.68 23.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 65.34 5.53 3.17 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.497 ' CZ3' HM21 ' P' ' 4' ' ' M3L . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 59.3 t30 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.657 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.482 ' SD ' HM32 ' P' ' 4' ' ' M3L . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.584 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 899' ' ' ILE . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.462 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 60.2 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm -79.06 -48.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 919' ' ' LYS 0.334 0.2 OUTLIER -83.33 76.66 9.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.347 1.07 . . . . 0.0 112.906 -178.079 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.06 178.82 9.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.16 -165.55 1.38 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -71.02 140.88 50.93 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -115.26 130.3 56.87 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.358 0.599 . . . . 0.0 112.196 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 176.699 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p -123.46 137.23 54.84 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.511 ' HD3' HM22 ' P' ' 4' ' ' M3L . . . . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 5' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 -167.0 90.61 0.38 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 124.579 1.174 . . . . 0.0 107.968 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -75.96 -40.31 54.2 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.08 81.38 0.14 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.826 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -66.44 -32.3 73.59 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.054 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 9' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' P' ' 9' ' ' LYS . 0.1 OUTLIER -102.52 119.94 39.69 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 172.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.0 m -135.03 -7.54 2.34 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.384 0.612 . . . . 0.0 110.708 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 33.1 m -119.15 143.33 47.26 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.38 66.26 3.93 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.518 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 -176.377 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.574 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.7 m 63.81 -78.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.026 1.33 . . . . 0.0 113.485 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 65.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.0 109.511 -172.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.7 ttt -114.35 134.7 54.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.22 90.75 3.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 57.8 ttp -152.14 100.24 2.6 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.379 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -89.55 177.06 6.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -88.33 8.62 26.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.423 ' CE3' HM11 ' P' ' 4' ' ' M3L . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 880' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.694 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 899' ' ' ILE . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.425 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.424 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm -82.31 -19.69 10.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 920' ' ' LYS . 61.5 tttm -115.62 172.99 6.77 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 919' ' ' LYS . 13.1 ptmm? 64.24 -32.48 0.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 14.3 t70 70.81 -165.84 0.15 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 125.293 1.437 . . . . 0.0 107.829 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -115.88 83.72 1.99 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -134.06 109.37 8.91 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.858 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 . . . . . 0 C--N 1.286 -2.172 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.934 175.036 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -113.67 114.81 26.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.563 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.81 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -156.78 142.46 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.559 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m -90.21 -57.93 2.68 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.99 -66.95 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 120.782 0.325 . . . . 0.0 111.591 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 8' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' P' ' 8' ' ' ARG . 64.8 mtm-85 -64.31 96.17 0.15 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.612 1.196 . . . . 0.0 114.04 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -93.31 161.83 14.24 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.397 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 37.6 m -88.0 111.35 21.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -120.31 125.05 47.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.505 0.669 . . . . 0.0 110.347 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.43 43.66 1.66 Allowed Glycine 0 CA--C 1.492 -1.377 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.501 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -177.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.8 m -123.6 149.29 45.51 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -73.88 -40.66 63.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt 69.02 3.85 4.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.358 1.463 . . . . 0.0 111.374 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -164.79 -175.42 3.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.8 mtm 52.23 73.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.916 0.76 . . . . 0.0 111.064 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.63 56.89 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 122.06 -0.4 . . . . 0.0 110.321 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -94.62 10.09 36.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.439 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.731 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.77 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.549 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.77 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 899' ' ' ILE . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.483 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.483 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm -59.55 -58.21 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.5 tttp 42.67 72.92 0.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.774 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.8 97.21 3.1 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.687 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 160.95 27.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.58 167.23 22.67 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 174.33 8.75 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p -113.32 143.21 44.83 Favored 'General case' 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.658 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -166.3 115.14 0.93 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -70.57 -51.79 26.05 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.02 -145.7 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 69.66 84.89 0.14 Allowed 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.963 1.305 . . . . 0.0 114.164 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -131.28 80.27 1.93 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -94.8 92.53 7.0 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.659 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -89.07 79.89 7.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.198 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.49 -38.44 0.59 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.836 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.687 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.621 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.697 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.9 t 71.07 145.93 0.07 Allowed 'General case' 0 C--O 1.249 1.047 0 C-N-CA 125.262 1.425 . . . . 0.0 110.871 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -98.52 -57.88 2.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.167 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp 49.92 75.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.115 0.966 . . . . 0.0 110.357 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -114.69 -67.93 0.96 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.06 0.933 . . . . 0.0 111.658 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.4 ptm -175.52 -154.96 0.05 OUTLIER 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.71 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -78.34 174.97 10.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 857' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 868' ' ' TRP . 78.0 m-85 -86.07 56.95 4.21 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.455 ' HB3' HG13 ' A' ' 867' ' ' ILE . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 861' ' ' ASP . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 857' ' ' TYR . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.658 ' SD ' HM12 ' P' ' 4' ' ' M3L . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.722 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 899' ' ' ILE . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.501 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -79.0 -23.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -114.09 -41.5 3.51 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.845 0.831 . . . . 0.0 110.808 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -132.98 -174.89 3.6 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.927 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.99 -56.13 2.22 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -170.94 -173.7 1.37 Allowed 'General case' 0 C--O 1.251 1.165 0 C-N-CA 124.163 0.985 . . . . 0.0 108.406 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 73.51 -177.6 0.18 Allowed 'General case' 0 C--O 1.253 1.283 0 C-N-CA 124.354 1.061 . . . . 0.0 109.952 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 34.9 p80 . . . . . 0 C--N 1.313 -1.01 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.414 178.528 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -107.84 128.45 54.62 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.594 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.289 -2.026 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -136.26 115.29 12.33 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -105.89 30.75 5.57 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.39 141.29 31.84 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.961 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -89.79 -17.75 27.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -130.29 115.34 16.8 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.701 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.5 m -74.36 100.82 3.88 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.82 92.92 6.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.228 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -41.89 6.12 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.903 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 177.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 63.21 81.25 0.21 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.917 1.287 . . . . 0.0 111.983 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.51 134.76 33.96 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.848 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 15.9 tpt -91.26 -11.99 36.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.659 0.742 . . . . 0.0 109.141 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -91.24 -168.67 2.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.119 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -140.29 167.06 23.02 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.33 -175.85 2.46 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 123.633 0.583 . . . . 0.0 110.287 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 69.33 6.68 5.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.138 0.975 . . . . 0.0 111.738 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.513 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 16.5 m120 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.444 ' CE3' HM11 ' P' ' 4' ' ' M3L . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.594 ' SD ' HM12 ' P' ' 4' ' ' M3L . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.64 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 889' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 890' ' ' ASP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.626 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 913' ' ' LYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.522 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 920' ' ' LYS . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt -63.13 -29.81 48.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.19 19.13 20.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.406 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 917' ' ' LYS . 61.5 pttt -127.14 -14.31 5.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.728 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.29 -79.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -6.68 57.72 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.508 0.671 . . . . 0.0 110.072 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -100.62 121.35 41.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.344 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.617 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.431 HG22 ' HE1' ' A' ' 894' ' ' TRP . 8.3 p -119.34 133.6 55.64 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.578 HM31 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.283 -2.318 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 5' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.5 tt0 -149.75 111.91 4.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m -67.61 -30.28 69.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.36 -174.58 0.17 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.304 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 8' ' ' ARG . . . . . 0.472 ' HD2' ' N ' ' P' ' 8' ' ' ARG . 0.0 OUTLIER -122.6 81.71 1.89 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 177.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -79.33 100.5 7.61 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.971 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -71.25 99.39 1.91 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.902 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 43.9 m -83.62 102.44 12.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.774 0.797 . . . . 0.0 110.08 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.56 -91.46 0.1 OUTLIER Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.689 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.184 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.155 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.535 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 36.5 m -58.0 -23.3 53.52 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -62.93 -30.88 71.9 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 120.565 0.221 . . . . 0.0 110.828 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 mmt -111.5 18.59 18.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.53 0.681 . . . . 0.0 109.164 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.46 40.81 1.59 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.0 mtt -74.8 85.02 2.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.861 0.839 . . . . 0.0 111.756 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -126.96 175.03 8.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -102.05 3.68 38.99 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 858' ' ' VAL . . . . . 0.403 ' HB ' ' NE1' ' A' ' 868' ' ' TRP . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.578 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.522 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 891' ' ' TRP . . . . . 0.459 ' CE2' HM32 ' P' ' 4' ' ' M3L . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.546 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.646 HD12 ' HG3' ' A' ' 903' ' ' PRO . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' P' ' 3' ' ' THR . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.646 ' HG3' HD12 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.433 ' HB2' ' C ' ' A' ' 906' ' ' GLU . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 906' ' ' GLU . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.433 ' C ' ' HB2' ' A' ' 904' ' ' PRO . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 905' ' ' GLU . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm -90.73 -45.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 919' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 13.7 ptmm? -90.26 73.03 7.14 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.248 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -138.58 122.83 18.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.13 -41.02 59.32 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -92.48 138.51 31.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -86.17 126.66 34.4 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--N 1.32 -0.701 0 C-N-CA 125.32 1.448 . . . . 0.0 111.097 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 3' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p -115.61 145.12 42.98 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.521 HM12 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -135.61 113.85 11.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 879' ' ' GLY . 8.8 t -102.78 63.95 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -34.42 19.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.898 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -162.16 -29.3 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.596 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 55.45 44.73 26.54 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.175 0.99 . . . . 0.0 112.296 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 m -68.37 -33.34 74.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -100.0 96.21 7.38 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.0 -76.61 0.25 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.493 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.094 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -81.56 -78.12 0.2 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.887 0.343 . . . . 0.0 111.893 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -81.11 -29.02 34.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.046 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 27.2 ptm -82.1 144.34 30.86 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.86 97.19 2.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.81 71.91 8.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.393 1.092 . . . . 0.0 110.769 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -131.74 107.25 8.66 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -83.23 62.35 6.61 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 871' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.521 ' OD2' HM12 ' P' ' 4' ' ' M3L . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' P' ' 6' ' ' THR . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.484 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.503 ' CD2' ' HB2' ' A' ' 881' ' ' PRO . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 899' ' ' ILE . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 897' ' ' VAL . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 908' ' ' GLN . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 907' ' ' MET . 15.0 mm100 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.473 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.675 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt -72.93 -46.24 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -155.01 -57.19 0.1 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.684 -1.206 . . . . 0.0 114.03 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 70.55 99.47 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.54 -59.72 0.44 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.208 -0.997 . . . . 0.0 112.981 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.51 -71.26 0.54 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.63 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 64.42 81.59 0.2 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -171.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.893 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -124.09 117.1 23.91 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.485 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 -163.9 103.84 0.9 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.47 38.9 1.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.21 -36.76 34.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.585 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 71.35 -62.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.344 1.058 . . . . 0.0 110.125 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -82.17 -48.15 11.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.7 m 69.64 -177.99 0.22 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.008 0.923 . . . . 0.0 109.521 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.5 p -73.52 -49.66 25.38 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.275 0.559 . . . . 0.0 110.258 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.46 -14.84 32.74 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.555 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.245 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.2 m -91.0 91.07 8.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.186 -0.596 . . . . 0.0 110.265 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -158.5 -174.2 4.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -80.92 136.63 36.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.014 0.435 . . . . 0.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -92.74 138.5 31.44 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -75.79 -33.43 60.15 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.209 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 23.55 -101.6 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.874 1.984 . . . . 0.0 113.653 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.39 34.69 3.71 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.133 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 859' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 867' ' ' ILE . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 26.5 m120 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 867' ' ' ILE . . . . . 0.427 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.42 ' CE3' HM31 ' P' ' 4' ' ' M3L . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.648 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 882' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 899' ' ' ILE . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 897' ' ' VAL . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 902' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 903' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 907' ' ' MET . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 907' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 904' ' ' PRO . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 908' ' ' GLN . . . . . 0.453 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 909' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 914' ' ' CYS . . . . . 0.696 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 915' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 918' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt -76.35 -14.07 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.62 -0.25 57.08 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.944 0.878 . . . . 0.0 108.98 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -91.21 117.75 29.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 64.6 -156.29 0.3 Allowed 'General case' 0 C--O 1.246 0.907 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 55.36 43.76 28.37 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -65.36 144.31 57.18 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.25 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--N 1.289 -2.049 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.684 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 2' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.19 123.03 20.05 Favored 'General case' 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 4' ' ' M3L . . . . . 0.44 HM12 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -111.4 112.81 24.82 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 6' ' ' THR . . . . . 0.649 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m -69.18 -11.16 60.56 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.95 98.53 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.542 1.137 . . . . 0.0 112.453 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -76.85 -14.68 59.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.186 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -104.91 148.96 26.12 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -118.2 88.69 2.97 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -161.46 18.72 0.11 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.632 0.73 . . . . 0.0 109.09 -176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.11 68.77 2.45 Favored Glycine 0 CA--C 1.503 -0.704 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.275 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.461 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 178.171 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 7.9 p -83.51 -26.73 29.93 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.8 m80 66.08 171.75 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.493 1.139 . . . . 0.0 112.509 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -145.42 113.96 6.74 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 71.39 157.49 0.18 Allowed 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.291 0.994 . . . . 0.0 109.325 -168.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 66.98 11.69 8.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.596 0.758 . . . . 0.0 112.229 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -112.08 -171.05 1.77 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -101.23 13.3 35.56 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 860' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 863' ' ' TRP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 865' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 868' ' ' TRP . . . . . 0.409 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 869' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 876' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 877' ' ' ASP . . . . . 0.44 ' OD2' HM12 ' P' ' 4' ' ' M3L . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 879' ' ' GLY . . . . . 0.649 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 883' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 886' ' ' ASP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 897' ' ' VAL . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 910' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 911' ' ' CYS . . . . . 0.45 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 912' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 917' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt -60.65 -41.79 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -97.05 -35.79 10.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.065 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 917' ' ' LYS . 29.6 mtmm 69.76 -47.8 0.61 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.891 1.677 . . . . 0.0 114.076 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -111.91 126.78 55.48 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.885 0.374 . . . . 0.0 110.33 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -115.77 99.41 7.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.743 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 923' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 924' ' ' HIS 0.319 10.5 ptpp? 46.05 -106.72 0.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.061 1.344 . . . . 0.0 114.056 -178.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 924' ' ' HIS . . . . . 0.56 ' H ' ' HG3' ' A' ' 923' ' ' LYS . 22.6 t60 . . . . . 0 C--N 1.288 -2.107 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 905' ' ' GLU . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.471 HG21 ' HD2' ' A' ' 903' ' ' PRO . 3.3 p . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.405 HG13 ' HB ' ' A' ' 867' ' ' ILE . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.405 ' HB ' HG13 ' A' ' 859' ' ' ILE . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.461 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.498 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 899' ' ' ILE . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' P' ' 3' ' ' THR . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' P' ' 2' ' ' ARG . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt . . . . . 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.608 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.472 HG21 ' HD2' ' A' ' 903' ' ' PRO . 5.6 p . . . . . 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.66 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.464 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.6 m-80 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 26.0 t-20 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.555 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.432 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 899' ' ' ILE . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 897' ' ' VAL . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' P' ' 3' ' ' THR . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.518 0.675 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.724 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.531 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.489 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 . . . . . 0 N--CA 1.431 -1.415 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.533 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m . . . . . 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.405 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.533 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.443 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.484 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 899' ' ' ILE . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 882' ' ' MET . 30.6 p . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.777 0.322 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 869' ' ' ILE . 85.6 m-85 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.557 HG11 HE21 ' A' ' 866' ' ' GLN . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 24.0 m-80 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.557 HE21 HG11 ' A' ' 858' ' ' VAL . 60.4 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 857' ' ' TYR . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 874' ' ' ASN . 0.8 OUTLIER 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' P' ' 3' ' ' THR . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.469 ' HB3' HE21 ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.414 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 899' ' ' ILE . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 905' ' ' GLU . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' A' ' 886' ' ' ASP . 45.1 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--O 1.218 -0.573 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.489 HG11 HE21 ' A' ' 866' ' ' GLN . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.5 m-80 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.489 HE21 HG11 ' A' ' 858' ' ' VAL . 56.3 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 874' ' ' ASN . 13.6 m120 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.476 ' HG2' ' CD2' ' A' ' 893' ' ' HIS . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.49 ' HB3' HE21 ' A' ' 908' ' ' GLN . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.452 ' H ' ' H ' ' A' ' 889' ' ' ASP . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 50.8 m80 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.598 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 899' ' ' ILE . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . 0.583 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.49 HE21 ' HB3' ' A' ' 886' ' ' ASP . 50.5 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.568 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt . . . . . 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 . . . . . 0 C--O 1.215 -0.715 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.425 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 38.8 m-80 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 891' ' ' TRP . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.464 ' H ' ' HB3' ' A' ' 890' ' ' ASP . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 899' ' ' ILE . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.483 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.702 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.414 -2.226 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.441 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m . . . . . 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.452 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 46.5 m-80 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.444 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt . . . . . 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.426 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . 0.436 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.4 tt0 . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.436 ' HG3' ' NE2' ' P' ' 5' ' ' GLN . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.489 ' SG ' ' SG ' ' A' ' 914' ' ' CYS . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.426 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.564 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt . . . . . 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.458 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.619 HG21 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p . . . . . 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.516 HG11 HE21 ' A' ' 866' ' ' GLN . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.408 HG13 ' HB ' ' A' ' 867' ' ' ILE . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.539 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.7 m-80 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.516 HE21 HG11 ' A' ' 858' ' ' VAL . 59.7 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.408 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.469 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.412 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.8 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.8 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.45 HG23 HG12 ' A' ' 899' ' ' ILE . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.619 ' HD2' HG21 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.61 ' HA ' HE21 ' A' ' 908' ' ' GLN . 0.0 OUTLIER -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.453 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.605 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 N--CA 1.414 -2.229 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.0 m . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.419 HG11 HE21 ' A' ' 866' ' ' GLN . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.419 HE21 HG11 ' A' ' 858' ' ' VAL . 56.0 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.461 ' NE1' HD11 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.283 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 . . . . . 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.584 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 899' ' ' ILE . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.462 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 14.4 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.558 HG11 HE21 ' A' ' 866' ' ' GLN . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.558 HE21 HG11 ' A' ' 858' ' ' VAL . 54.3 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.432 ' HG3' ' NE2' ' P' ' 5' ' ' GLN . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.694 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 899' ' ' ILE . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.425 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.424 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.559 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--O 1.217 -0.653 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.452 HG11 HE21 ' A' ' 866' ' ' GLN . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.452 HE21 HG11 ' A' ' 858' ' ' VAL . 58.7 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.77 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.549 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.77 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 899' ' ' ILE . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . 0.483 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . 0.483 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p . . . . . 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 868' ' ' TRP . 78.0 m-85 . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.455 ' HB3' HG13 ' A' ' 867' ' ' ILE . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 861' ' ' ASP . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 857' ' ' TYR . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.722 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 899' ' ' ILE . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.501 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.303 0.573 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.487 HG11 HE21 ' A' ' 866' ' ' GLN . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.513 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.485 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 31.2 m-80 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.487 HE21 HG11 ' A' ' 858' ' ' VAL . 45.1 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.64 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.626 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.522 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.431 HG22 ' HE1' ' A' ' 894' ' ' TRP . 8.3 p . . . . . 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.5 tt0 . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m . . . . . 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.403 ' HB ' ' NE1' ' A' ' 868' ' ' TRP . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . 0.403 ' NE1' ' HB ' ' A' ' 858' ' ' VAL . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.546 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.646 HD12 ' HG3' ' A' ' 903' ' ' PRO . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' P' ' 3' ' ' THR . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.646 ' HG3' HD12 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . 0.433 ' HB2' ' C ' ' A' ' 906' ' ' GLU . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 906' ' ' GLU . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.433 ' C ' ' HB2' ' A' ' 904' ' ' PRO . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 905' ' ' GLU . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm . . . . . 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 879' ' ' GLY . 8.8 t . . . . . 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.438 -1.046 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' P' ' 6' ' ' THR . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.484 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.503 ' CD2' ' HB2' ' A' ' 881' ' ' PRO . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 899' ' ' ILE . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 897' ' ' VAL . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 908' ' ' GLN . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 907' ' ' MET . 18.2 mm-40 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.473 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.675 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.01 0.909 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.45 HG11 HE21 ' A' ' 866' ' ' GLN . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 867' ' ' ILE . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 50.3 m-80 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.45 HE21 HG11 ' A' ' 858' ' ' VAL . 52.8 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . 0.427 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . 0.618 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 899' ' ' ILE . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 897' ' ' VAL . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 907' ' ' MET . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 904' ' ' PRO . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . 0.453 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . 0.696 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' P' P ' 2' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 . . . . . 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' P' P ' 6' ' ' THR . . . . . 0.649 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 858' ' ' VAL . . . . . 0.513 HG11 HE21 ' A' ' 866' ' ' GLN . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 863' ' ' TRP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 865' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 866' ' ' GLN . . . . . 0.513 HE21 HG11 ' A' ' 858' ' ' VAL . 55.0 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 869' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 876' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 879' ' ' GLY . . . . . 0.649 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 883' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 886' ' ' ASP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 897' ' ' VAL . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' CYS . . . . . 0.45 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.633 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 905' ' ' GLU . 34.6 ttm180 -85.3 111.65 20.07 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 115.166 -0.924 . . . . 0.0 108.775 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.471 HG21 ' HD2' ' A' ' 903' ' ' PRO . 3.3 p -114.26 127.95 56.12 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.883 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.509 HM13 ' OG1' ' P' ' 6' ' ' THR . . . . . . . . 0 C--N 1.308 -1.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.33 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -116.82 125.43 51.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.509 ' OG1' HM13 ' P' ' 4' ' ' M3L . 0.3 OUTLIER -79.4 75.88 5.99 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.98 140.52 52.25 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.65 0.738 . . . . 0.0 112.872 -171.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -99.14 -5.99 29.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.197 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -152.32 119.3 5.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 34.4 t -137.87 149.83 46.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 23.8 m -97.94 104.59 16.63 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.04 -63.6 2.79 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.441 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 50.2 m -75.95 -15.46 60.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.185 0.493 . . . . 0.0 111.399 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -69.67 99.05 1.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.104 0.954 . . . . 0.0 111.263 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.07 -73.95 0.61 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 178.97 89.04 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 124.155 0.982 . . . . 0.0 109.898 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 41.8 tpp -85.54 77.13 9.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.181 0.991 . . . . 0.0 108.446 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -169.53 -176.86 2.58 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.551 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 79.3 m-85 -87.96 64.92 8.06 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 122.553 1.168 . . . . 0.0 111.946 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 868' ' ' TRP . 26.0 t -146.5 137.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.082 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.405 HG13 ' HB ' ' A' ' 867' ' ' ILE . 37.9 pt -135.71 170.32 19.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 17.5 ptt180 -114.86 148.71 38.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.67 -175.55 5.22 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -64.79 -27.98 69.25 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -80.57 -34.16 35.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.881 0.372 . . . . 0.0 110.169 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 118.03 23.09 3.68 Favored Glycine 0 C--N 1.305 -1.163 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.735 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.1 m-80 -89.07 147.96 23.97 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -77.69 125.9 30.05 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.368 0.604 . . . . 0.0 110.163 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.405 ' HB ' HG13 ' A' ' 859' ' ' ILE . 51.9 mm -110.46 118.29 56.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 858' ' ' VAL . 27.9 m-90 -85.57 142.61 29.0 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.635 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 21.1 mm -107.56 134.71 48.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.72 119.29 76.3 Favored Pre-proline 0 N--CA 1.429 -1.506 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.28 -7.0 19.73 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.464 2.109 . . . . 0.0 111.492 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.43 -52.66 8.29 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.079 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.3 p -107.72 -19.7 13.45 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 122.968 0.507 . . . . 0.0 111.622 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 79.39 20.84 0.65 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.486 1.514 . . . . 0.0 108.693 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.1 mttm -98.65 141.34 22.75 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.903 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 59.0 Cg_endo -72.79 168.65 24.02 Favored 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.206 1.937 . . . . 0.0 111.717 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.517 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 10.3 t70 -72.73 133.67 44.66 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.389 175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -104.11 6.89 36.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.656 0.741 . . . . 0.0 109.772 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 94.97 40.28 4.36 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.6 p -108.0 155.25 40.36 Favored Pre-proline 0 N--CA 1.412 -2.326 0 CA-C-N 113.431 -1.385 . . . . 0.0 110.383 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.86 120.11 7.11 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.103 1.869 . . . . 0.0 110.125 175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 71.5 mtp -120.64 156.54 31.47 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -118.09 135.31 58.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.28 137.9 13.53 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 31.1 t -71.15 152.21 43.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.89 -3.16 58.85 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.935 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -114.91 -62.68 1.57 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.926 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 28.7 p -81.73 -18.63 43.65 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.281 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 63.07 29.46 16.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.569 0.748 . . . . 0.0 110.745 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.498 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 9.0 t0 -81.91 160.64 23.36 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -121.01 110.12 15.88 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.304 0.573 . . . . 0.0 112.409 -173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -110.94 156.37 21.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.215 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.1 m80 -78.41 158.13 28.81 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.3 m0 -61.85 -54.47 50.67 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.25 -5.52 15.12 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 121.966 1.777 . . . . 0.0 112.985 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 42.9 m -93.27 -19.96 20.88 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.9 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 899' ' ' ILE . 16.1 m -118.76 -17.09 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 107.64 27.18 5.31 Favored Glycine 0 C--N 1.303 -1.277 0 C-N-CA 119.428 -1.368 . . . . 0.0 112.511 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.1 mm -105.22 140.95 21.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -131.52 -21.28 2.55 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.003 0.43 . . . . 0.0 110.835 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -135.27 146.27 48.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.95 84.03 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' P' ' 3' ' ' THR . 5.7 Cg_endo -83.83 159.5 14.01 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 C-N-CA 121.683 1.588 . . . . 0.0 108.611 170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.33 162.91 35.55 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.611 2.207 . . . . 0.0 111.345 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' P' ' 2' ' ' ARG . 37.4 mt-10 -72.62 -17.42 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.204 0.526 . . . . 0.0 110.554 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.98 -33.05 74.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.893 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 27.6 ttt -91.75 136.03 33.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.52 153.99 19.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.248 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -150.25 141.42 23.11 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.32 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -132.61 136.97 46.87 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 24.9 p -72.18 168.77 20.26 Favored Pre-proline 0 C--N 1.29 -2.019 0 O-C-N 123.994 0.809 . . . . 0.0 111.008 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.4 Cg_endo -54.65 -16.87 11.82 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 C-N-CA 123.225 2.617 . . . . 0.0 113.042 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 44.9 mtpt -75.09 -59.21 2.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 84.4 m -80.02 -37.44 34.13 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.282 -1.326 . . . . 0.0 114.297 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.47 63.15 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.028 0.442 . . . . 0.0 111.66 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -79.88 -42.57 23.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.859 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 62.8 pttt -68.4 -33.38 74.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 914' ' ' CYS . 40.1 mt -65.22 -43.88 95.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.437 174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 87.1 tttt 82.25 -40.34 0.12 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.684 1.593 . . . . 0.0 112.23 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.455 ' HB2' ' NZ ' ' A' ' 920' ' ' LYS . 7.9 mtmp? 62.56 65.01 0.87 Allowed 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 923' ' ' LYS . 10.6 t70 -65.84 161.36 21.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.329 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.45 -37.81 88.83 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.511 0.725 . . . . 0.0 110.388 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 921' ' ' ASP . 60.7 pttt -68.14 126.37 29.31 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.657 0.741 . . . . 0.0 110.864 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 . . . . . 0 C--N 1.29 -1.986 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.754 -178.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.608 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 11.1 mtm180 -62.73 116.52 5.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.265 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.472 HG21 ' HD2' ' A' ' 903' ' ' PRO . 5.6 p -124.4 139.32 54.01 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.351 -178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.517 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 CA--C 1.496 -1.134 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.229 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 144.15 46.8 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 166.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.56 -66.01 0.51 Allowed 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.681 0.613 . . . . 0.0 110.96 -174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -179.93 -87.51 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 123.914 0.885 . . . . 0.0 108.883 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -138.84 -51.62 0.56 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . 0.422 ' HD3' ' CA ' ' A' ' 879' ' ' GLY . 58.1 mtpt 63.92 20.18 12.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.395 1.093 . . . . 0.0 111.922 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 41.8 t -125.0 132.72 53.21 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -103.96 26.02 9.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 122.033 0.92 . . . . 0.0 109.405 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.37 -16.81 6.64 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.377 -0.916 . . . . 0.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.834 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.825 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 69.4 m -107.23 176.94 5.0 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 122.615 -0.344 . . . . 0.0 110.264 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -78.1 94.2 4.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.59 0.709 . . . . 0.0 110.287 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 77.8 mtp -105.69 -63.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.41 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 855' ' ' MET . . . 52.64 -96.61 0.05 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . 0.411 ' H ' ' HB3' ' A' ' 854' ' ' ALA . 52.8 mtm -149.41 161.04 42.88 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.11 90.63 0.09 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 125.485 1.514 . . . . 0.0 110.048 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.66 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 61.9 m-85 -107.9 11.32 28.1 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.981 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 6.3 p -84.37 116.48 28.17 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.369 0.604 . . . . 0.0 111.653 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 29.1 pt -123.0 170.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.7 mtt180 -107.61 152.35 24.4 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 118.366 0.53 . . . . 0.0 110.986 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -95.83 -172.38 2.58 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.95 -27.11 65.02 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 124.525 1.13 . . . . 0.0 113.346 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.464 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.0 m0 -96.8 -8.25 31.62 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 122.134 -0.353 . . . . 0.0 111.075 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.95 37.41 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.997 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.6 m-80 -81.38 145.21 30.94 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -82.11 122.5 27.93 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.858 0.837 . . . . 0.0 110.065 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 31.3 mm -111.43 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 27.7 m-90 -88.73 138.81 31.08 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' A' ' 857' ' ' TYR . 24.2 mm -104.26 130.04 55.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 174.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 874' ' ' ASN . 41.8 t -70.95 126.3 92.1 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.6 -3.91 14.6 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.001 1.801 . . . . 0.0 111.341 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.34 -60.66 3.2 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 5.1 p -104.75 -20.73 13.52 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 0.0 111.734 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 870' ' ' CYS . 26.0 t-20 68.57 71.02 0.29 Allowed 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.108 1.363 . . . . 0.0 109.029 -172.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.555 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 3.9 ttmp? -145.76 145.53 25.71 Favored Pre-proline 0 N--CA 1.412 -2.336 0 CA-C-N 112.82 -1.991 . . . . 0.0 106.758 -176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.56 168.63 23.36 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.341 2.027 . . . . 0.0 113.055 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 5.7 t70 -74.5 131.1 40.72 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.495 177.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -101.08 19.32 17.69 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.432 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 79.65 37.14 24.13 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 106.772 -2.531 . . . . 0.0 106.772 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 882' ' ' MET . 5.8 p -109.12 147.91 36.9 Favored Pre-proline 0 N--CA 1.41 -2.465 0 CA-C-N 113.163 -1.519 . . . . 0.0 112.991 -167.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 82.6 Cg_exo -50.4 121.4 7.72 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.287 2.658 . . . . 0.0 111.878 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.5 mtp -129.35 158.16 39.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.3 tt -129.3 133.76 64.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.279 0.561 . . . . 0.0 109.495 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -90.99 124.59 7.62 Favored Glycine 0 N--CA 1.418 -2.563 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 40.4 t -67.08 134.07 51.11 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -76.62 -6.52 52.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.06 -58.52 1.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 94.7 m -60.04 -35.4 75.02 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.56 0.538 . . . . 0.0 112.225 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.8 t70 68.99 18.7 8.36 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.532 1.158 . . . . 0.0 108.781 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -111.68 168.06 9.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.485 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.608 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 92.4 m95 -109.72 112.55 24.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -106.79 153.56 22.28 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -79.2 163.76 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.723 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.486 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.8 m0 -67.61 -56.31 12.47 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.3 -21.41 72.58 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.892 . . . . 0.0 112.699 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 12.9 m -75.73 -40.26 55.84 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.376 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 899' ' ' ILE . 31.1 m -98.39 -12.95 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.83 31.95 5.82 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.161 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 897' ' ' VAL . 27.6 mm -105.63 133.48 49.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -117.52 -22.71 8.01 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.175 0.512 . . . . 0.0 110.733 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.84 143.97 41.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -71.69 123.0 88.76 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 123.812 0.695 . . . . 0.0 111.94 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' P' ' 3' ' ' THR . 8.7 Cg_endo -85.6 160.11 10.79 Favored 'Trans proline' 0 N--CA 1.418 -2.915 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 169.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.84 141.8 91.28 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.093 1.862 . . . . 0.0 111.25 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 10.6 pt-20 -72.49 -18.51 61.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.273 0.559 . . . . 0.0 111.956 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.83 -10.92 56.69 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.049 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.6 tpt -96.81 148.37 22.99 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -93.95 148.09 22.48 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.52 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 75.7 t90 -151.33 143.93 24.3 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 124.303 1.041 . . . . 0.0 108.444 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -134.81 145.5 48.42 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 31.6 p -59.9 161.0 13.16 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -48.26 -30.24 14.57 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.02 2.48 . . . . 0.0 113.186 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -70.68 -53.68 14.79 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 109.382 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 77.0 m -70.66 -35.82 73.04 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.61 62.25 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.291 0.567 . . . . 0.0 111.064 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -70.47 -44.34 67.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.4 pttt -72.77 -10.31 59.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.639 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 914' ' ' CYS . 26.7 mt -91.48 -42.6 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -82.75 -31.98 28.09 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.942 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 54.75 28.5 10.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.971 0.908 . . . . 0.0 111.74 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 923' ' ' LYS . 0.6 OUTLIER 60.09 107.81 0.02 OUTLIER 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.125 0.97 . . . . 0.0 111.5 -172.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.65 -24.23 67.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.462 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 921' ' ' ASP . 61.9 mttp 75.19 119.67 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 125.328 1.451 . . . . 0.0 113.288 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.418 -2.053 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.863 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 8.9 ttm180 -86.98 115.76 24.59 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 23.6 p -118.19 134.13 55.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.748 HM32 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -164.13 138.03 5.47 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' P' ' 9' ' ' LYS . 9.2 t -152.86 -40.31 0.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.113 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.78 -155.13 0.29 Allowed 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -118.59 85.05 2.29 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' P' ' 6' ' ' THR . 67.8 mttm -70.62 135.27 48.3 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.431 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 7.2 m -67.12 -41.93 85.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.9 t -152.7 132.93 13.56 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.278 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.18 -41.89 3.88 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -178.662 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.635 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 6.4 p -94.93 175.24 6.72 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -66.55 -59.96 3.16 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.0 ttt -146.69 100.44 3.33 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.659 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.04 7.48 1.82 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.418 172.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 89.1 mtp 65.87 36.95 5.76 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.023 -174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 71.5 173.94 0.3 Allowed 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.792 1.637 . . . . 0.0 109.642 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -84.64 48.85 1.59 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.557 -0.714 . . . . 0.0 112.071 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.16 120.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.596 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.8 pt -115.24 170.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -108.41 132.0 54.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 1.6 t70 -71.68 165.29 24.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.146 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.17 -34.1 73.11 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 123.681 0.793 . . . . 0.0 112.158 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.407 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 30.2 m95 -87.98 1.48 54.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 122.68 0.392 . . . . 0.0 110.79 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 92.97 11.75 58.49 Favored Glycine 0 C--O 1.242 0.632 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 51.6 m-80 -77.09 150.14 35.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -85.45 125.45 33.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 46.2 mm -113.16 113.93 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.443 ' CZ3' HM21 ' P' ' 4' ' ' M3L . 18.9 m-90 -80.3 152.95 28.73 Favored 'General case' 0 C--N 1.278 -2.501 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.198 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.95 125.11 70.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.8 t -71.29 120.89 82.36 Favored Pre-proline 0 N--CA 1.432 -1.368 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -67.68 -12.54 35.87 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.429 2.086 . . . . 0.0 111.452 177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -76.07 -51.33 6.97 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.424 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 18.3 p -108.07 -21.57 12.75 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.23 12.34 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.107 1.363 . . . . 0.0 111.138 -174.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 98.1 mttt -90.25 144.74 31.5 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.83 163.4 35.68 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.729 2.286 . . . . 0.0 112.915 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 7.6 t70 -86.0 149.34 25.24 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 125.286 1.434 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -117.21 3.8 12.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.735 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.454 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 97.87 26.62 9.56 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -171.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -80.26 170.47 15.64 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 124.924 1.29 . . . . 0.0 111.429 -170.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -69.94 108.6 2.15 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.314 1.342 . . . . 0.0 109.539 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.748 ' SD ' HM32 ' P' ' 4' ' ' M3L . 70.7 mtp -125.79 159.32 32.73 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.145 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 19.7 tt -126.28 129.8 72.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -102.9 31.97 8.12 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.885 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 909' ' ' TRP . 46.9 t 56.5 -165.48 0.14 Allowed 'General case' 0 C--O 1.259 1.594 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -127.89 -7.01 5.55 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.0 -62.27 1.62 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.807 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 889' ' ' ASP . 25.2 p -72.43 -28.25 62.84 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 888' ' ' CYS . 25.6 t70 77.32 9.5 2.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.115 0.96 . . . . 0.0 110.264 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -85.38 137.61 32.82 Favored 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.725 -0.61 . . . . 0.0 109.58 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -89.7 111.3 22.24 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.197 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -104.17 150.78 24.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.014 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.724 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 40.0 m80 -77.96 156.69 30.07 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.531 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.6 m0 -62.99 -55.64 35.79 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.61 -8.02 19.78 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.993 1.795 . . . . 0.0 113.055 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.2 m -90.24 -20.41 23.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.489 HG23 HG12 ' A' ' 899' ' ' ILE . 27.3 m -119.94 -6.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.12 15.65 25.37 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.85 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 27.2 mm -96.72 134.25 35.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 84.5 mtp -117.74 -35.93 3.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -127.36 142.41 51.44 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -62.4 125.33 85.59 Favored Pre-proline 0 C--N 1.309 -1.178 0 O-C-N 123.809 0.693 . . . . 0.0 111.362 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.19 159.71 15.31 Favored 'Trans proline' 0 N--CA 1.439 -1.722 0 N-CA-C 108.188 -1.505 . . . . 0.0 108.188 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.44 147.22 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.139 1.893 . . . . 0.0 112.509 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.467 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 0.5 OUTLIER -76.06 -15.05 60.18 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.899 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.23 -6.88 57.56 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.91 0.862 . . . . 0.0 109.567 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 45.1 ttm -96.87 142.27 29.06 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -92.19 147.46 22.92 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.021 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 885' ' ' CYS . 81.3 t90 -151.68 139.49 19.88 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.65 142.82 50.45 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.72 163.17 70.1 Favored Pre-proline 0 C--N 1.305 -1.341 0 O-C-N 123.636 0.585 . . . . 0.0 110.707 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -50.99 -26.27 18.16 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.34 2.693 . . . . 0.0 113.213 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -76.14 -52.44 10.09 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 120.826 0.346 . . . . 0.0 110.584 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 65.8 m -69.21 -38.79 78.77 Favored 'General case' 0 C--O 1.202 -1.423 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.32 65.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.563 0.697 . . . . 0.0 111.137 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -75.9 -34.06 59.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.821 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 47.5 pttt -75.01 -17.3 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.213 0.53 . . . . 0.0 109.801 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 914' ' ' CYS . 41.0 mt -86.96 -42.71 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.114 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -76.09 -58.35 3.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.338 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 62.22 -176.41 0.13 Allowed 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.207 0.942 . . . . 0.0 111.64 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -147.47 125.29 11.91 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 70.42 174.73 0.3 Allowed 'General case' 0 C--O 1.246 0.873 0 O-C-N 124.28 0.988 . . . . 0.0 111.69 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -93.7 95.06 8.93 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.44 0.638 . . . . 0.0 109.903 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.423 -1.791 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.135 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -80.51 123.34 28.01 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.3 p -121.96 127.31 50.2 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.042 0.449 . . . . 0.0 111.451 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.545 ' HD3' HM33 ' P' ' 4' ' ' M3L . . . . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -142.73 115.86 8.89 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.533 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 86.6 m -67.81 -31.24 70.97 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.206 0.316 . . . . 0.0 111.403 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.08 151.06 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.701 1.201 . . . . 0.0 112.966 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -87.77 -3.69 58.93 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.969 -0.457 . . . . 0.0 110.579 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 63.46 28.89 15.5 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.692 0.797 . . . . 0.0 110.785 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.8 t -135.15 14.47 3.54 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.38 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m 67.17 92.52 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.668 0.747 . . . . 0.0 110.496 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.36 143.85 29.94 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.223 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.464 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 177.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 22.7 t -82.72 93.01 7.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.64 99.6 8.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -90.88 155.74 18.53 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.128 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -79.51 95.99 5.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -146.01 19.29 1.43 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.489 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 67.72 -158.99 0.22 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.407 1.083 . . . . 0.0 109.556 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.34 7.32 19.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 868' ' ' TRP . 7.3 p -91.1 132.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-O 121.225 0.536 . . . . 0.0 110.878 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.85 165.93 11.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -104.21 136.37 43.95 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.973 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.06 170.69 16.19 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.36 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.79 -28.9 68.76 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.11 0.564 . . . . 0.0 111.793 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -95.53 9.46 40.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.182 0.515 . . . . 0.0 110.546 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.69 62.62 Favored Glycine 0 C--N 1.314 -0.688 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.244 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.53 143.76 34.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -86.67 122.46 30.61 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.561 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.9 mm -115.45 114.45 46.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 858' ' ' VAL . 19.1 m-90 -89.91 133.16 34.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.558 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -91.02 126.11 43.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -76.4 122.24 86.35 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.7 2.53 4.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.363 2.042 . . . . 0.0 111.734 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -86.1 -37.44 9.16 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.874 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.2 p -122.51 -13.63 7.96 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 70.2 25.58 4.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 122.822 1.296 . . . . 0.0 107.812 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 139.05 22.16 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.058 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 57.5 Cg_endo -72.95 171.22 17.94 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.852 2.368 . . . . 0.0 112.911 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.521 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 34.3 t0 -72.18 120.54 17.93 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.416 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.94 -9.59 30.86 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.742 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.533 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 118.68 35.03 1.01 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 4.8 p -110.05 163.14 17.83 Favored Pre-proline 0 C--N 1.276 -2.589 0 CA-C-N 113.921 -1.139 . . . . 0.0 111.147 -171.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 2.7 Cg_exo -78.55 130.7 10.01 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.085 1.857 . . . . 0.0 110.519 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.521 ' SD ' HM32 ' P' ' 4' ' ' M3L . 50.8 mtp -125.41 155.38 40.49 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.0 tt -126.92 139.21 52.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -104.61 128.74 9.57 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.089 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.7 t -68.26 135.3 51.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.24 -13.13 58.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.449 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 7.9 t0 -91.0 -57.39 2.82 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 23.9 p -92.15 -21.88 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 23.8 t70 66.22 69.07 0.44 Allowed 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.964 1.364 . . . . 0.0 108.793 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.28 152.91 51.95 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.783 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -117.51 119.96 36.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -115.75 159.05 21.93 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.429 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.691 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 38.0 m80 -81.03 159.36 24.83 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 173.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.484 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.9 m0 -60.84 -56.68 32.73 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.41 -20.37 69.93 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.99 1.794 . . . . 0.0 113.114 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 54.5 m -78.44 -27.75 46.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.811 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 899' ' ' ILE . 15.9 m -108.6 -14.35 9.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 100.39 20.79 14.36 Favored Glycine 0 C--N 1.307 -1.035 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.986 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 19.7 mm -88.73 135.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.3 mtt -122.61 -30.15 3.94 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.196 0.522 . . . . 0.0 110.526 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -129.35 155.82 45.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -84.35 127.58 65.51 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 123.126 0.266 . . . . 0.0 111.184 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -85.39 158.77 11.02 Favored 'Trans proline' 0 N--CA 1.419 -2.906 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -68.11 154.86 71.48 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.566 1.511 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.1 pm0 -73.47 -11.06 60.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.336 0.589 . . . . 0.0 110.789 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.26 -4.81 59.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.744 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.5 ttt -110.0 142.38 41.48 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -98.94 151.44 20.88 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.851 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -143.58 144.81 32.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 56.2 m-85 -130.46 139.5 50.55 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.47 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.7 p -65.81 163.97 31.38 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 123.559 0.537 . . . . 0.0 109.689 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.9 Cg_endo -57.25 -11.4 8.0 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.929 2.419 . . . . 0.0 113.359 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -83.04 -55.6 4.28 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.79 -27.64 58.06 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -15.66 55.62 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.145 0.498 . . . . 0.0 110.767 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -80.69 -37.16 31.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.785 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -61.97 -22.51 65.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.279 0.561 . . . . 0.0 111.43 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 46.4 mt -70.34 -33.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.432 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -83.75 -16.4 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.14 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -66.83 -32.32 73.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.3 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.37 -45.88 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.52 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 64.8 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.878 0.871 . . . . 0.0 112.967 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -86.7 172.25 10.33 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 74.4 t60 . . . . . 0 C--N 1.291 -1.953 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 176.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.574 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.487 -1.457 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -106.3 126.91 52.82 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 882' ' ' MET . 30.6 p -123.66 133.42 53.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 118.154 0.434 . . . . 0.0 111.473 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.563 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.316 -0.848 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -114.26 127.82 56.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.228 0.33 . . . . 0.0 110.326 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.511 ' OG1' HM23 ' P' ' 4' ' ' M3L . 0.2 OUTLIER -92.56 37.22 1.0 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.079 0.942 . . . . 0.0 110.358 -176.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 879' ' ' GLY . . . -110.18 10.72 23.81 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.425 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 67.45 5.36 4.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.498 1.119 . . . . 0.0 110.864 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -92.02 92.08 8.13 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.8 p -121.11 157.09 30.87 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.255 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -91.7 -74.39 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.78 11.58 10.17 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.401 -3.694 0 N-CA-C 105.411 -3.076 . . . . 0.0 105.411 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.766 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.3 m -83.38 174.07 10.99 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -88.1 68.94 9.23 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.687 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 96.1 mmm -65.04 -45.0 87.24 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -93.64 101.08 13.23 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.6 ptp -105.01 9.7 34.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.903 0.859 . . . . 0.0 109.863 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -83.84 148.2 27.12 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 869' ' ' ILE . 85.6 m-85 -95.35 19.61 10.54 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 122.347 1.07 . . . . 0.0 111.392 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.557 HG11 HE21 ' A' ' 866' ' ' GLN . 57.7 t -119.93 119.38 60.01 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.767 172.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 48.2 pt -129.49 170.42 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 78.0 mtt180 -104.85 143.05 33.68 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.868 175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.424 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 9.4 p-10 -81.54 -171.35 3.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.23 -27.14 68.78 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.635 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 16.0 m95 -87.13 -31.65 20.3 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.595 0.236 . . . . 0.0 110.668 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.33 26.54 3.69 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.117 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 24.0 m-80 -101.47 159.87 14.91 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.557 HE21 HG11 ' A' ' 858' ' ' VAL . 60.4 mt-30 -73.52 126.01 29.25 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.18 0.514 . . . . 0.0 110.584 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 51.0 mm -116.46 133.26 63.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 176.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -99.1 134.29 42.16 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.306 0.574 . . . . 0.0 110.612 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 857' ' ' TYR . 36.8 mm -104.7 131.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 39.2 t -79.23 123.85 84.56 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -68.78 -7.49 20.74 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.051 1.834 . . . . 0.0 111.376 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.89 -56.83 5.16 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 7.1 p -98.95 -31.56 11.76 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.746 0.308 . . . . 0.0 111.271 -177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 874' ' ' ASN . 0.8 OUTLIER 85.0 30.64 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.183 1.793 . . . . 0.0 110.142 -174.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.17 152.44 45.88 Favored Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.412 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.56 168.02 24.79 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 122.313 2.009 . . . . 0.0 109.556 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.524 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 28.8 t0 -78.54 131.34 36.75 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.136 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.07 -29.42 28.81 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' P' ' 7' ' ' ALA . . . 132.4 62.58 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.272 0 N-CA-C 108.326 -1.91 . . . . 0.0 108.326 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 35.9 m -130.99 162.63 54.37 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -65.21 125.85 15.32 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.038 1.825 . . . . 0.0 110.362 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.563 ' SD ' HM12 ' P' ' 4' ' ' M3L . 65.5 mtp -114.84 155.7 26.31 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.62 134.06 66.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.771 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -96.52 128.16 9.44 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 889' ' ' ASP . 37.2 t -65.5 156.78 31.45 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.472 0.748 . . . . 0.0 109.143 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.469 ' HB3' HE21 ' A' ' 908' ' ' GLN . 6.3 m-20 -93.3 -12.45 30.04 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.846 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.09 -52.28 4.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 118.719 -1.193 . . . . 0.0 109.93 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.71 -21.61 21.52 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.2 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.572 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 35.1 t70 61.85 30.26 18.17 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 123.061 1.41 . . . . 0.0 109.227 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.414 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 35.0 t0 -99.48 164.87 11.91 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.51 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -110.03 116.29 31.3 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -113.82 160.23 18.94 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -83.9 154.13 23.58 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 36.8 m0 -59.03 -57.73 24.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -65.84 -14.72 45.93 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 121.995 1.797 . . . . 0.0 113.171 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 68.8 m -81.12 -32.55 33.76 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.452 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.51 HG23 HG12 ' A' ' 899' ' ' ILE . 26.9 m -107.44 -8.99 10.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.05 20.53 20.68 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.618 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.7 mm -92.8 125.35 45.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.0 mtt -113.71 -21.78 10.56 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 120.918 0.39 . . . . 0.0 110.647 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.05 143.48 38.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.817 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -74.23 120.56 82.0 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 123.743 0.652 . . . . 0.0 112.069 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -81.26 160.53 20.2 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 C-N-CA 121.522 1.482 . . . . 0.0 109.277 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.31 146.24 80.24 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.793 1.662 . . . . 0.0 110.861 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 905' ' ' GLU . 2.9 mp0 -50.28 -44.47 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 124.705 1.202 . . . . 0.0 110.437 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -70.08 -12.82 61.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.171 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -89.2 134.55 33.99 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.469 HE21 ' HB3' ' A' ' 886' ' ' ASP . 45.1 mt-30 -89.65 145.99 24.85 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.09 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -144.84 144.43 31.12 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.128 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.4 m-85 -133.85 139.45 46.24 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 25.1 p -67.82 166.62 21.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 123.659 0.6 . . . . 0.0 111.549 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 11.4 Cg_endo -55.82 -9.63 3.16 Favored 'Trans proline' 0 CA--C 1.553 1.427 0 C-N-CA 123.532 2.821 . . . . 0.0 113.262 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mmtp -88.89 -57.35 2.94 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.6 m -74.51 -39.8 62.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.11 -27.52 66.54 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.197 0.998 . . . . 0.0 110.281 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 27.2 t-20 -70.05 -45.9 66.16 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.267 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.8 pttt -68.19 -28.58 67.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.42 -175.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 914' ' ' CYS . 43.8 mt -67.65 -43.65 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 0.0 109.934 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -76.17 -7.68 55.34 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.339 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 916' ' ' ASN . 62.4 mtpt -85.83 4.38 37.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.682 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.49 -5.73 59.31 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . 0.309 47.0 tptt 89.43 92.27 0.02 OUTLIER 'General case' 0 C--O 1.244 0.81 0 C-N-CA 127.409 2.284 . . . . 0.0 112.736 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -92.31 145.4 24.51 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.433 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 54.2 t60 . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.622 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.93 132.86 36.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -119.64 145.62 46.29 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.177 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.581 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.291 -1.936 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -152.23 -58.69 0.15 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 27.8 m 57.94 76.87 0.31 Allowed 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.525 1.14 . . . . 0.0 111.746 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.91 81.86 3.47 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.35 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -122.76 6.59 9.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.301 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 878' ' ' ASP . 38.8 ttpt -156.98 -64.97 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m 69.39 151.95 0.09 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 30.7 m -82.47 -31.83 29.2 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.606 0.717 . . . . 0.0 109.183 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.67 -36.46 0.02 OUTLIER Glycine 0 CA--C 1.491 -1.448 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.087 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 176.002 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.528 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -73.78 109.39 7.26 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -74.53 104.96 5.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.92 119.37 13.14 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.39 0.23 Allowed 'General case' 0 C--N 1.317 -0.806 0 O-C-N 123.757 0.66 . . . . 0.0 111.849 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 59.2 mtt -141.72 116.53 9.81 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.928 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.54 136.35 42.14 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 173.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.15 -3.42 52.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.393 0.616 . . . . 0.0 111.25 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.489 HG11 HE21 ' A' ' 866' ' ' GLN . 41.5 t -90.41 110.75 22.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.7 pt -118.66 170.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 70.9 mtt180 -106.92 143.31 35.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.455 0.169 . . . . 0.0 110.87 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.24 -169.82 2.64 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -63.02 -29.55 70.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.06 0.457 . . . . 0.0 111.638 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.546 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 35.0 m95 -87.56 -1.05 57.68 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.19 0.596 . . . . 0.0 111.401 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 73.46 33.23 58.82 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.505 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 32.5 m-80 -94.09 163.66 13.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.489 HE21 HG11 ' A' ' 858' ' ' VAL . 56.3 mt-30 -83.22 120.65 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 40.1 mm -116.25 128.82 73.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -97.17 118.09 32.83 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.408 0.623 . . . . 0.0 111.654 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.25 126.53 40.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 42.6 t -72.96 128.68 87.61 Favored Pre-proline 0 N--CA 1.438 -1.038 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 14.9 Cg_exo -71.8 -3.21 12.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.036 1.824 . . . . 0.0 112.137 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -75.98 -56.91 4.25 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.971 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 1.8 p -106.38 -30.29 9.22 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 122.951 0.501 . . . . 0.0 111.336 -176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 874' ' ' ASN . 13.6 m120 84.16 32.3 0.05 Allowed 'General case' 0 C--O 1.241 0.656 0 C-N-CA 126.559 1.943 . . . . 0.0 109.959 -172.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 32.5 ttmt -101.69 138.72 19.92 Favored Pre-proline 0 N--CA 1.427 -1.597 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.552 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.82 178.87 6.25 Favored 'Trans proline' 0 C--O 1.254 1.287 0 C-N-CA 123.986 3.124 . . . . 0.0 113.037 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -72.08 95.66 1.65 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.962 1.363 . . . . 0.0 109.553 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' P' ' 9' ' ' LYS . 27.4 t70 -90.1 -17.78 27.07 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.681 -1.6 . . . . 0.0 110.357 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 121.01 27.17 1.92 Allowed Glycine 0 C--N 1.302 -1.307 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.053 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 24.6 m -104.15 152.45 39.17 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 31.4 Cg_exo -62.41 126.53 18.66 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.379 2.052 . . . . 0.0 111.605 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.476 ' HG2' ' CD2' ' A' ' 893' ' ' HIS . 57.9 mtp -122.9 154.14 38.72 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.749 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.1 tt -127.77 137.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.94 137.61 13.48 Favored Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.927 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.1 t -76.13 141.95 41.77 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.49 ' HB3' HE21 ' A' ' 908' ' ' GLN . 22.2 m-20 -86.01 -12.58 49.93 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.973 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 14.8 t70 -90.01 -55.49 3.6 Favored 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.424 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 889' ' ' ASP . 12.5 p -83.23 -84.85 0.13 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 20.1 t70 157.52 5.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 125.723 1.609 . . . . 0.0 108.356 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.452 ' H ' ' H ' ' A' ' 889' ' ' ASP . 4.3 t0 -78.06 162.72 26.49 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -170.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.7 120.94 33.26 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 122.894 0.477 . . . . 0.0 110.287 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.5 157.38 26.4 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 50.8 m80 -80.5 156.49 26.51 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.598 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 45.4 m0 -60.09 -53.41 65.41 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.99 -18.1 62.39 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 121.996 1.797 . . . . 0.0 112.599 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 51.9 m -80.0 -28.77 39.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 899' ' ' ILE . 22.7 m -111.23 -20.26 6.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.15 29.56 5.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.324 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.6 mm -98.68 125.89 51.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -109.43 -25.74 10.36 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 122.189 -0.32 . . . . 0.0 111.674 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.38 145.64 39.2 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.03 124.92 90.73 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 123.818 0.699 . . . . 0.0 111.686 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.07 157.26 20.3 Favored 'Trans proline' 0 N--CA 1.43 -2.219 0 N-CA-C 107.911 -1.611 . . . . 0.0 107.911 172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.583 ' HB2' ' HG2' ' A' ' 906' ' ' GLU . 60.8 Cg_endo -70.71 163.96 37.18 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 C-N-CA 121.898 1.732 . . . . 0.0 111.355 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.83 -17.84 59.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.623 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 904' ' ' PRO . 11.3 pt-20 -74.05 -12.26 60.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.514 0.673 . . . . 0.0 109.585 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.9 tpt -102.55 138.55 39.32 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.49 HE21 ' HB3' ' A' ' 886' ' ' ASP . 50.5 mt-30 -95.05 154.21 17.28 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.149 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -144.74 143.87 30.91 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.568 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 56.6 m-85 -132.82 135.1 45.45 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.3 p -65.26 160.07 60.92 Favored Pre-proline 0 C--N 1.309 -1.193 0 O-C-N 123.868 0.73 . . . . 0.0 111.36 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -52.88 -16.47 6.02 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.686 2.924 . . . . 0.0 114.006 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -82.45 -52.88 6.46 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.8 m -72.88 -37.87 67.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -69.43 -26.89 64.83 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.952 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -77.15 -42.35 38.13 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -66.59 -16.83 64.46 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.635 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 914' ' ' CYS . 67.3 mt -62.51 -42.85 97.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 C-N-CA 123.127 0.571 . . . . 0.0 111.136 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -170.3 -45.74 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.442 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.277 23.4 pttp 49.79 77.92 0.1 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-O 122.531 1.158 . . . . 0.0 110.719 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.14 146.29 53.57 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.859 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -75.75 -14.98 60.33 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.896 0.379 . . . . 0.0 111.46 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -91.74 109.6 20.92 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.263 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -92.83 132.17 37.23 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -120.41 137.5 54.28 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.526 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.458 HM31 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -149.9 125.48 10.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 31.8 m -69.23 -50.8 43.9 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.335 0.588 . . . . 0.0 110.548 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -173.14 -171.24 0.71 Allowed 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -133.32 111.78 11.1 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.762 0.791 . . . . 0.0 111.455 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 114.89 18.25 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.983 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 t -131.18 123.42 28.47 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -89.8 -24.81 21.36 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.46 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.38 -59.35 3.03 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.199 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 178.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.713 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 33.5 p -119.79 25.07 10.22 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-O 120.963 0.411 . . . . 0.0 110.778 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.12 -38.05 78.67 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 90.8 mtp -79.29 118.21 20.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.044 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.39 -178.76 4.99 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.191 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 72.0 mtm -68.57 117.33 10.17 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -66.98 78.11 0.12 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . 0.257 98.5 m-85 64.79 -39.87 0.26 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 127.406 2.282 . . . . 0.0 116.809 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.68 109.16 20.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-O 122.04 0.924 . . . . 0.0 110.031 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.1 pt -114.4 170.94 4.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 26.0 ptt180 -112.76 153.89 27.07 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.559 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -97.79 -176.62 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.29 -14.45 62.95 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.425 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.8 m0 -96.17 -15.85 21.83 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 104.1 14.46 24.45 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.538 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 38.8 m-80 -85.53 148.01 26.16 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 117.214 0.507 . . . . 0.0 109.948 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -82.33 121.34 26.56 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 37.9 mm -108.56 125.15 65.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.458 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 10.9 m-90 -95.78 113.9 25.58 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.449 0.642 . . . . 0.0 111.437 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.1 mm -78.87 112.61 17.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 36.7 t -63.99 119.47 55.48 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.29 -2.61 6.15 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.769 2.312 . . . . 0.0 113.091 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -83.53 -48.32 5.34 Favored Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.774 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.7 p -112.29 -17.34 12.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.092 0.472 . . . . 0.0 111.777 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 71.56 20.95 4.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.145 1.378 . . . . 0.0 110.868 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -98.13 143.36 26.13 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.261 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 172.48 15.56 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.26 2.64 . . . . 0.0 112.546 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.7 142.84 26.92 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.002 0.43 . . . . 0.0 110.169 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -168.54 9.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.239 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . -174.13 -80.09 0.05 OUTLIER Glycine 0 CA--C 1.477 -2.307 0 C-N-CA 118.058 -2.02 . . . . 0.0 113.417 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 881' ' ' PRO . 7.2 m -47.76 141.17 7.78 Favored Pre-proline 0 C--O 1.244 0.776 0 O-C-N 125.431 1.312 . . . . 0.0 112.778 -172.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 25.6 Cg_exo -59.57 143.73 99.6 Favored 'Trans proline' 0 C--O 1.252 1.178 0 C-N-CA 122.851 2.367 . . . . 0.0 111.38 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.4 mtp -125.73 156.09 39.95 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.819 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -133.4 140.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.55 133.05 11.21 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.703 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 44.7 t -74.49 141.52 44.91 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -99.27 6.47 46.24 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.699 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 11.7 t70 -117.27 -59.39 1.95 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.802 -0.759 . . . . 0.0 112.268 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 27.3 p -77.9 -81.17 0.1 Allowed 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.415 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.13 -56.13 0.22 Allowed 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 -175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 891' ' ' TRP . 2.9 m-20 -144.93 -164.3 1.9 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -162.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.464 ' H ' ' HB3' ' A' ' 890' ' ' ASP . 68.7 m95 -86.6 145.53 26.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.427 -1.26 . . . . 0.0 113.985 -172.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -127.01 164.11 22.23 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -84.12 154.45 23.14 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 31.4 m0 -57.14 -58.51 17.42 Favored Pre-proline 0 C--N 1.311 -1.065 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.7 -16.09 49.37 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.002 1.801 . . . . 0.0 113.075 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.5 m -78.13 -36.54 47.69 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.845 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 899' ' ' ILE . 28.1 m -100.72 -16.42 7.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 105.35 25.04 6.84 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 120.195 -1.003 . . . . 0.0 112.429 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.5 mm -100.89 128.31 53.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 70.5 mtm -124.96 -7.66 7.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.75 146.65 39.79 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -81.77 120.86 78.74 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -79.19 164.77 24.27 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.925 1.75 . . . . 0.0 108.983 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.7 142.87 65.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.814 1.676 . . . . 0.0 110.403 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.8 -4.93 46.09 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.28 -29.65 57.48 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.8 tpt -87.38 145.52 26.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.45 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -98.82 154.33 18.1 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.448 0.642 . . . . 0.0 110.993 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.483 ' NE1' HD11 ' A' ' 899' ' ' ILE . 81.9 t90 -139.74 145.52 38.4 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 41.2 m-85 -134.18 135.87 43.35 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 27.8 p -58.95 164.34 4.49 Favored Pre-proline 0 C--N 1.32 -0.685 0 O-C-N 123.59 0.556 . . . . 0.0 111.953 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 8.9 Cg_endo -51.9 -13.59 1.85 Allowed 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.698 2.932 . . . . 0.0 113.965 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.7 -57.01 3.51 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.702 ' O ' HG12 ' A' ' 918' ' ' ILE . 73.7 m -70.1 -47.79 60.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.258 -172.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -67.59 -19.8 65.29 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.431 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -75.35 -48.42 23.09 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.969 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 40.3 pttt -66.44 -27.48 67.85 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.44 -176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.702 HG12 ' O ' ' A' ' 914' ' ' CYS . 35.8 mm -66.87 -45.52 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.648 0.737 . . . . 0.0 109.739 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -89.19 -21.14 23.43 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.65 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 920' ' ' LYS 0.256 0.0 OUTLIER -64.62 121.38 14.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.223 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -100.48 -61.23 1.39 Allowed 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 57.4 tttm 43.52 85.04 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.673 ' HG2' ' H ' ' A' ' 924' ' ' HIS 0.306 0.0 OUTLIER -170.27 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.855 1.262 . . . . 0.0 109.96 167.176 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . 0.673 ' H ' ' HG2' ' A' ' 923' ' ' LYS . 30.2 p80 . . . . . 0 C--N 1.282 -2.365 0 C-N-CA 128.324 2.65 . . . . 0.0 104.583 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -80.59 132.4 35.63 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 18.2 p -124.09 130.37 52.45 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.008 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.549 ' HG3' ' CH2' ' A' ' 891' ' ' TRP . . . . . . . . 0 N--CA 1.439 -1.006 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.071 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -146.18 149.72 34.5 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.441 ' OG1' ' HA2' ' A' ' 879' ' ' GLY . 30.0 m -56.81 -46.05 81.87 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.591 0.632 . . . . 0.0 110.93 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.58 100.26 5.69 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . 0.437 ' H ' ' HD2' ' P' ' 8' ' ' ARG . 5.7 mpt_? -76.72 -40.42 48.66 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt 68.37 29.43 5.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.919 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 32.8 t -85.54 -30.09 23.66 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.975 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 12.2 m -85.35 75.85 10.19 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.57 -169.97 35.73 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.757 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.236 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.77 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 13.9 p -74.48 -44.48 51.3 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.263 0.554 . . . . 0.0 110.679 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -103.15 87.93 3.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.584 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 17.1 tpt -97.93 -53.42 3.4 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 52.09 -159.15 0.12 Allowed 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.797 1.311 . . . . 0.0 112.266 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 28.3 ttt -143.02 86.39 1.92 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.44 0.85 Allowed 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.854 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -85.58 -7.8 58.65 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.92 107.71 16.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.065 0.936 . . . . 0.0 109.274 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 34.4 pt -116.24 169.68 6.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.278 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -104.33 137.97 41.45 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.833 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.2 173.95 11.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.575 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.49 -28.44 64.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.103 0.561 . . . . 0.0 111.054 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.452 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -85.59 0.12 53.44 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.058 0.456 . . . . 0.0 109.798 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 82.16 43.4 8.12 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.206 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 46.5 m-80 -107.33 145.62 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -82.96 116.17 22.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.83 126.75 67.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -96.53 115.12 26.91 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.81 127.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.24 121.17 83.46 Favored Pre-proline 0 N--CA 1.428 -1.53 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -68.2 -1.02 6.42 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.244 1.963 . . . . 0.0 112.329 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -53.96 3.49 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.024 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 875' ' ' LYS . 4.8 p -109.84 -11.86 14.65 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.26 22.22 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.009 1.324 . . . . 0.0 108.531 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.9 tttp -101.18 138.26 19.91 Favored Pre-proline 0 N--CA 1.421 -1.898 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.68 175.18 9.94 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.168 2.579 . . . . 0.0 112.281 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.94 99.09 2.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 123.447 1.594 . . . . 0.0 109.25 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -91.03 -11.38 38.97 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 112.69 -2.05 . . . . 0.0 110.958 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' P' ' 6' ' ' THR . . . 124.7 -15.09 7.56 Favored Glycine 0 C--N 1.292 -1.88 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.402 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 39.6 m -70.03 148.87 96.26 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.24 141.92 77.66 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.827 2.351 . . . . 0.0 111.286 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.473 ' SD ' HM22 ' P' ' 4' ' ' M3L . 60.3 mtp -129.29 156.0 44.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.46 137.55 54.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -92.4 123.59 7.34 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 45.3 t -67.61 138.91 56.77 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.18 -7.02 57.88 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -106.21 -52.91 2.72 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.689 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 79.7 m -65.77 -43.12 89.81 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.761 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 10.3 t70 72.22 13.62 5.67 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.718 1.607 . . . . 0.0 108.834 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -98.74 169.84 9.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.027 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.549 ' CH2' ' HG3' ' P' ' 4' ' ' M3L . 98.5 m95 -106.12 126.38 52.14 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -122.19 141.51 51.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 48.1 m80 -72.8 157.74 36.9 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.686 -0.805 . . . . 0.0 110.096 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.578 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 42.2 m0 -61.88 -59.04 14.41 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.75 -24.97 78.18 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 121.845 1.697 . . . . 0.0 112.78 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 23.8 m -71.67 -41.08 69.14 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.98 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 899' ' ' ILE . 27.1 m -93.39 -22.86 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.161 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 113.37 17.57 7.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.913 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.9 mm -93.68 129.45 44.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.8 ptp -114.18 -26.33 8.09 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.409 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.57 146.04 49.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -70.16 128.25 91.65 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 123.7 0.625 . . . . 0.0 111.472 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.61 171.55 15.58 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.28 1.986 . . . . 0.0 107.927 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 907' ' ' MET . 23.4 Cg_exo -63.42 143.19 87.88 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 121.007 1.138 . . . . 0.0 109.527 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -79.19 -2.07 39.25 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.089 0.471 . . . . 0.0 110.581 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.42 -17.68 29.95 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 904' ' ' PRO . 14.9 tpt -83.08 141.96 31.63 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.23 147.93 24.12 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.729 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -146.3 143.01 28.86 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.543 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 77.4 m-85 -131.93 141.26 49.28 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.444 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.1 p -59.52 165.15 4.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.466 0.479 . . . . 0.0 110.83 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.7 Cg_endo -54.35 -8.67 1.19 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.379 2.72 . . . . 0.0 114.148 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -94.13 -51.86 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.509 ' O ' HG13 ' A' ' 918' ' ' ILE . 88.6 m -69.4 -37.71 77.62 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -77.57 -15.41 59.27 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.076 0.941 . . . . 0.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.31 -40.23 12.25 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.214 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 914' ' ' CYS . 61.1 pttt -63.13 -28.24 69.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 914' ' ' CYS . 49.1 mt -74.89 -31.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.19 0.519 . . . . 0.0 110.318 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -98.65 78.89 2.4 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 122.155 0.978 . . . . 0.0 111.208 -173.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -136.48 18.41 3.12 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.395 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -60.31 100.89 0.11 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.929 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 57.88 26.87 13.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.061 0.944 . . . . 0.0 110.955 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -141.16 -179.01 5.86 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.906 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.426 ' NH2' ' HZ2' ' A' ' 891' ' ' TRP . 18.2 ttp180 -91.14 128.27 36.89 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -113.37 134.59 54.55 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.602 0.239 . . . . 0.0 111.049 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.54 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.416 -2.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . 0.436 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.4 tt0 -164.45 152.32 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 38.2 m -135.06 80.32 1.83 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.847 0.832 . . . . 0.0 109.689 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.42 -175.78 3.81 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.202 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.95 -47.89 70.82 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 124.449 1.1 . . . . 0.0 108.457 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -104.98 134.73 47.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.9 t 65.02 82.0 0.2 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.917 0.865 . . . . 0.0 109.429 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -95.72 -20.54 18.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.629 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.66 -143.93 6.56 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.817 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.765 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 32.2 t -162.41 137.39 6.93 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 858' ' ' VAL . 68.0 t60 -137.56 104.66 5.4 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.376 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 3.7 tpt -147.4 34.46 0.87 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -117.53 144.78 44.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.895 -175.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.49 88.7 4.45 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -132.38 -153.88 0.58 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.237 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 852' ' ' HIS . 99.3 t -89.62 117.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 45.3 pt -126.49 170.38 16.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 49.5 mtm180 -101.86 150.25 23.36 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -84.43 -170.18 2.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -64.33 -28.61 69.82 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -90.22 -11.2 41.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 101.14 16.33 25.7 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.887 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.9 m-80 -90.29 149.65 22.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -74.36 121.52 21.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.473 0.654 . . . . 0.0 110.963 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 51.7 mm -111.45 119.24 59.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.429 ' CZ3' HM11 ' P' ' 4' ' ' M3L . 10.0 m-90 -89.14 124.86 34.73 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.284 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -88.5 124.21 41.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 170.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.06 117.78 55.14 Favored Pre-proline 0 N--CA 1.427 -1.596 0 O-C-N 124.209 0.943 . . . . 0.0 108.871 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 892' ' ' TYR . 7.6 Cg_exo -72.04 7.91 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.597 2.198 . . . . 0.0 112.394 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -93.03 -28.41 11.95 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 16.8 p -126.67 -25.67 3.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.951 0.405 . . . . 0.0 111.369 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 75.8 25.41 1.15 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.946 1.298 . . . . 0.0 110.414 -174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -106.45 137.32 19.4 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 35.0 Cg_endo -68.67 169.72 16.82 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.581 2.188 . . . . 0.0 112.461 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 879' ' ' GLY . 22.5 t70 -98.23 144.47 27.64 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.74 1.59 23.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.778 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 102.19 43.31 2.07 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.54 169.32 8.05 Favored Pre-proline 0 C--N 1.294 -1.838 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 28.1 Cg_exo -65.15 111.08 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 121.922 1.748 . . . . 0.0 110.424 174.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 46.7 mtp -120.4 160.37 23.21 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.7 tt -125.95 137.36 57.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -100.18 127.76 9.35 Favored Glycine 0 N--CA 1.425 -2.078 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.079 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.67 128.55 36.86 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.17 -11.79 60.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.3 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -103.15 -58.76 1.82 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.36 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 91.5 m -70.54 -32.2 69.55 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 34.7 t70 59.14 70.0 0.68 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 123.023 1.392 . . . . 0.0 108.104 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 892' ' ' TYR . 27.1 t0 -143.82 160.7 40.29 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.426 ' HZ2' ' NH2' ' P' ' 2' ' ' ARG . 96.2 m95 -116.26 109.72 17.8 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.663 0.744 . . . . 0.0 111.979 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 871' ' ' PRO . 76.8 m-85 -109.43 145.01 36.86 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.859 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.6 m80 -74.45 155.17 38.32 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.564 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 43.0 m0 -59.09 -58.13 21.88 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.78 -21.56 72.44 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 121.932 1.754 . . . . 0.0 113.066 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.4 m -74.95 -37.33 62.0 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.643 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.481 HG23 HG12 ' A' ' 899' ' ' ILE . 22.4 m -101.56 -12.84 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 106.52 18.41 11.0 Favored Glycine 0 C--N 1.316 -0.549 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.777 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 32.8 mm -95.86 133.76 35.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.5 mmt -118.42 -23.44 7.2 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.802 0.334 . . . . 0.0 110.587 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.0 161.67 36.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -88.22 118.44 69.55 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -86.75 159.45 9.07 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.115 1.877 . . . . 0.0 110.14 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.25 154.02 61.7 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.199 1.933 . . . . 0.0 112.031 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.26 -15.84 62.96 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 111.007 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.66 -35.06 76.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.067 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 15.5 tpt -88.84 131.06 35.26 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -90.49 146.46 24.09 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -138.73 138.57 37.8 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 914' ' ' CYS . 45.6 m-85 -129.94 147.44 51.7 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 28.2 p -63.65 165.59 11.7 Favored Pre-proline 0 C--N 1.312 -1.044 0 O-C-N 123.579 0.549 . . . . 0.0 110.023 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -51.24 -18.01 4.58 Favored 'Trans proline' 0 CA--C 1.549 1.274 0 C-N-CA 123.162 2.575 . . . . 0.0 113.126 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 34.2 mtmm -81.43 -44.91 16.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.319 0.581 . . . . 0.0 109.613 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 95.0 m -84.57 -38.56 19.81 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.38 62.78 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.461 0.648 . . . . 0.0 111.086 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.19 -29.24 26.76 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.823 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 54.5 pttt -73.68 -20.54 60.52 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.092 -0.38 . . . . 0.0 110.709 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 914' ' ' CYS . 58.6 mt -63.47 -52.91 52.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.448 ' HE3' ' HB2' ' A' ' 919' ' ' LYS . 36.8 ttmt 72.4 -38.29 0.41 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.952 1.701 . . . . 0.0 114.08 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 76.3 -26.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.958 1.303 . . . . 0.0 114.391 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.58 -45.24 94.97 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.3 17.83 10.78 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.657 1.183 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -141.99 107.76 5.12 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 23.6 t60 . . . . . 0 C--O 1.248 1.021 0 C-N-CA 124.906 1.282 . . . . 0.0 110.735 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.458 ' HB3' ' CH2' ' A' ' 891' ' ' TRP . 0.0 OUTLIER -88.99 109.38 20.21 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.619 HG21 ' HD2' ' A' ' 903' ' ' PRO . 4.4 p -108.17 141.56 39.73 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.265 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.507 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -128.09 -63.69 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.741 0.651 . . . . 0.0 110.018 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.419 HG22 ' HA ' ' P' ' 9' ' ' LYS . 10.7 m 62.68 50.37 3.48 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.097 0.951 . . . . 0.0 108.564 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . -56.67 103.71 0.12 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.557 -1.202 . . . . 0.0 112.103 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 54.63 26.11 7.07 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 110.103 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . 0.419 ' HA ' HG22 ' P' ' 6' ' ' THR . 28.8 mtpp 63.68 18.99 11.48 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.612 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 52.7 p -156.53 -76.05 0.09 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.408 0.623 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t 172.09 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 126.383 1.873 . . . . 0.0 106.74 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.37 -133.44 11.66 Favored Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.089 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.656 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 15.1 m -89.45 118.38 29.06 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -148.56 153.33 38.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt -78.91 77.89 5.37 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.077 0.942 . . . . 0.0 109.557 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -104.42 86.02 2.45 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.586 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 94.4 mmm -128.64 28.48 5.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 70.8 175.19 0.29 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.268 1.427 . . . . 0.0 110.701 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.495 ' CD2' ' HB ' ' A' ' 869' ' ' ILE . 9.0 m-85 -103.22 -0.19 30.76 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.147 0.499 . . . . 0.0 112.057 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.516 HG11 HE21 ' A' ' 866' ' ' GLN . 48.5 t -109.26 107.17 22.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.408 HG13 ' HB ' ' A' ' 867' ' ' ILE . 39.2 pt -108.12 167.79 3.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -101.26 146.57 27.36 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.863 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 8.6 t70 -87.65 167.3 14.01 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.04 -26.78 65.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.539 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 6.3 m0 -84.1 -7.16 59.46 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 120.885 0.374 . . . . 0.0 110.268 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 96.04 23.9 16.34 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.32 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 44.7 m-80 -85.92 151.59 23.64 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.516 HE21 HG11 ' A' ' 858' ' ' VAL . 59.7 mt-30 -83.97 121.25 27.12 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.408 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.6 mm -111.76 115.36 49.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.084 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.451 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 16.0 m-90 -88.3 144.26 26.53 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.528 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 857' ' ' TYR . 43.4 mm -99.75 131.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 51.8 t -79.1 121.4 83.18 Favored Pre-proline 0 N--CA 1.433 -1.316 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.19 -11.95 33.46 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.509 2.139 . . . . 0.0 112.136 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -73.04 -52.9 8.37 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.769 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 6.2 p -108.75 -24.36 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.589 -0.359 . . . . 0.0 111.829 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 85.73 11.72 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.678 1.991 . . . . 0.0 109.441 -174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 55.9 mtpt -85.89 141.01 35.34 Favored Pre-proline 0 N--CA 1.436 -1.136 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.128 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.58 169.56 18.29 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.332 2.688 . . . . 0.0 112.971 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.469 ' HB2' ' SD ' ' A' ' 882' ' ' MET . 16.8 t0 -72.99 135.77 45.01 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.002 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.07 8.87 13.46 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 122.485 1.136 . . . . 0.0 108.822 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 89.54 47.56 3.97 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 105.012 -3.235 . . . . 0.0 105.012 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 5.2 p -115.97 155.55 47.76 Favored Pre-proline 0 N--CA 1.409 -2.495 0 CA-C-N 113.466 -1.367 . . . . 0.0 111.346 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.7 111.92 2.04 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.985 1.79 . . . . 0.0 110.565 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.507 ' SD ' HM12 ' P' ' 4' ' ' M3L . 72.9 mtp -125.08 156.86 37.59 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.9 tt -124.59 130.56 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.81 130.29 10.24 Favored Glycine 0 N--CA 1.417 -2.621 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.3 t -71.97 144.25 48.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 61.5 m-20 -80.76 -18.38 47.88 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -93.26 -57.25 2.67 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.428 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 18.1 p -86.46 -19.24 29.88 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.248 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 24.5 t70 70.15 23.31 5.27 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.829 1.252 . . . . 0.0 109.984 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.412 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 3.9 t70 -87.04 162.11 17.79 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.661 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' P' ' 2' ' ' ARG . 87.8 m95 -120.79 115.62 23.63 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.233 0.54 . . . . 0.0 112.311 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.6 157.3 23.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.8 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 58.3 m80 -80.77 159.77 25.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 46.6 m0 -61.9 -56.53 31.19 Favored Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.69 -19.5 67.41 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.053 1.835 . . . . 0.0 112.702 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.8 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 34.9 m -74.45 -39.71 62.37 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.195 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.45 HG23 HG12 ' A' ' 899' ' ' ILE . 18.0 m -100.04 -17.46 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 108.55 25.58 5.69 Favored Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.897 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 29.2 mm -101.05 140.34 20.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -124.87 -22.69 4.45 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.267 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -134.8 154.2 51.71 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -82.06 122.06 79.42 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 123.173 0.296 . . . . 0.0 111.355 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.619 ' HD2' HG21 ' P' ' 3' ' ' THR . 73.9 Cg_endo -77.23 158.24 33.49 Favored 'Trans proline' 0 N--CA 1.426 -2.459 0 N-CA-C 106.951 -1.98 . . . . 0.0 106.951 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -60.36 147.26 94.57 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.662 1.574 . . . . 0.0 110.823 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.76 -1.66 7.58 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 121.073 0.463 . . . . 0.0 111.669 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.39 -23.38 22.2 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 26.4 ttt -83.49 144.6 29.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.556 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.61 ' HA ' HE21 ' A' ' 908' ' ' GLN . 0.0 OUTLIER -85.4 149.33 25.5 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.453 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 84.3 t90 -160.44 137.7 9.32 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 63.4 m-85 -130.04 145.7 51.68 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.6 p -69.61 167.75 21.18 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 123.538 0.524 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.2 Cg_endo -55.25 -11.02 3.63 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.42 2.747 . . . . 0.0 113.722 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.5 -53.75 5.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.605 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 98.1 m -78.36 -42.32 30.78 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -68.95 -32.79 72.64 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.202 1.001 . . . . 0.0 110.219 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.71 -25.11 33.25 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.675 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 45.9 pttt -74.78 -20.34 59.83 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.729 0.776 . . . . 0.0 109.717 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -78.95 -59.18 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 62.14 -48.98 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.113 2.165 . . . . 0.0 113.547 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 72.02 98.99 0.07 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 124.999 1.319 . . . . 0.0 112.424 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.38 -165.07 1.27 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -78.87 103.11 8.59 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -85.87 97.29 10.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.856 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.644 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.476 -1.88 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -94.55 104.4 16.35 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.5 p -103.75 119.88 39.82 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.26 0.553 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.488 ' HG3' ' CZ3' ' A' ' 891' ' ' TRP . . . . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.99 108.28 4.59 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.0 m -61.47 -48.66 80.1 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 879' ' ' GLY . . . 62.37 163.13 0.09 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.965 -1.471 . . . . 0.0 113.993 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -136.47 20.3 3.14 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -117.09 83.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.198 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -84.8 -60.77 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -101.95 -38.66 7.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 166.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.9 -44.4 0.28 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.068 -1.423 . . . . 0.0 109.612 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.767 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.831 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 14.7 m -69.92 -37.56 75.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.184 0.516 . . . . 0.0 109.645 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -84.77 121.7 28.07 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.307 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 ttt -78.18 -32.24 50.01 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -140.43 139.99 35.35 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 85.6 mtp -68.52 -28.88 67.38 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 122.538 1.161 . . . . 0.0 109.889 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -164.0 142.85 7.62 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 112.067 -2.333 . . . . 0.0 105.808 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.426 ' HB3' ' HB ' ' A' ' 869' ' ' ILE . 75.3 m-85 -85.46 61.88 7.13 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.523 1.154 . . . . 0.0 110.982 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.419 HG11 HE21 ' A' ' 866' ' ' GLN . 60.6 t -147.73 126.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 107.18 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.0 pt -126.83 168.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -112.41 141.11 46.53 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.36 -172.32 3.23 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.65 -26.02 68.42 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.468 0.652 . . . . 0.0 111.108 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -77.32 -10.55 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 85.79 -2.28 87.86 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.449 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.97 145.02 34.2 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.219 -0.491 . . . . 0.0 110.081 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.419 HE21 HG11 ' A' ' 858' ' ' VAL . 56.0 mt-30 -74.75 127.41 33.08 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.348 1.03 . . . . 0.0 110.191 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.1 mm -112.58 110.55 32.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.447 ' CE3' HM21 ' P' ' 4' ' ' M3L . 16.1 m-90 -77.6 135.92 38.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.97 0.414 . . . . 0.0 109.899 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 40.2 mm -100.97 131.05 49.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 53.6 t -77.9 116.23 56.8 Favored Pre-proline 0 N--CA 1.425 -1.705 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -68.66 0.29 5.05 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.037 2.492 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -87.01 -38.0 8.13 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.906 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 9.6 p -119.89 -17.26 8.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 122.221 -0.576 . . . . 0.0 112.505 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 76.3 16.03 2.2 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.794 1.283 . . . . 0.0 109.037 -176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 65.4 mttm -101.66 142.44 24.59 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.099 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 97.5 Cg_endo -77.98 160.78 30.24 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.251 2.634 . . . . 0.0 113.341 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.03 124.67 25.96 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -100.56 -7.8 23.71 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.557 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' P' ' 7' ' ' ALA . . . 119.31 40.17 0.64 Allowed Glycine 0 N--CA 1.411 -3.007 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 40.2 m -102.45 167.18 10.75 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.834 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -72.46 128.93 14.13 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.994 1.796 . . . . 0.0 108.252 168.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 63.0 mmm -130.39 159.06 38.15 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -173.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.0 tt -127.9 136.2 60.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-O 121.284 0.564 . . . . 0.0 110.461 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -94.42 124.55 7.95 Favored Glycine 0 N--CA 1.422 -2.24 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.646 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 53.2 t -69.1 137.76 53.72 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -73.72 -12.55 60.75 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.219 0.324 . . . . 0.0 111.682 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -107.55 -47.14 3.68 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 119.519 -0.873 . . . . 0.0 111.117 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 74.4 m -61.31 -39.07 89.12 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.737 -0.785 . . . . 0.0 112.166 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.2 t70 65.15 31.08 11.16 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 123.769 1.747 . . . . 0.0 106.668 -171.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 33.9 t0 -120.69 171.05 8.87 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.054 -175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.488 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.4 m95 -117.73 117.46 29.4 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.395 0.616 . . . . 0.0 112.581 -175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -114.73 151.81 33.07 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.145 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 33.1 m80 -73.76 162.65 28.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.582 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 37.9 m0 -68.26 -57.2 9.31 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.19 -18.19 60.54 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.245 1.964 . . . . 0.0 112.389 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.6 m -79.56 -25.97 41.5 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.435 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 893' ' ' HIS . 28.4 m -113.64 -11.45 11.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.52 35.21 5.01 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.866 -1.159 . . . . 0.0 112.065 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.582 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 39.7 mm -109.73 127.09 66.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.92 -33.95 7.07 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.256 0.551 . . . . 0.0 109.689 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.94 146.65 41.28 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -64.02 120.19 61.86 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 123.716 0.635 . . . . 0.0 111.873 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.4 Cg_exo -79.26 167.07 21.93 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.229 1.953 . . . . 0.0 108.917 175.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.65 134.13 52.47 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 121.909 1.739 . . . . 0.0 111.587 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 12.1 pt-20 -69.02 -19.66 64.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.513 . . . . 0.0 110.894 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.12 2.34 43.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.385 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 51.1 ttp -109.42 147.96 31.94 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.37 157.03 19.34 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.984 0.421 . . . . 0.0 110.436 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.461 ' NE1' HD11 ' A' ' 899' ' ' ILE . 64.7 t90 -156.94 143.53 18.33 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 67.3 m-85 -132.25 145.43 51.31 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 32.1 p -61.59 166.2 6.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 O-C-N 123.496 0.498 . . . . 0.0 110.646 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.6 Cg_endo -58.61 -2.25 0.97 Allowed 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.057 2.505 . . . . 0.0 113.848 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -97.81 -50.65 4.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.56 ' O ' HG13 ' A' ' 918' ' ' ILE . 65.7 m -73.29 -38.39 65.9 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -73.48 -23.92 60.12 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.038 0.923 . . . . 0.0 109.416 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 53.1 t-20 -72.96 -45.19 59.43 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.781 -175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 48.1 pttt -69.76 -13.21 62.17 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.661 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 914' ' ' CYS . 22.9 mt -94.87 -33.13 4.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.319 0.58 . . . . 0.0 109.95 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 33.0 mmtp -82.19 -37.14 26.52 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . 0.264 64.8 mttm 69.69 127.24 0.03 OUTLIER 'General case' 0 C--O 1.246 0.902 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 175.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -92.32 167.52 11.94 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.414 -1.721 . . . . 0.0 106.429 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -69.83 -79.49 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 118.475 0.58 . . . . 0.0 109.831 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -179.22 90.29 0.02 OUTLIER 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.087 0.946 . . . . 0.0 110.511 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.414 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.666 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -86.91 141.82 28.46 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 26.6 p -128.06 143.38 51.07 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.497 HM21 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 881' ' ' PRO . 0.0 OUTLIER -161.8 171.16 18.25 Favored 'General case' 0 N--CA 1.432 -1.36 0 O-C-N 124.149 0.906 . . . . 0.0 111.283 177.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -105.53 -50.5 3.2 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.739 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.76 176.6 9.75 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.756 0.789 . . . . 0.0 111.159 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -139.42 121.46 15.69 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.98 90.02 4.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 110.38 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -83.35 119.82 25.1 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.02 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.1 m -109.85 36.72 2.89 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.67 -64.69 0.56 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.423 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 175.693 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 24.0 t -154.36 95.59 1.83 Allowed 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -108.38 -67.73 0.95 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.933 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 88.9 mtp -119.3 14.0 12.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.018 0.914 . . . . 0.0 108.996 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -159.92 176.35 11.98 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -126.22 108.18 11.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -93.84 111.68 23.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.488 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 65.34 5.53 3.17 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.8 124.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.7 pt -124.54 169.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.5 mtt180 -110.06 149.64 29.72 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.477 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -89.54 -170.17 2.74 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.95 -30.08 71.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 122.587 0.355 . . . . 0.0 111.324 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 20.9 m95 -81.55 -36.39 29.15 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 120.925 0.393 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.74 25.42 3.67 Favored Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.747 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 29.6 m-80 -89.44 162.22 15.86 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -90.1 119.35 30.37 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 121.492 0.663 . . . . 0.0 111.397 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.17 119.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.497 ' CZ3' HM21 ' P' ' 4' ' ' M3L . 11.8 m-90 -85.8 137.38 32.82 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 120.884 0.374 . . . . 0.0 110.629 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 44.9 mm -97.36 128.41 48.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 44.2 t -82.94 120.36 76.02 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.04 0.03 7.23 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.378 2.052 . . . . 0.0 111.953 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -85.9 -44.01 6.18 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 14.9 p -107.49 -25.62 11.3 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 116.791 0.295 . . . . 0.0 111.548 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 80.61 19.89 0.5 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.907 1.683 . . . . 0.0 108.815 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 59.1 mtpt -105.89 150.9 39.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.73 168.31 24.11 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.758 1.639 . . . . 0.0 110.719 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.657 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 20.3 t0 -79.59 137.6 37.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.511 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.42 2.85 45.48 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 877' ' ' ASP . . . 92.76 30.22 9.86 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 19.8 m -106.48 164.83 14.09 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.668 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.516 ' HA ' ' HB3' ' P' ' 5' ' ' GLN . 84.5 Cg_exo -48.25 111.57 0.46 Allowed 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.277 2.651 . . . . 0.0 113.813 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.482 ' SD ' HM32 ' P' ' 4' ' ' M3L . 55.8 mtp -116.64 156.58 26.81 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.591 177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -124.18 140.68 46.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.7 134.71 11.8 Favored Glycine 0 N--CA 1.424 -2.162 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.6 t -73.4 137.76 44.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 31.3 m-20 -88.44 -0.52 57.28 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.488 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 10.0 t70 -111.54 -42.35 3.88 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.32 176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 95.8 m -69.79 -88.66 0.02 OUTLIER 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.437 174.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 888' ' ' CYS . 34.4 t70 141.64 -10.02 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.462 2.305 . . . . 0.0 105.608 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.72 165.97 16.5 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.876 -173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -118.13 130.89 56.39 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.2 -173.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.88 156.54 29.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 47.8 m80 -82.66 156.12 24.01 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.758 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.584 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -61.09 -56.35 35.53 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.77 -18.72 62.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.243 1.962 . . . . 0.0 112.935 -177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -79.62 -44.34 21.16 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.216 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 899' ' ' ILE . 28.8 m -92.31 -15.24 8.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 102.23 15.06 26.73 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 21.0 mm -83.74 130.75 35.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 65.2 mtt -113.32 -27.63 7.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.199 0.524 . . . . 0.0 110.579 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.98 147.5 42.27 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -67.23 129.54 93.79 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 123.521 0.513 . . . . 0.0 111.618 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -85.41 165.7 10.8 Favored 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 121.882 1.721 . . . . 0.0 108.397 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.86 141.97 67.37 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.602 1.535 . . . . 0.0 109.835 178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 0.0 OUTLIER -62.79 -28.76 70.22 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.65 -14.28 61.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.131 0.573 . . . . 0.0 112.018 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 44.2 tpp -89.5 138.41 31.48 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.462 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 14.4 mt-30 -93.0 144.41 25.28 Favored 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.686 -176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 74.5 t90 -139.49 144.77 38.11 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 46.4 m-85 -133.06 143.7 49.52 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 26.4 p -64.4 169.98 4.26 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 123.78 0.675 . . . . 0.0 112.108 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 19.2 Cg_endo -59.34 -2.58 1.4 Allowed 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 122.818 2.345 . . . . 0.0 113.518 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 26.6 mtpp -97.37 -54.07 3.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 918' ' ' ILE . 68.9 m -77.23 -31.22 54.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -78.22 -26.54 47.43 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 38.3 t-20 -61.42 -44.95 96.25 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.171 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 61.0 pttt -74.46 -6.75 50.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.93 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 914' ' ' CYS . 41.5 mm -79.06 -48.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 919' ' ' LYS 0.334 0.2 OUTLIER -83.33 76.66 9.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.347 1.07 . . . . 0.0 112.906 -178.079 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.06 178.82 9.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -91.16 -165.55 1.38 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -71.02 140.88 50.93 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -115.26 130.3 56.87 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.358 0.599 . . . . 0.0 112.196 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 176.699 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.502 -0.895 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.7 132.33 38.11 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 24.5 p -123.46 137.23 54.84 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.532 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.511 ' HD3' HM22 ' P' ' 4' ' ' M3L . . . . . . . . 0 C--N 1.286 -2.182 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 59.4 tt0 -167.0 90.61 0.38 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 124.579 1.174 . . . . 0.0 107.968 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 21.1 m -75.96 -40.31 54.2 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.689 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 57.08 81.38 0.14 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.826 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -66.44 -32.3 73.59 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.054 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' P' ' 9' ' ' LYS . 0.1 OUTLIER -102.52 119.94 39.69 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 172.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 44.0 m -135.03 -7.54 2.34 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.384 0.612 . . . . 0.0 110.708 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 33.1 m -119.15 143.33 47.26 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.38 66.26 3.93 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.518 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 -176.377 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.574 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 25.7 m 63.81 -78.46 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.026 1.33 . . . . 0.0 113.485 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 65.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.938 1.295 . . . . 0.0 109.511 -172.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 26.7 ttt -114.35 134.7 54.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -77.22 90.75 3.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 57.8 ttp -152.14 100.24 2.6 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.876 -1.057 . . . . 0.0 109.379 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -89.55 177.06 6.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -88.33 8.62 26.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.678 0.752 . . . . 0.0 111.57 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.558 HG11 HE21 ' A' ' 866' ' ' GLN . 48.8 t -103.69 117.8 49.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.262 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 40.6 pt -117.75 162.63 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -93.01 141.8 28.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 0.8 OUTLIER -83.64 169.58 15.19 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.988 174.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.26 -33.64 75.01 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.612 0.765 . . . . 0.0 111.97 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 4.9 m0 -91.7 0.86 57.46 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.439 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 94.1 17.28 40.98 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.033 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 861' ' ' ASP . 46.2 m-80 -80.91 174.98 11.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.558 HE21 HG11 ' A' ' 858' ' ' VAL . 54.3 mt-30 -110.65 129.64 55.77 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 120.928 0.394 . . . . 0.0 110.45 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.37 131.21 70.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.423 ' CE3' HM11 ' P' ' 4' ' ' M3L . 13.4 m-90 -102.5 133.91 46.68 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.393 0.616 . . . . 0.0 112.025 -178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.7 mp -94.01 127.21 46.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.559 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 891' ' ' TRP . 42.9 t -71.27 118.25 64.19 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.14 5.95 1.64 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.543 2.162 . . . . 0.0 112.234 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -82.29 -59.03 2.33 Favored Glycine 0 N--CA 1.422 -2.252 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 4.7 p -102.34 -22.37 14.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.65 0.38 . . . . 0.0 111.401 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 82.69 21.37 0.22 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.855 1.662 . . . . 0.0 110.447 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 66.9 mttm -100.99 140.69 21.51 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 39.9 Cg_endo -70.83 173.65 11.6 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.013 2.475 . . . . 0.0 113.841 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -94.5 155.27 17.01 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -122.34 26.32 8.48 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 76.02 21.98 75.02 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 882' ' ' MET . 6.3 m -71.11 168.87 17.58 Favored Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 124.017 0.927 . . . . 0.0 110.999 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 24.6 Cg_exo -63.32 109.98 1.1 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 121.541 1.494 . . . . 0.0 110.072 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 880' ' ' SER . 73.1 mtp -124.13 158.96 31.06 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.085 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.5 tt -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -100.83 129.43 9.89 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 888' ' ' CYS . 51.9 t -69.97 143.86 52.51 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.88 -15.49 57.27 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.517 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.89 -55.79 3.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.728 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 885' ' ' CYS . 23.6 p -83.97 -28.87 27.47 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 12.9 t70 73.09 18.47 3.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.144 1.377 . . . . 0.0 109.272 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -94.57 148.68 22.0 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.721 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 870' ' ' CYS . 88.0 m95 -97.54 120.87 38.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.33 -172.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.74 156.45 20.28 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.05 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.694 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.3 m80 -82.51 153.8 25.39 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.526 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.45 -53.57 64.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 -23.57 74.12 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.124 1.883 . . . . 0.0 113.177 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 44.1 m -78.03 -26.67 48.55 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.791 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 899' ' ' ILE . 19.1 m -112.79 -8.15 12.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 91.53 38.38 5.89 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.203 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 25.8 mm -110.54 134.16 53.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 173.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -118.76 -23.58 6.96 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.813 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.63 151.25 48.11 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.78 128.79 86.22 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.38 171.66 9.86 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.282 1.988 . . . . 0.0 108.867 172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.13 139.0 64.5 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 121.473 1.448 . . . . 0.0 111.685 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' P' ' 1' ' ' ALA . 35.0 mt-10 -82.47 -1.82 51.46 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.693 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.69 17.17 22.92 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.645 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.8 tpp -129.55 145.34 51.48 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -90.73 151.61 21.16 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.425 ' CB ' ' HB2' ' P' ' 1' ' ' ALA . 69.7 t90 -150.14 145.68 26.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.216 -1.356 . . . . 0.0 107.857 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.424 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 77.5 m-85 -132.7 140.82 48.28 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 26.7 p -71.2 163.04 69.04 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.24 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 10.7 Cg_endo -55.54 -15.81 12.92 Favored 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.567 2.845 . . . . 0.0 113.775 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.39 -45.01 9.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.703 -0.623 . . . . 0.0 110.309 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 86.6 m -78.42 -34.39 47.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -74.23 -15.84 60.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.586 0.708 . . . . 0.0 110.659 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.12 -35.42 76.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.396 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 22.3 pttp -85.07 -5.63 59.34 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.091 0.472 . . . . 0.0 111.13 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 44.8 mm -82.31 -19.69 10.43 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 122.45 1.119 . . . . 0.0 108.039 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 920' ' ' LYS . 61.5 tttm -115.62 172.99 6.77 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 919' ' ' LYS . 13.1 ptmm? 64.24 -32.48 0.13 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 115.94 1.829 . . . . 0.0 115.94 174.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 14.3 t70 70.81 -165.84 0.15 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 125.293 1.437 . . . . 0.0 107.829 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -115.88 83.72 1.99 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -134.06 109.37 8.91 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.858 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 . . . . . 0 C--N 1.286 -2.172 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.934 175.036 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.707 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -90.86 115.51 27.96 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 4.9 p -113.67 114.81 26.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.749 0.785 . . . . 0.0 111.693 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.563 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 C--N 1.302 -1.497 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.81 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -156.78 142.46 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.559 ' HB ' ' CA ' ' A' ' 879' ' ' GLY . 29.7 m -90.21 -57.93 2.68 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.99 -66.95 0.02 OUTLIER 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 120.782 0.325 . . . . 0.0 111.591 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' P' ' 8' ' ' ARG . 64.8 mtm-85 -64.31 96.17 0.15 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.612 1.196 . . . . 0.0 114.04 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -93.31 161.83 14.24 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.397 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 37.6 m -88.0 111.35 21.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -120.31 125.05 47.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.505 0.669 . . . . 0.0 110.347 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.43 43.66 1.66 Allowed Glycine 0 CA--C 1.492 -1.377 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.403 -3.501 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 -177.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.545 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.8 m -123.6 149.29 45.51 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -73.88 -40.66 63.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 13.0 tpt 69.02 3.85 4.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.358 1.463 . . . . 0.0 111.374 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -164.79 -175.42 3.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 64.8 mtm 52.23 73.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.916 0.76 . . . . 0.0 111.064 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -116.3 131.63 56.89 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 122.06 -0.4 . . . . 0.0 110.321 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -94.62 10.09 36.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.863 0.839 . . . . 0.0 111.113 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.452 HG11 HE21 ' A' ' 866' ' ' GLN . 60.4 t -117.38 125.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 173.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.49 170.04 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 99.1 mtt180 -111.04 145.99 37.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.654 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.46 -166.86 1.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.42 -32.88 74.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.408 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 7.3 m0 -85.55 -29.27 24.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.465 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.77 31.58 2.28 Favored Glycine 0 C--N 1.307 -1.037 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.38 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 33.2 m-80 -96.75 149.93 21.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.452 HE21 HG11 ' A' ' 858' ' ' VAL . 58.7 mt-30 -75.23 117.59 17.22 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 123.621 0.576 . . . . 0.0 110.049 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.5 120.92 62.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.439 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 9.6 m-90 -85.41 135.01 34.05 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.616 0.722 . . . . 0.0 112.081 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.75 125.32 54.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 53.5 t -68.75 122.05 83.45 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.57 4.57 2.91 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.238 1.958 . . . . 0.0 112.141 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -90.09 -54.02 2.24 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 13.3 p -105.11 -20.7 13.44 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 77.39 22.05 0.98 Allowed 'General case' 0 C--O 1.246 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 110.896 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.42 145.33 30.26 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.539 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.0 167.08 28.31 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.711 2.274 . . . . 0.0 111.694 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.731 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.7 t70 -74.41 117.47 16.26 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.52 -29.71 65.09 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.577 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' P' ' 6' ' ' THR . . . 129.49 38.1 0.34 Allowed Glycine 0 N--CA 1.411 -3.004 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -176.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 9.7 t -107.74 164.92 13.73 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 33.0 Cg_exo -60.98 127.4 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.088 1.859 . . . . 0.0 110.69 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 71.7 mtp -123.41 157.16 34.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.3 tt -120.64 131.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.992 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -98.29 130.48 10.25 Favored Glycine 0 N--CA 1.417 -2.606 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 40.9 t -69.8 151.15 46.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.353 0.678 . . . . 0.0 109.551 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.85 -25.19 26.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -87.12 -74.39 0.44 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.177 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 27.4 p -68.98 -36.77 78.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.709 0.29 . . . . 0.0 111.687 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 29.1 t70 74.78 64.63 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.465 1.103 . . . . 0.0 110.3 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -119.31 168.14 11.2 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 95.2 m95 -116.03 115.42 26.09 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -109.91 162.29 14.65 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.77 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 44.9 m80 -84.47 167.77 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.549 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.1 m0 -69.68 -58.07 6.02 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 -22.56 74.59 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.465 2.11 . . . . 0.0 112.749 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.77 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 26.7 m -73.72 -35.83 65.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.502 -175.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 899' ' ' ILE . 28.3 m -100.54 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.924 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 112.34 5.05 25.01 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.366 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.9 mm -79.64 127.88 38.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 88.9 mtp -121.3 -18.31 7.4 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.323 0.582 . . . . 0.0 110.304 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.42 144.87 38.3 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -68.51 126.39 92.67 Favored Pre-proline 0 C--N 1.307 -1.274 0 O-C-N 123.365 0.416 . . . . 0.0 110.698 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.82 169.48 22.28 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.901 1.734 . . . . 0.0 108.916 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.483 ' HD2' ' SD ' ' A' ' 907' ' ' MET . 11.4 Cg_exo -60.37 147.79 92.7 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.718 1.612 . . . . 0.0 110.498 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.53 -11.52 59.89 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.209 0.528 . . . . 0.0 110.362 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.89 -4.54 52.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.354 0.597 . . . . 0.0 109.807 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.483 ' SD ' ' HD2' ' A' ' 904' ' ' PRO . 22.4 ttt -95.01 139.32 31.53 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.086 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -94.75 151.11 19.53 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -143.03 145.09 32.58 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.42 ' HA ' ' SG ' ' A' ' 885' ' ' CYS . 62.0 m-85 -132.37 134.49 45.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 23.6 p -73.11 167.98 29.21 Favored Pre-proline 0 C--N 1.302 -1.471 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.55 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -54.76 -13.1 5.42 Favored 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.883 3.055 . . . . 0.0 114.045 174.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 46.6 mtpt -75.44 -54.31 7.25 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 81.7 m -77.08 -47.25 21.04 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 113.395 -1.73 . . . . 0.0 114.55 -170.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.17 64.71 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.2 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -86.11 -35.35 20.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -72.07 -16.81 62.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.354 -0.216 . . . . 0.0 110.76 -177.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 914' ' ' CYS . 50.5 mm -59.55 -58.21 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 55.5 tttp 42.67 72.92 0.15 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 113.588 -1.642 . . . . 0.0 111.774 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.8 97.21 3.1 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.687 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 160.95 27.21 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.58 167.23 22.67 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 174.33 8.75 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -1.785 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -86.18 114.34 22.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.483 HG21 ' HD2' ' A' ' 903' ' ' PRO . 17.0 p -113.32 143.21 44.83 Favored 'General case' 0 C--N 1.273 -2.736 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.459 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.658 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -166.3 115.14 0.93 Allowed 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -70.57 -51.79 26.05 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -172.02 -145.7 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 69.66 84.89 0.14 Allowed 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 124.963 1.305 . . . . 0.0 114.164 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -131.28 80.27 1.93 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -94.8 92.53 7.0 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.659 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -89.07 79.89 7.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.198 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.49 -38.44 0.59 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.836 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.687 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.621 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.697 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 17.9 t 71.07 145.93 0.07 Allowed 'General case' 0 C--O 1.249 1.047 0 C-N-CA 125.262 1.425 . . . . 0.0 110.871 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -98.52 -57.88 2.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.167 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 54.3 ttp 49.92 75.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.115 0.966 . . . . 0.0 110.357 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -114.69 -67.93 0.96 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 122.06 0.933 . . . . 0.0 111.658 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 23.4 ptm -175.52 -154.96 0.05 OUTLIER 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.71 -170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -78.34 174.97 10.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 868' ' ' TRP . 78.0 m-85 -86.07 56.95 4.21 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.874 0.845 . . . . 0.0 111.512 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 46.5 t -138.18 133.36 43.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.65 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 43.3 pt -137.7 170.62 17.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 11.7 ptt180 -108.93 151.29 26.49 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 171.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.455 ' HB3' HG13 ' A' ' 867' ' ' ILE . 7.1 p-10 -94.93 -171.95 2.57 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.77 -28.54 68.48 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -83.58 -26.39 30.08 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 106.23 36.15 2.76 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.355 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 21.3 m-80 -103.17 157.21 17.16 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -82.24 112.8 19.58 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 861' ' ' ASP . 47.8 mm -102.56 119.34 50.77 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 857' ' ' TYR . 12.7 m-90 -83.92 151.31 25.15 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.626 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.21 122.16 85.41 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.75 -7.49 19.64 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.042 1.828 . . . . 0.0 111.652 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -77.47 -56.03 4.07 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 121.274 -0.488 . . . . 0.0 112.03 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 875' ' ' LYS . 7.6 p -106.32 -19.66 13.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 8.7 t30 78.49 20.16 0.88 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.818 1.647 . . . . 0.0 109.019 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 873' ' ' CYS . 97.5 mttt -97.54 147.93 33.7 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.113 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.42 163.51 27.14 Favored 'Trans proline' 0 C--N 1.327 -0.584 0 C-N-CA 123.413 2.742 . . . . 0.0 115.889 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.13 143.3 47.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.749 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -129.62 18.81 5.72 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.03 0.919 . . . . 0.0 109.323 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 87.45 24.95 34.65 Favored Glycine 0 CA--C 1.498 -1.005 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 13.6 m -93.45 168.59 11.72 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.706 -0.747 . . . . 0.0 110.687 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 22.3 Cg_exo -64.23 118.17 5.14 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.841 1.694 . . . . 0.0 110.523 174.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.658 ' SD ' HM12 ' P' ' 4' ' ' M3L . 71.8 mtp -130.84 163.52 27.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.1 tt -127.62 132.14 69.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.39 0.614 . . . . 0.0 110.383 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 890' ' ' ASP . . . -93.98 121.87 6.84 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 37.0 t -62.32 137.56 58.28 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -71.61 -9.69 58.62 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.67 -59.78 1.75 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.518 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 78.5 m -62.99 -34.97 78.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.191 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 27.9 t70 65.84 17.51 10.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 122.576 1.179 . . . . 0.0 109.028 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.457 ' O ' ' HA2' ' A' ' 884' ' ' GLY . 1.5 t0 -103.59 170.93 7.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.39 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' P' ' 4' ' ' M3L . 97.9 m95 -110.16 111.77 23.31 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.78 152.91 20.31 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.722 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 43.4 m80 -82.11 159.6 23.35 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.5 m0 -65.04 -54.71 32.06 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.74 -16.36 54.91 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.173 1.915 . . . . 0.0 112.821 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 35.5 m -81.96 -37.4 26.74 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 899' ' ' ILE . 29.8 m -100.26 -24.4 4.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.61 4.24 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.762 -1.208 . . . . 0.0 112.218 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 26.3 mm -100.82 129.8 51.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 96.1 mmm -111.88 -25.73 9.28 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.895 0.379 . . . . 0.0 110.927 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -138.88 147.54 42.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -73.82 114.32 31.37 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 123.619 0.574 . . . . 0.0 112.184 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' P' ' 3' ' ' THR . 39.7 Cg_endo -82.71 155.25 15.67 Favored 'Trans proline' 0 N--CA 1.424 -2.571 0 C-N-CA 120.858 1.038 . . . . 0.0 109.416 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.53 155.21 69.81 Favored 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 121.778 1.652 . . . . 0.0 111.552 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.88 -43.3 66.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.098 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.99 -14.7 61.06 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.461 1.104 . . . . 0.0 113.616 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 24.2 ttt -76.94 -25.25 52.64 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.859 1.314 . . . . 0.0 109.636 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 59.1 160.02 0.03 OUTLIER 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 111.464 -2.607 . . . . 0.0 114.667 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -167.38 139.45 3.25 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.049 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 64.7 m-85 -131.47 145.78 51.94 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.27 163.84 7.68 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.488 0.493 . . . . 0.0 111.285 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.16 -7.97 1.35 Allowed 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 123.554 2.836 . . . . 0.0 113.441 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -96.63 -50.6 4.65 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.501 ' O ' HG13 ' A' ' 918' ' ' ILE . 52.2 m -72.35 -34.94 68.38 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -75.85 -21.62 57.06 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.38 0.61 . . . . 0.0 110.23 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -72.8 -51.88 17.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.59 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 60.0 pttt -62.16 -17.57 58.35 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.699 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 914' ' ' CYS . 35.7 mt -79.0 -23.62 12.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.207 0.527 . . . . 0.0 110.054 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -114.09 -41.5 3.51 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.845 0.831 . . . . 0.0 110.808 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -132.98 -174.89 3.6 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.927 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.99 -56.13 2.22 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -170.94 -173.7 1.37 Allowed 'General case' 0 C--O 1.251 1.165 0 C-N-CA 124.163 0.985 . . . . 0.0 108.406 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 73.51 -177.6 0.18 Allowed 'General case' 0 C--O 1.253 1.283 0 C-N-CA 124.354 1.061 . . . . 0.0 109.952 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 34.9 p80 . . . . . 0 C--N 1.313 -1.01 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.414 178.528 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 905' ' ' GLU . . . . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -84.79 100.32 11.46 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -107.84 128.45 54.62 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.953 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.594 HM12 ' SD ' ' A' ' 882' ' ' MET . . . . . . . . 0 C--N 1.289 -2.026 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -136.26 115.29 12.33 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 7.0 m -105.89 30.75 5.57 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 122.542 1.163 . . . . 0.0 107.985 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.39 141.29 31.84 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.961 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -89.79 -17.75 27.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -130.29 115.34 16.8 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.701 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 21.5 m -74.36 100.82 3.88 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.82 92.92 6.07 Favored 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.228 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -41.89 6.12 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.903 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 177.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 19.9 m 63.21 81.25 0.21 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.917 1.287 . . . . 0.0 111.983 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 854' ' ' ALA . 31.3 p-80 -89.51 134.76 33.96 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.848 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 15.9 tpt -91.26 -11.99 36.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.659 0.742 . . . . 0.0 109.141 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . 0.41 ' O ' ' HD2' ' A' ' 852' ' ' HIS . . . -91.24 -168.67 2.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.119 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -140.29 167.06 23.02 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -74.33 -175.85 2.46 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 123.633 0.583 . . . . 0.0 110.287 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 69.33 6.68 5.81 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.138 0.975 . . . . 0.0 111.738 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.487 HG11 HE21 ' A' ' 866' ' ' GLN . 26.9 t -109.7 103.59 15.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.68 169.56 5.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 82.7 mtt180 -104.04 145.28 30.39 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.513 ' HB3' HG13 ' A' ' 867' ' ' ILE . 10.6 p-10 -93.88 -171.83 2.69 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.2 -29.05 68.46 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.222 0.609 . . . . 0.0 112.376 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.485 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 17.2 m95 -86.1 -26.07 25.46 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 120.987 0.422 . . . . 0.0 111.363 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.95 4.98 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.186 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 31.2 m-80 -92.27 164.85 13.38 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.487 HE21 HG11 ' A' ' 858' ' ' VAL . 45.1 mt-30 -84.29 112.84 20.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 861' ' ' ASP . 49.3 mm -104.53 115.24 46.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.807 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.444 ' CE3' HM11 ' P' ' 4' ' ' M3L . 20.2 m-90 -87.4 134.42 33.58 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.378 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 51.3 mm -89.34 118.87 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.99 125.75 88.61 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.02 0.825 . . . . 0.0 109.268 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -1.99 12.03 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.108 1.872 . . . . 0.0 111.395 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -78.11 -54.74 4.32 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 8.1 p -107.06 -27.54 10.56 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.735 0.302 . . . . 0.0 111.795 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 82.28 21.88 0.25 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.932 1.693 . . . . 0.0 110.499 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -102.09 144.5 28.72 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.67 157.77 47.95 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 123.131 2.554 . . . . 0.0 115.277 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.57 147.34 37.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.378 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.45 7.29 6.98 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.448 0.642 . . . . 0.0 109.272 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 104.78 31.27 4.55 Favored Glycine 0 N--CA 1.421 -2.311 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -170.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 160.33 78.4 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 114.29 -0.955 . . . . 0.0 109.443 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.84 108.02 2.34 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.25 -1.866 . . . . 0.0 107.25 172.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.594 ' SD ' HM12 ' P' ' 4' ' ' M3L . 67.6 mtp -119.6 162.25 19.27 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.456 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 21.4 tt -125.75 133.08 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -97.52 133.23 11.28 Favored Glycine 0 N--CA 1.423 -2.219 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.333 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 41.7 t -76.72 161.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.64 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 27.7 t70 -97.95 -28.15 13.93 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.079 0.466 . . . . 0.0 111.402 -176.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 11.5 t70 -80.3 -55.49 4.87 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.853 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 890' ' ' ASP . 24.6 p -90.17 -21.04 22.4 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.936 -0.706 . . . . 0.0 112.026 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 885' ' ' CYS . 33.7 t70 66.52 28.2 9.49 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.944 1.354 . . . . 0.0 109.136 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 888' ' ' CYS . 3.2 t0 -88.39 175.19 7.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.532 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -125.5 116.81 22.38 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -115.03 154.2 29.28 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.3 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 41.5 m80 -80.61 163.08 23.92 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.626 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.4 m0 -67.66 -53.33 22.45 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.91 -11.26 31.49 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.276 1.984 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 18.8 m -84.34 -27.01 28.04 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.788 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -113.5 -15.25 10.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.22 28.14 6.97 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.348 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 894' ' ' TRP . 31.3 mm -103.15 130.9 52.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 89.0 mtp -112.18 -34.09 6.03 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.044 0.45 . . . . 0.0 110.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -133.72 148.19 51.41 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -67.33 122.27 82.26 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 123.723 0.64 . . . . 0.0 110.82 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 3.8 Cg_exo -75.15 168.82 23.9 Favored 'Trans proline' 0 C--O 1.251 1.13 0 C-N-CA 122.122 1.881 . . . . 0.0 108.674 174.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.79 131.32 32.65 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.64 1.56 . . . . 0.0 109.83 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 905' ' ' GLU . 1.4 mp0 -53.04 -36.51 60.67 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.623 1.169 . . . . 0.0 111.363 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.87 -19.61 62.61 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.268 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 907' ' ' MET . 0.6 OUTLIER -87.49 128.83 35.23 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -80.22 157.28 26.55 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-O 121.16 0.505 . . . . 0.0 111.9 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -151.76 146.0 25.41 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 75.7 m-85 -134.92 144.3 47.39 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 913' ' ' LYS . 27.6 p -68.52 169.55 10.36 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 20.1 Cg_endo -61.02 1.73 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.39 2.727 . . . . 0.0 113.303 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 911' ' ' CYS . 74.0 mmtt -97.97 -58.46 1.98 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.522 ' O ' HG13 ' A' ' 918' ' ' ILE . 96.7 m -74.61 -35.14 62.95 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -78.93 -15.85 57.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.673 0.749 . . . . 0.0 109.936 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -85.73 -44.55 12.44 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.149 -176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 920' ' ' LYS . 62.6 pttt -57.84 -37.56 74.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.297 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 914' ' ' CYS . 46.7 mt -63.13 -29.81 48.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 122.255 1.026 . . . . 0.0 109.462 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.19 19.13 20.7 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.406 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 917' ' ' LYS . 61.5 pttt -127.14 -14.31 5.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.728 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.29 -79.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 -6.68 57.72 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.508 0.671 . . . . 0.0 110.072 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -100.62 121.35 41.47 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.344 -176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.617 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.494 -1.202 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -56.46 130.54 45.35 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.431 HG22 ' HE1' ' A' ' 894' ' ' TRP . 8.3 p -119.34 133.6 55.64 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-O 121.295 0.569 . . . . 0.0 111.356 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.578 HM31 ' CZ3' ' A' ' 868' ' ' TRP . . . . . . . . 0 C--N 1.283 -2.318 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 8.5 tt0 -149.75 111.91 4.64 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 45.6 m -67.61 -30.28 69.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.577 0.548 . . . . 0.0 109.613 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.36 -174.58 0.17 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.304 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . 0.472 ' HD2' ' N ' ' P' ' 8' ' ' ARG . 0.0 OUTLIER -122.6 81.71 1.89 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 177.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -79.33 100.5 7.61 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.971 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -71.25 99.39 1.91 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.902 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 43.9 m -83.62 102.44 12.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.774 0.797 . . . . 0.0 110.08 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -148.56 -91.46 0.1 OUTLIER Glycine 0 N--CA 1.432 -1.621 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.689 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.184 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.155 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.535 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 36.5 m -58.0 -23.3 53.52 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -62.93 -30.88 71.9 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-O 120.565 0.221 . . . . 0.0 110.828 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 24.6 mmt -111.5 18.59 18.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.53 0.681 . . . . 0.0 109.164 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -142.46 40.81 1.59 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 65.0 mtt -74.8 85.02 2.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.861 0.839 . . . . 0.0 111.756 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -126.96 175.03 8.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -102.05 3.68 38.99 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.403 ' HB ' ' NE1' ' A' ' 868' ' ' TRP . 7.7 p -84.59 135.91 23.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.883 175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.04 170.73 19.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 4.4 ptp180 -108.61 141.78 40.05 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.63 174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -82.95 -174.67 5.42 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.16 -32.65 73.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -80.68 -32.51 35.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.767 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 114.25 32.58 1.96 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.884 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 26.9 m-80 -97.73 161.86 13.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -88.13 115.06 25.34 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.475 0.655 . . . . 0.0 110.292 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.73 118.7 56.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.578 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 10.6 m-90 -93.25 138.98 31.13 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.276 0.56 . . . . 0.0 111.523 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.8 mp -100.75 133.86 42.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.418 -1.265 . . . . 0.0 107.702 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.3 t -71.47 116.34 46.49 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.53 2.59 2.29 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.745 2.296 . . . . 0.0 112.615 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -88.78 -36.68 7.71 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.275 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.3 p -120.45 -20.95 7.01 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 120.979 0.418 . . . . 0.0 111.818 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 65.4 t30 76.13 24.38 1.16 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.059 1.744 . . . . 0.0 109.6 -176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -101.04 138.2 19.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.159 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 26.6 Cg_endo -68.91 174.66 8.43 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.634 2.223 . . . . 0.0 112.241 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.522 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 16.5 t0 -72.83 119.28 16.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.138 0.97 . . . . 0.0 111.577 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -90.28 -4.16 57.34 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.571 -1.65 . . . . 0.0 109.958 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.509 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 106.29 37.56 2.45 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 10.7 m -108.09 163.59 16.63 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 115.051 -0.574 . . . . 0.0 109.966 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' P' ' 4' ' ' M3L . 17.0 Cg_exo -71.52 128.06 13.97 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.944 1.762 . . . . 0.0 109.524 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.427 ' O ' ' HA ' ' P' ' 3' ' ' THR . 60.1 mtp -124.27 153.79 41.18 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.81 136.61 59.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -96.86 131.11 10.49 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 42.5 t -75.98 141.82 42.09 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.587 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 25.4 t70 -73.91 -24.15 59.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.97 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.45 -62.48 1.52 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.625 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 8.6 p -77.61 -28.7 51.6 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.16 0.505 . . . . 0.0 111.129 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 26.9 t70 58.89 62.67 1.83 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 110.348 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -135.23 176.36 8.74 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . 0.459 ' CE2' HM32 ' P' ' 4' ' ' M3L . 80.1 m95 -119.67 120.83 37.78 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -168.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -105.59 157.15 17.6 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.957 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 36.0 m80 -81.53 152.38 27.31 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.546 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 38.3 m0 -58.78 -55.98 40.55 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.71 -19.63 64.66 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 121.647 1.564 . . . . 0.0 112.802 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 64.6 m -77.89 -31.47 51.27 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.14 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 899' ' ' ILE . 17.6 m -104.44 -9.25 9.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 98.12 19.66 23.11 Favored Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.026 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.646 HD12 ' HG3' ' A' ' 903' ' ' PRO . 36.2 mm -97.08 136.24 28.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -120.37 -22.61 6.44 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.904 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.58 150.38 44.96 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' P' ' 3' ' ' THR . . . -61.35 115.38 14.38 Favored Pre-proline 0 C--N 1.322 -0.606 0 O-C-N 124.021 0.826 . . . . 0.0 111.222 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.646 ' HG3' HD12 ' A' ' 899' ' ' ILE 0.293 0.2 OUTLIER -118.29 173.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.309 2.006 . . . . 0.0 116.874 -172.875 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.433 ' HB2' ' C ' ' A' ' 906' ' ' GLU . 39.7 Cg_endo -121.72 169.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.083 0 C-N-CA 124.015 3.144 . . . . 0.0 110.268 156.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 906' ' ' GLU . 40.7 mt-10 -85.15 -61.88 1.67 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 100.766 -3.791 . . . . 0.0 100.766 152.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.433 ' C ' ' HB2' ' A' ' 904' ' ' PRO . 10.5 pt-20 -113.79 -31.67 6.36 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 109.612 -3.449 . . . . 0.0 104.894 170.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 53.7 ttp 167.01 -27.39 0.0 OUTLIER 'General case' 0 C--N 1.385 2.14 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.652 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 905' ' ' GLU . 17.6 mm100 -56.31 -102.19 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.268 0 CA-C-N 112.035 -2.348 . . . . 0.0 115.534 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 73.5 t90 81.14 133.04 0.06 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 126.042 1.737 . . . . 0.0 110.416 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 78.7 m-85 -131.48 143.33 50.33 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 29.5 p -66.81 159.43 75.29 Favored Pre-proline 0 C--N 1.312 -1.032 0 O-C-N 123.412 0.445 . . . . 0.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 9.6 Cg_endo -52.68 -15.13 3.92 Favored 'Trans proline' 0 CA--C 1.551 1.348 0 C-N-CA 123.762 2.975 . . . . 0.0 114.486 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -86.02 -47.28 9.72 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.684 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 93.7 m -79.74 -35.0 39.47 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.756 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 919' ' ' LYS . . . -72.2 -21.03 61.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.836 0.35 . . . . 0.0 110.852 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.17 -34.36 78.2 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 64.2 pttt -75.95 -8.88 57.97 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.301 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 31.3 mm -90.73 -45.46 14.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 915' ' ' ALA . 13.7 ptmm? -90.26 73.03 7.14 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.248 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -138.58 122.83 18.15 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.805 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.13 -41.02 59.32 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -92.48 138.51 31.45 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -86.17 126.66 34.4 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.53 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 . . . . . 0 C--N 1.32 -0.701 0 C-N-CA 125.32 1.448 . . . . 0.0 111.097 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.02 127.71 32.7 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 882' ' ' MET . 40.0 p -115.61 145.12 42.98 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.521 HM12 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -135.61 113.85 11.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.408 HG23 ' HA2' ' A' ' 879' ' ' GLY . 8.8 t -102.78 63.95 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 122.974 1.369 . . . . 0.0 110.651 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -34.42 19.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.898 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -162.16 -29.3 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.596 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 55.45 44.73 26.54 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.175 0.99 . . . . 0.0 112.296 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 38.4 m -68.37 -33.34 74.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -100.0 96.21 7.38 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.0 -76.61 0.25 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 119.184 -0.787 . . . . 0.0 112.493 177.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.094 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 10.8 p -81.56 -78.12 0.2 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.887 0.343 . . . . 0.0 111.893 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -81.11 -29.02 34.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.046 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 27.2 ptm -82.1 144.34 30.86 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -148.86 97.19 2.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.81 71.91 8.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.393 1.092 . . . . 0.0 110.769 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -131.74 107.25 8.66 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -83.23 62.35 6.61 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.652 1.215 . . . . 0.0 113.693 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . . . . . . . . . 8.4 p -157.57 125.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 113.32 -1.763 . . . . 0.0 109.26 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.76 170.65 16.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -104.28 143.83 32.44 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 867' ' ' ILE . 0.9 OUTLIER -87.54 -176.74 5.69 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.01 -31.44 71.06 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 123.111 0.564 . . . . 0.0 112.518 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -82.01 -29.78 31.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.935 0.398 . . . . 0.0 110.133 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 113.23 24.6 4.73 Favored Glycine 0 C--O 1.238 0.36 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.215 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -94.36 154.82 17.29 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -76.18 116.32 16.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.422 0.629 . . . . 0.0 110.642 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 861' ' ' ASP . 49.0 mm -105.42 107.65 23.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -75.45 143.82 42.43 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . . . . . . . . . 37.1 mm -104.4 131.93 52.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 871' ' ' PRO . 53.2 t -73.14 114.32 30.06 Favored Pre-proline 0 N--CA 1.44 -0.969 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 870' ' ' CYS . 6.3 Cg_exo -75.43 10.55 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.739 2.293 . . . . 0.0 112.262 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -91.51 -50.78 2.67 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 7.8 p -103.86 -22.69 13.47 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 122.909 -0.171 . . . . 0.0 111.202 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 7.8 t30 72.6 63.72 0.11 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.29 . . . . 0.0 108.844 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -140.95 142.25 27.13 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.996 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -74.94 163.51 35.28 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 122.656 2.238 . . . . 0.0 112.636 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.521 ' OD2' HM12 ' P' ' 4' ' ' M3L . 51.5 t0 -78.45 127.58 32.39 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -92.75 -7.53 46.35 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.701 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' P' ' 6' ' ' THR . . . 108.57 42.35 1.36 Allowed Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 107.224 -2.35 . . . . 0.0 107.224 -171.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 16.9 p -108.99 169.92 5.97 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 114.137 -1.032 . . . . 0.0 110.698 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.3 Cg_exo -72.7 119.13 5.91 Favored 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.327 1.351 . . . . 0.0 109.69 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 893' ' ' HIS . 62.0 mmm -120.41 156.38 31.52 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.26 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 18.9 tt -126.13 132.71 70.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 123.761 0.663 . . . . 0.0 109.534 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.34 129.43 9.9 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 910' ' ' PHE . 43.6 t -65.02 142.42 58.43 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 122.938 0.495 . . . . 0.0 110.15 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.58 -3.74 58.96 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.484 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 15.9 t70 -96.03 -52.9 3.85 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.144 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . . . . . . . . . 19.8 p -88.65 -89.19 0.14 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.748 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 28.1 t70 161.61 -2.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.562 1.545 . . . . 0.0 109.145 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -73.63 143.23 46.41 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 121.68 -0.638 . . . . 0.0 111.176 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -103.58 123.91 47.82 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.109 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.19 154.09 29.63 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 42.8 m80 -72.56 150.59 43.01 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.503 ' CD2' ' HB2' ' A' ' 881' ' ' PRO . 28.6 m0 -58.64 -54.61 54.43 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.8 -19.5 68.7 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.11 1.874 . . . . 0.0 113.679 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 66.6 m -79.23 -33.85 43.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.82 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 899' ' ' ILE . 18.5 m -103.37 -13.21 8.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 99.48 20.85 16.16 Favored Glycine 0 C--O 1.242 0.654 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.125 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 897' ' ' VAL . 31.4 mm -90.92 115.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 68.5 mtm -97.79 -32.65 11.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.763 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.12 155.05 48.17 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -62.27 127.92 90.38 Favored Pre-proline 0 C--N 1.313 -1.017 0 O-C-N 124.068 0.855 . . . . 0.0 109.97 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 49.8 Cg_exo -60.61 168.59 6.58 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.201 2.6 . . . . 0.0 112.708 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -49.84 158.77 1.89 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.033 3.155 . . . . 0.0 115.127 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.97 -1.22 16.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.15 0.976 . . . . 0.0 110.078 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.01 2.27 35.75 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.77 1.228 . . . . 0.0 108.69 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 908' ' ' GLN . 91.0 mmm 53.52 -140.29 0.95 Allowed 'General case' 0 N--CA 1.385 -3.722 0 C-N-CA 127.749 2.42 . . . . 0.0 114.641 175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 907' ' ' MET . 18.2 mm-40 77.32 -136.74 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.32 2.248 . . . . 0.0 112.617 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.473 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 78.7 t90 77.07 131.63 0.05 Allowed 'General case' 0 C--N 1.278 -2.54 0 C-N-CA 125.408 1.483 . . . . 0.0 109.173 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 887' ' ' ASP . 96.2 m-85 -128.54 134.84 48.75 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.465 -173.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.4 p -64.51 158.53 66.43 Favored Pre-proline 0 N--CA 1.439 -0.995 0 O-C-N 123.678 0.611 . . . . 0.0 110.74 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 916' ' ' ASN . 2.3 Cg_endo -41.25 -37.91 3.21 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 124.332 3.355 . . . . 0.0 114.146 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -72.62 -51.97 17.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.555 0.693 . . . . 0.0 110.266 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.675 ' O ' HG13 ' A' ' 918' ' ' ILE . 94.3 m -68.66 -38.26 80.27 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.16 -176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -72.58 -26.02 61.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.248 0.547 . . . . 0.0 111.07 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 912' ' ' PRO . 66.1 t30 -76.33 -37.14 57.79 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.487 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 46.0 pttt -75.04 -13.52 60.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.01 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 914' ' ' CYS . 57.5 mt -72.93 -46.24 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.806 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -155.01 -57.19 0.1 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.684 -1.206 . . . . 0.0 114.03 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 70.55 99.47 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -169.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.54 -59.72 0.44 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.208 -0.997 . . . . 0.0 112.981 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -85.51 -71.26 0.54 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.63 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 64.42 81.59 0.2 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -171.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 909' ' ' TRP . . . . . . . . 0 CA--C 1.481 -1.702 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -80.07 135.28 36.31 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -124.09 117.1 23.91 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.305 0.574 . . . . 0.0 112.157 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.485 ' O ' ' HA ' ' A' ' 881' ' ' PRO . . . . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' HG3' ' A' ' 881' ' ' PRO . 64.3 tt0 -163.9 103.84 0.9 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.47 38.9 1.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.952 0.882 . . . . 0.0 108.771 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.21 -36.76 34.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.808 -1.087 . . . . 0.0 113.585 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 71.35 -62.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.344 1.058 . . . . 0.0 110.125 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -82.17 -48.15 11.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 17.7 m 69.64 -177.99 0.22 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.008 0.923 . . . . 0.0 109.521 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 8.5 p -73.52 -49.66 25.38 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.275 0.559 . . . . 0.0 110.258 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.46 -14.84 32.74 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.555 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.245 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 20.2 m -91.0 91.07 8.15 Favored 'General case' 0 N--CA 1.433 -1.313 0 O-C-N 122.186 -0.596 . . . . 0.0 110.265 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -158.5 -174.2 4.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -80.92 136.63 36.08 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.014 0.435 . . . . 0.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -92.74 138.5 31.44 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -75.79 -33.43 60.15 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.209 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 23.55 -101.6 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 O-C-N 125.874 1.984 . . . . 0.0 113.653 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -132.39 34.69 3.71 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.133 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.45 HG11 HE21 ' A' ' 866' ' ' GLN . 23.6 t -129.47 113.27 27.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.598 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . 0.427 HG13 ' HB ' ' A' ' 867' ' ' ILE . 43.0 pt -108.72 157.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -97.35 142.87 28.7 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.0 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 865' ' ' ASN . 10.5 t70 -85.51 171.27 11.89 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.626 173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -64.92 -29.8 70.76 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 122.966 0.506 . . . . 0.0 111.37 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 5.9 m0 -89.33 -1.47 58.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.209 0.528 . . . . 0.0 110.625 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 95.33 10.93 56.64 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.62 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 863' ' ' TRP . 50.3 m-80 -71.5 141.89 50.16 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.45 HE21 HG11 ' A' ' 858' ' ' VAL . 52.8 mt-30 -84.54 115.23 22.49 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.111 0.481 . . . . 0.0 109.928 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . 0.427 ' HB ' HG13 ' A' ' 859' ' ' ILE . 48.0 mm -107.15 122.89 61.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.42 ' CE3' HM31 ' P' ' 4' ' ' M3L . 7.6 m-90 -89.45 141.59 28.43 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.714 0.768 . . . . 0.0 111.822 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 44.4 mm -99.66 131.17 47.54 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . . . . . . . . . 41.0 t -73.24 118.9 72.6 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.95 -3.06 11.38 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.237 1.958 . . . . 0.0 111.769 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -79.2 -48.8 6.65 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . . . . . . . . . 19.9 p -112.39 -21.44 11.37 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.748 0.309 . . . . 0.0 111.78 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 80.66 19.2 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.65 1.58 . . . . 0.0 111.377 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -100.94 144.77 29.19 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.525 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 62.7 Cg_endo -73.14 176.12 9.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.131 2.554 . . . . 0.0 111.917 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.648 ' HA ' ' HE2' ' A' ' 893' ' ' HIS . 12.1 t0 -72.69 115.86 12.47 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.096 0.474 . . . . 0.0 110.551 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -82.68 -14.06 55.3 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.058 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . . . . . . . . . . . 114.28 50.16 0.51 Allowed Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 106.588 -2.605 . . . . 0.0 106.588 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 41.9 m -129.64 168.41 16.57 Favored Pre-proline 0 N--CA 1.413 -2.314 0 CA-C-N 114.438 -0.881 . . . . 0.0 109.151 -174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.51 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 6.5 Cg_exo -75.64 132.21 14.36 Favored 'Trans proline' 0 N--CA 1.437 -1.852 0 C-N-CA 121.551 1.501 . . . . 0.0 110.889 175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . 0.618 ' SD ' ' HB2' ' A' ' 877' ' ' ASP . 59.2 mtp -126.76 155.08 43.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . . . . . . . . . 20.5 tt -124.34 139.19 51.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -99.83 133.42 11.3 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.04 143.54 50.7 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 908' ' ' GLN . 29.3 m-20 -84.18 -11.06 57.19 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 910' ' ' PHE . 9.5 t70 -99.14 -53.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.694 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 914' ' ' CYS . 28.9 p -86.93 -27.7 23.19 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.409 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 21.8 t70 73.14 19.64 3.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.854 1.261 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -93.1 164.05 13.41 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -112.39 123.95 51.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -115.06 159.67 20.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 45.5 m80 -83.72 156.69 22.46 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.516 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 41.0 m0 -60.58 -55.84 41.05 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.74 -18.1 62.69 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.943 1.762 . . . . 0.0 113.295 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 56.6 m -79.65 -34.88 40.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.322 0.582 . . . . 0.0 110.925 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 899' ' ' ILE . 29.6 m -106.39 -5.43 10.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 89.73 23.93 31.86 Favored Glycine 0 C--N 1.309 -0.946 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.923 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 897' ' ' VAL . 25.4 mm -91.22 131.56 38.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 64.6 mtm -115.67 -25.89 7.66 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.079 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -137.65 150.38 47.34 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 903' ' ' PRO . . . -78.82 120.48 81.06 Favored Pre-proline 0 C--N 1.308 -1.214 0 O-C-N 123.607 0.567 . . . . 0.0 111.624 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 902' ' ' ALA . 7.0 Cg_endo -86.48 163.47 9.55 Favored 'Trans proline' 0 N--CA 1.433 -2.076 0 C-N-CA 121.683 1.588 . . . . 0.0 109.144 172.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 907' ' ' MET . 17.8 Cg_endo -64.86 149.69 89.2 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -35.31 77.65 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -175.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.31 -22.36 59.3 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . 0.411 ' HB2' ' HG2' ' A' ' 904' ' ' PRO . 25.5 ttt -72.63 138.71 46.92 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . 0.453 ' HA ' ' OD2' ' A' ' 886' ' ' ASP . 23.9 mm-40 -87.16 138.58 31.37 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.769 0.795 . . . . 0.0 111.308 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' P' ' 1' ' ' ALA . 81.5 t90 -146.85 139.22 24.83 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 915' ' ' ALA . 58.0 m-85 -129.6 139.33 51.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 31.6 p -65.2 162.92 35.55 Favored Pre-proline 0 C--N 1.311 -1.085 0 O-C-N 123.573 0.546 . . . . 0.0 111.322 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 13.0 Cg_endo -55.85 -13.01 7.82 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.329 2.686 . . . . 0.0 113.928 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.43 -49.9 5.9 Favored 'General case' 0 C--O 1.244 0.763 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . 0.696 ' O ' ' HG2' ' A' ' 917' ' ' LYS . 91.0 m -71.09 -42.69 69.0 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 910' ' ' PHE . . . -66.55 -15.02 63.1 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.489 0.662 . . . . 0.0 111.22 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -84.86 -42.64 14.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' A' ' 914' ' ' CYS . 51.2 pttt -72.12 -28.9 63.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 914' ' ' CYS . 55.7 mt -76.35 -14.07 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 122.122 0.963 . . . . 0.0 109.571 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -88.62 -0.25 57.08 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 121.944 0.878 . . . . 0.0 108.98 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -91.21 117.75 29.89 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 64.6 -156.29 0.3 Allowed 'General case' 0 C--O 1.246 0.907 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 55.36 43.76 28.37 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -65.36 144.31 57.18 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.25 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--N 1.289 -2.049 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 175.684 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 2' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 883' ' ' ILE . 2.4 mmp_? -64.8 130.54 43.87 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.386 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.19 123.03 20.05 Favored 'General case' 0 C--N 1.272 -2.804 0 O-C-N 124.041 0.838 . . . . 0.0 110.732 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 4' ' ' M3L . . . . . 0.44 HM12 ' OD2' ' A' ' 877' ' ' ASP . . . . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 5' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -111.4 112.81 24.82 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 6' ' ' THR . . . . . 0.649 ' HB ' ' HA2' ' A' ' 879' ' ' GLY . 24.4 m -69.18 -11.16 60.56 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.95 98.53 0.06 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.542 1.137 . . . . 0.0 112.453 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 8' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -76.85 -14.68 59.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.186 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 9' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -104.91 148.96 26.12 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -118.2 88.69 2.97 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 11' ' ' THR . . . . . . . . . . . . . 11.0 t -161.46 18.72 0.11 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.632 0.73 . . . . 0.0 109.09 -176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.11 68.77 2.45 Favored Glycine 0 CA--C 1.503 -0.704 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.275 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.461 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 178.171 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 850' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 851' ' ' SER . . . . . . . . . . . . . 7.9 p -83.51 -26.73 29.93 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 852' ' ' HIS . . . . . . . . . . . . . 32.8 m80 66.08 171.75 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.493 1.139 . . . . 0.0 112.509 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 853' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -145.42 113.96 6.74 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . 71.39 157.49 0.18 Allowed 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.291 0.994 . . . . 0.0 109.325 -168.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 855' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 66.98 11.69 8.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.596 0.758 . . . . 0.0 112.229 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -112.08 -171.05 1.77 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.407 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 857' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -101.23 13.3 35.56 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.962 0.887 . . . . 0.0 110.474 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 858' ' ' VAL . . . . . 0.513 HG11 HE21 ' A' ' 866' ' ' GLN . 58.4 t -118.1 114.28 44.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.54 176.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 859' ' ' ILE . . . . . . . . . . . . . 36.4 pt -119.57 170.44 9.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 865' ' ' ASN . 27.2 ptt180 -108.93 145.1 35.97 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.153 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 861' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -86.46 -164.23 1.02 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.61 -31.19 69.17 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.471 0.177 . . . . 0.0 111.353 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 863' ' ' TRP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 865' ' ' ASN . 25.0 m95 -78.32 -40.17 37.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . 115.27 31.59 1.99 Allowed Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.046 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 865' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 860' ' ' ARG . 31.5 m-80 -89.89 166.2 13.65 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 866' ' ' GLN . . . . . 0.513 HE21 HG11 ' A' ' 858' ' ' VAL . 55.0 mt-30 -83.74 120.22 25.76 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 867' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.43 118.65 57.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 868' ' ' TRP . . . . . 0.409 ' CZ3' HM31 ' P' ' 4' ' ' M3L . 24.3 m-90 -91.45 139.6 30.56 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.231 0.539 . . . . 0.0 111.858 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 869' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 876' ' ' PRO . 1.9 mp -104.23 127.86 58.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.909 174.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 870' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 873' ' ' CYS . 42.6 t -72.11 117.52 59.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 871' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.4 -0.6 5.24 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.526 2.15 . . . . 0.0 112.676 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 872' ' ' GLY . . . . . . . . . . . . . . . -81.56 -38.75 13.52 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.94 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 873' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 870' ' ' CYS . 5.9 p -118.51 -21.67 7.89 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.923 0.392 . . . . 0.0 111.897 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 10.9 t30 77.82 22.32 0.87 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.58 1.552 . . . . 0.0 109.424 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -102.31 137.7 19.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.551 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 876' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 869' ' ' ILE . 27.9 Cg_endo -70.41 171.46 15.14 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.684 2.256 . . . . 0.0 112.879 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 877' ' ' ASP . . . . . 0.44 ' OD2' HM12 ' P' ' 4' ' ' M3L . 55.9 t0 -71.55 127.63 33.21 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.664 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 878' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -110.56 3.31 19.34 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.866 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 879' ' ' GLY . . . . . 0.649 ' HA2' ' HB ' ' P' ' 6' ' ' THR . . . 113.75 30.24 2.64 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 880' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.65 158.32 48.3 Favored Pre-proline 0 C--N 1.278 -2.52 0 CA-C-N 114.445 -0.877 . . . . 0.0 110.801 -169.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 894' ' ' TRP . 4.7 Cg_exo -77.11 119.13 4.93 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 106.802 -2.038 . . . . 0.0 106.802 166.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 882' ' ' MET . . . . . . . . . . . . . 66.1 mtp -121.41 155.33 35.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.311 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 883' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' P' ' 2' ' ' ARG . 20.6 tt -126.45 137.42 57.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.223 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . -95.6 125.03 8.23 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.283 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 885' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 888' ' ' CYS . 52.3 t -75.52 142.75 42.77 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 886' ' ' ASP . . . . . 0.66 ' HB3' ' CE1' ' A' ' 910' ' ' PHE . 22.0 t70 -77.68 -30.35 51.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.086 0.469 . . . . 0.0 110.232 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 887' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -85.38 -55.7 3.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.718 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 888' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 885' ' ' CYS . 97.1 m -60.16 -47.43 85.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.19 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 889' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.1 18.88 3.77 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.144 1.45 . . . . 0.0 108.33 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 890' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -106.17 165.14 11.45 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.356 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 891' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -105.0 125.75 51.32 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 123.434 0.459 . . . . 0.0 110.814 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 892' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.54 154.26 25.05 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.895 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 893' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 896' ' ' CYS . 37.0 m80 -82.54 152.15 26.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 894' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 899' ' ' ILE . 44.6 m0 -59.39 -56.46 35.73 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 895' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.63 -18.59 64.94 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 121.951 1.767 . . . . 0.0 112.99 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 896' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 893' ' ' HIS . 60.1 m -78.94 -40.66 31.32 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.321 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 899' ' ' ILE . 27.7 m -98.4 -10.19 8.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' GLY . . . . . . . . . . . . . . . 101.86 18.16 18.77 Favored Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.814 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 897' ' ' VAL . 28.9 mm -93.27 134.69 30.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' MET . . . . . . . . . . . . . 23.3 ptp -121.62 -21.16 6.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.2 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' ALA . . . . . . . . . . . . . . . -139.54 153.69 47.5 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' ALA . . . . . . . . . . . . . . . -79.44 125.66 82.53 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 123.219 0.324 . . . . 0.0 111.373 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.34 166.42 20.28 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 122.144 1.896 . . . . 0.0 110.177 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -66.98 144.4 69.94 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.661 1.574 . . . . 0.0 110.776 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -74.69 -7.84 54.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.164 0.507 . . . . 0.0 111.198 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -80.68 -7.16 59.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.818 0.818 . . . . 0.0 109.454 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' MET . . . . . . . . . . . . . 14.5 tpt -106.34 139.71 40.41 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.684 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -87.87 165.9 14.94 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -156.2 143.81 19.38 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.091 0.472 . . . . 0.0 109.914 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 886' ' ' ASP . 70.8 m-85 -137.09 140.33 41.9 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' CYS . . . . . 0.45 ' HB2' ' HD2' ' A' ' 912' ' ' PRO . 28.2 p -61.75 164.43 9.91 Favored Pre-proline 0 CA--C 1.56 1.328 0 O-C-N 123.249 0.343 . . . . 0.0 111.152 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 911' ' ' CYS . 3.7 Cg_endo -46.9 -25.56 3.99 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 124.033 3.155 . . . . 0.0 114.691 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.25 -54.56 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 110.365 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' CYS . . . . . . . . . . . . . 95.3 m -66.82 -30.22 70.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' ALA . . . . . . . . . . . . . . . -80.96 -19.8 43.33 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.21 0.528 . . . . 0.0 110.636 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.26 -44.27 14.03 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.948 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 920' ' ' LYS . 23.0 pttp -55.32 -25.8 36.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.304 0.641 . . . . 0.0 112.721 -176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' ILE . . . . . . . . . . . . . 48.1 mt -60.65 -41.79 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.928 0.871 . . . . 0.0 108.953 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -97.05 -35.79 10.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.065 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 917' ' ' LYS . 29.6 mtmm 69.76 -47.8 0.61 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.891 1.677 . . . . 0.0 114.076 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -111.91 126.78 55.48 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.885 0.374 . . . . 0.0 110.33 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -115.77 99.41 7.29 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.743 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 924' ' ' HIS 0.319 10.5 ptpp? 46.05 -106.72 0.13 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.061 1.344 . . . . 0.0 114.056 -178.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' HIS . . . . . 0.56 ' H ' ' HG3' ' A' ' 923' ' ' LYS . 22.6 t60 . . . . . 0 C--N 1.288 -2.107 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_